Goldman Sachs BDC, Inc. - Quarter Report: 2021 September (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 814-00998

Goldman Sachs BDC, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	46-2176593
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

200 West Street, New York, New York	10282
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s Telephone Number, Including Area Code: (212) 902-0300

Not Applicable

Former Name, Former Address and Former Fiscal Year, If Changed Since Last Report.

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, par value

$0.001 per share

GSBD

The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☐ NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer:	X	Accelerated filer:	☐	Non-accelerated filer:	☐	Smaller reporting company:	☐
Emerging growth company:	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES ☐ NO X

As of November 4, 2021, there were 101,818,811 shares of the registrant’s common stock outstanding.

Table of Contents

GOLDMAN SACHS BDC, INC.

QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2021



	INDEX	PAGE
	Cautionary Statement Regarding Forward-Looking Statements	3
PART I	FINANCIAL INFORMATION	4
ITEM 1.	Financial Statements (Unaudited)	4
	Consolidated Statements of Assets and Liabilities	4
	Consolidated Statements of Operations	5
	Consolidated Statements of Changes in Net Assets	6
	Consolidated Statements of Cash Flows	7
	Consolidated Schedules of Investments	8
	Notes to the Consolidated Financial Statements	23
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	45
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	59
ITEM 4.	Controls and Procedures	60

PART II	OTHER INFORMATION	60
ITEM 1.	Legal Proceedings	60
ITEM 1A.	Risk Factors	60
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	63
ITEM 3.	Defaults Upon Senior Securities	63
ITEM 4.	Mine Safety Disclosures	63
ITEM 5.	Other Information	63
ITEM 6.	Exhibits	63

SIGNATURES		64

Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that involve substantial risks and uncertainties. You can identify these statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “project,” “target,” “estimate,” “intend,” “continue” or “believe” or the negatives of, or other variations on, these terms or comparable terminology. You should read statements that contain these words carefully because they discuss our plans, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. We believe that it is important to communicate our future expectations to our investors. Our forward-looking statements include information in this report regarding general domestic and global economic conditions, our future financing plans, our ability to operate as a business development company (“BDC”) and the expected performance of, and the yield on, our portfolio companies. There may be events in the future, however, that we are not able to predict accurately or control. The factors listed under “Risk Factors” in this report and in our annual report on Form 10-K for the year ended December 31, 2020 and our quarterly reports on Form 10-Q for the quarters ended March 31, 2021 and June 30, 2021, as well as any cautionary language in this report, provide examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. The occurrence of the events described in these risk factors and elsewhere in this report could have a material adverse effect on our business, results of operations and financial position. Any forward-looking statement made by us in this report speaks only as of the date of this report. Factors or events that could cause our actual results to differ from our forward-looking statements may emerge from time to time, and it is not possible for us to predict all of them. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the U.S. Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, registration statements on Form N-2, quarterly reports on Form 10-Q and current reports on Form 8-K. Under Section 21E(b)(2)(B) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 do not apply to statements made in periodic reports we file under the Exchange Act, such as this quarterly report on Form 10-Q.

The following factors are among those that may cause actual results to differ materially from our forward-looking statements:

•

our future operating results;

•

the impact of the novel coronavirus (“COVID-19”) pandemic on our business and our portfolio companies, including our and their ability to access capital and liquidity;

•

changes in political, economic or industry conditions, the interest rate environment or conditions affecting the financial and capital markets, including the effect of the current COVID-19 pandemic;

•

uncertainty surrounding the financial and political stability of the United States, the United Kingdom, the European Union and China, including the effect of the current COVID-19 pandemic;

•

our business prospects and the prospects of our portfolio companies;

•

the impact of investments that we expect to make;

•

the impact of increased competition;

•

our contractual arrangements and relationships with third parties;

•

the dependence of our future success on the general economy and its impact on the industries in which we invest;

•

the ability of our current and prospective portfolio companies to achieve their objectives;

•

the relative and absolute performance of Goldman Sachs Asset Management, L.P., the investment adviser (the “Investment Adviser”) of the Company;

•

the use of borrowed money to finance a portion of our investments;

•

our ability to make distributions;

•

the adequacy of our cash resources and working capital;

•

changes in interest rates, including the decommissioning of London InterBank Offered Rate (“LIBOR”);

•

the timing of cash flows, if any, from the operations of our portfolio companies;

•

the impact of future acquisitions and divestitures;

•

the effect of changes in tax laws and regulations and interpretations thereof;

•

our ability to maintain our status as a BDC and a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”);

•

actual and potential conflicts of interest with the Investment Adviser and its affiliates;

•

general price and volume fluctuations in the stock market;

•

the ability of the Investment Adviser to attract and retain highly talented professionals;

•

the impact on our business from new or amended legislation or regulations;

•

the availability of credit and/or our ability to access the equity and capital markets;

•

currency fluctuations, particularly to the extent that we receive payments denominated in currency other than U.S. dollars; and

•

the ability to realize the anticipated benefits of the Merger (as defined below).

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

Goldman Sachs BDC, Inc.

Consolidated Statements of Assets and Liabilities

(in thousands, except share and per share amounts)

	September 30, 2021 (Unaudited)			December 31, 2020
Assets
Investments, at fair value
Non-controlled/non-affiliated investments (cost of $3,032,037 and $3,089,481)	$	3,057,767		$	3,135,745
Non-controlled affiliated investments (cost of $58,629 and $64,699)		33,862			87,211
Controlled affiliated investments (cost of $32,651 and $28,400)		20,495			19,810
Total investments, at fair value (cost of $3,123,317 and $3,182,580)	$	3,112,124		$	3,242,766
Cash		171,600			32,137
Receivable for investments sold		455			2,600
Unrealized appreciation on foreign currency forward contracts		41			—
Interest and dividends receivable		21,583			21,593
Deferred financing costs		13,331			11,350
Other assets		3,826			1,916
Total assets	$	3,322,960		$	3,312,362
Liabilities
Debt (net of debt issuance costs of $13,564 and $17,323)	$	1,626,298		$	1,627,060
Interest and other debt expenses payable		9,820			10,163
Management fees payable		7,962			5,945
Incentive fees payable		7,885			2,665
Distribution payable		45,789			45,690
Payable for investments purchased		388			—
Unrealized depreciation on foreign currency forward contracts		—			355
Directors’ fees payable		231			—
Accrued expenses and other liabilities		4,498			5,343
Total liabilities	$	1,702,871		$	1,697,221
Commitments and contingencies (Note 8)
Net assets
Preferred stock, par value $0.001 per share (1,000,000 shares authorized, no shares issued and outstanding)	$	—		$	—
Common stock, par value $0.001 per share (200,000,000 shares authorized, 101,753,598 and 101,534,370 shares issued and outstanding as of September 30, 2021 and December 31, 2020)		102			102
Paid-in capital in excess of par		1,625,801			1,621,813
Distributable earnings		(4,393	)		(5,353	)
Allocated income tax expense		(1,421	)		(1,421	)
Total net assets	$	1,620,089		$	1,615,141
Total liabilities and net assets	$	3,322,960		$	3,312,362
Net asset value per share	$	15.92		$	15.91

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

(Unaudited)

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Investment income:
From non-controlled/non-affiliated investments:
Interest income	$	90,043		$	27,907		$	246,570		$	85,528
Payment-in-kind		4,768			1,057			11,179			2,609
Other income		1,101			1,152			2,717			1,644
From non-controlled affiliated investments:
Dividend income		90			32			916			75
Interest income		119			656			282			1,744
Payment-in-kind		175			265			478			840
Other income		—			5			—			51
From controlled affiliated investments:
Payment-in-kind		365			331			1,008			1,327
Interest income		23			48			69			209
Total investment income	$	96,684		$	31,453		$	263,219		$	94,027
Expenses:
Interest and other debt expenses	$	14,449		$	8,889		$	43,953		$	26,897
Incentive fees		9,326			737			32,551			737
Management fees		7,962			3,618			24,241			10,901
Professional fees		724			554			2,257			1,891
Directors’ fees		234			139			698			417
Other general and administrative expenses		793			677			2,691			1,980
Total expenses	$	33,488		$	14,614		$	106,391		$	42,823
Fee waivers		(1,441	)		(1,734	)		(24,192	)		(4,544	)
Net expenses	$	32,047		$	12,880		$	82,199		$	38,279
Net investment income before taxes	$	64,637		$	18,573		$	181,020		$	55,748
Income tax expense, including excise tax	$	305		$	375		$	929		$	1,191
Net investment income after taxes	$	64,332		$	18,198		$	180,091		$	54,557
Net realized and unrealized gains (losses) on investment transactions:
Net realized gain (loss) from:
Non-controlled/non-affiliated investments	$	(1,606	)	$	1		$	4,628		$	(6,615	)
Non-controlled affiliated investments		35,916			—			35,916			(211	)
Controlled affiliated investments		—			(35,984	)		—			(40,688	)
Foreign currency forward contracts		(49	)		29			(220	)		109
Foreign currency and other transactions		69			34			113			16
Net change in unrealized appreciation (depreciation) from:
Non-controlled/non-affiliated investments		(21,412	)		19,884			(20,534	)		(21,362	)
Non-controlled affiliated investments		(39,257	)		1,149			(47,279	)		13,111
Controlled affiliated investments		(1,391	)		30,907			(3,566	)		6,294
Foreign currency forward contracts		122			(132	)		396			(131	)
Foreign currency translations and other transactions		1,392			(1,639	)		4,234			(1,694	)
Net realized and unrealized gains (losses)	$	(26,216	)	$	14,249		$	(26,312	)	$	(51,171	)
(Provision) benefit for taxes on realized gain/loss on investments		—			—			(53	)		—
(Provision) benefit for taxes on unrealized appreciation/depreciation on investments		(83	)		(7	)		(253	)		92
Net increase in net assets from operations	$	38,033		$	32,440		$	153,473		$	3,478
Weighted average shares outstanding		101,727,464			40,440,982			101,654,241			40,413,082
Net investment income per share (basic and diluted)	$	0.63		$	0.45		$	1.77		$	1.35
Earnings per share (basic and diluted)	$	0.37		$	0.80		$	1.51		$	0.09

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Statements of Changes in Net Assets

(in thousands, except share and per share amounts)

(Unaudited)

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Net assets at beginning of period	$	1,631,525		$	611,496		$	1,615,141		$	676,125
Increase (decrease) in net assets from operations:
Net investment income	$	64,332		$	18,198		$	180,091		$	54,557
Net realized gain (loss)		34,330			(35,920	)		40,437			(47,389	)
Net change in unrealized appreciation (depreciation)		(60,546	)		50,169			(66,749	)		(3,782	)
(Provision) benefit for taxes on realized gain/loss on investments		—			—			(53	)		—
(Provision) benefit for taxes on unrealized appreciation/depreciation on investments		(83	)		(7	)		(253	)		92
Net increase in net assets from operations	$	38,033		$	32,440		$	153,473		$	3,478
Distributions to stockholders from:
Distributable earnings	$	(50,876	)	$	(18,202	)	$	(152,513	)	$	(54,564	)
Total distributions to stockholders	$	(50,876	)	$	(18,202	)	$	(152,513	)	$	(54,564	)
Capital transactions:
Reinvestment of stockholder distributions	$	1,407		$	689		$	3,988		$	1,384
Net increase in net assets from capital transactions	$	1,407		$	689		$	3,988		$	1,384
Total increase (decrease) in net assets	$	(11,436	)	$	14,927		$	4,948		$	(49,702	)
Net assets at end of period	$	1,620,089		$	626,423		$	1,620,089		$	626,423
Distributions declared per share	$	0.50		$	0.45		$	1.50		$	1.35

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Statements of Cash Flows

(in thousands, except share and per share amounts)

(Unaudited)

	For the Nine Months Ended
	September 30, 2021			September 30, 2020
Cash flows from operating activities:
Net increase in net assets from operations:	$	153,473		$	3,478
Adjustments to reconcile net increase (decrease) in net assets from operations to net cash provided by (used for) operating activities:
Purchases of investments		(1,039,961	)		(125,418	)
Payment-in-kind interest capitalized		(12,868	)		(4,326	)
Investments in affiliated money market fund, net		—			(97,232	)
Proceeds from sales of investments and principal repayments		1,223,537			107,459
Net realized (gain) loss		(41,246	)		47,517
Net change in unrealized (appreciation) depreciation on investments		71,379			1,957
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts and transactions		(185	)		112
Amortization of premium and accretion of discount, net		(70,199	)		(4,133	)
Amortization of deferred financing and debt issuance costs		5,488			3,157
Amortization of original issue discount on convertible notes		350			332
Change in operating assets and liabilities:
(Increase) decrease in receivable for investments sold		2,145			(321	)
(Increase) decrease in interest and dividends receivable		10			(3,901	)
(Increase) decrease in other assets		(1,910	)		(3,851	)
Increase (decrease) in interest and other debt expenses payable		142			3,660
Increase (decrease) in management fees payable		2,017			(1,032	)
Increase (decrease) in incentive fees payable		5,220			(1,850	)
Increase (decrease) in investments purchased payable		388			—
Increase (decrease) in directors’ fees payable		231			136
Increase (decrease) in accrued expenses and other liabilities		(845	)		676
Net cash provided by (used for) operating activities	$	297,166		$	(73,580	)
Cash flows from financing activities:
Offering costs paid	$	—		$	(127	)
Distributions paid		(148,426	)		(53,143	)
Deferred financing and debt issuance costs paid		(4,545	)		(11,737	)
Borrowings on debt		622,672			555,413
Repayments of debt		(627,193	)		(408,676	)
Net cash provided by (used for) financing activities	$	(157,492	)	$	81,730
Net increase (decrease) in cash		139,674			8,150
Effect of foreign exchange rate changes on cash and cash equivalents		(211	)		19
Cash, beginning of period		32,137			9,409
Cash, end of period	$	171,600		$	17,578
Supplemental and non-cash activities
Interest expense paid	$	35,132		$	18,990
Accrued but unpaid excise tax expense	$	1,026		$	1,399
Accrued but unpaid distributions	$	45,789		$	18,202
Reinvestment of stockholder distributions	$	3,988		$	1,384
Exchange of investments	$	9,469		$	63,499

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of September 30, 2021

(in thousands, except share and per share amounts)

(Unaudited)

Investment *#	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
1st Lien/Senior Secured Debt - 161.90%
1272775 B.C. LTD. (dba Everest Clinical Research)	Professional Services	6.50%	L + 5.50%	1.00%	11/06/26	$	9,359	$	9,237		$	9,219		^{(1) (2) (3)}
1272775 B.C. LTD. (dba Everest Clinical Research)	Professional Services	6.95%	CDN P + 4.50%		11/06/26		CAD 139		109			103		^{(1) (2) (3)}
1272775 B.C. LTD. (dba Everest Clinical Research)	Professional Services		L + 5.50%	1.00%	11/06/26		1,151		(15	)		(17	)	^{(1) (2) (3) (4)}
3SI Security Systems, Inc.	Commercial Services & Supplies	6.75%	L + 5.75%	1.00%	06/16/23		13,982		13,919			13,912		⁽³⁾
3SI Security Systems, Inc.	Commercial Services & Supplies	6.75%	L + 5.75%	1.00%	06/16/23		2,129		2,032			2,118		⁽³⁾
A Place For Mom, Inc.	Diversified Consumer Services	4.75%	L + 3.75%	1.00%	08/10/24		8,684		8,679			7,989
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings)	Software	7.25%	L + 6.25%	1.00%	03/10/27		16,429		16,049			16,059		^{(2) (3)}
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings)	Software	7.25%	L + 6.25%	1.00%	03/10/27		1,220		155			156		^{(2) (3) (4)}
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings)	Software		L + 6.25%	1.00%	03/10/27		3,046		(35	)		(69	)	^{(2) (3) (4)}
Acquia, Inc.	Software	8.00%	L + 7.00%	1.00%	10/31/25		42,164		40,476			41,532		^{(2) (3)}
Acquia, Inc.	Software	8.00%	L + 7.00%	1.00%	10/31/25		3,268		188			212		^{(2) (3) (4)}
Ansira Partners, Inc.	Professional Services	7.50%	L + 6.50% PIK	1.00%	12/20/24		5,019		5,001			4,141
Ansira Partners, Inc.	Professional Services	7.50%	L + 6.50% PIK	1.00%	12/20/24		309		308			255
Apptio, Inc.	IT Services	8.25%	L + 7.25%	1.00%	01/10/25		79,154		76,356			79,154		^{(2) (3)}
Apptio, Inc.	IT Services		L + 7.25%	1.00%	01/10/25		5,385		2,092			2,154		^{(2) (3) (4)}
AQ Helios Buyer, Inc. (aka SurePoint)	Software	8.00%	L + 7.00%	1.00%	07/01/26		32,010		31,396			31,370		⁽²⁾
AQ Helios Buyer, Inc. (aka SurePoint)	Software	8.00%	L + 7.00%	1.00%	07/01/26		4,570		461			457		^{(2) (4)}
AQ Helios Buyer, Inc. (aka SurePoint)	Software		L + 7.00%	1.00%	07/01/26		11,560		—			—		^{(2) (4)}
Aria Systems, Inc.	Diversified Financial Services	8.00%	L + 7.00%	1.00%	06/30/26		16,559		16,320			16,352		^{(2) (3)}
Aria Systems, Inc.	Diversified Financial Services		L + 7.00%	1.00%	06/30/26		4,160		—			(52	)	^{(2) (3) (4)}
Assembly Intermediate LLC	Diversified Consumer Services		L + 7.00%	1.00%	10/19/27		43,991		—			—		^{(2) (4)}
Assembly Intermediate LLC	Diversified Consumer Services		L + 7.00%	1.00%	10/19/27		10,998		—			—		^{(2) (4)}
Assembly Intermediate LLC	Diversified Consumer Services		L + 7.00%	1.00%	10/19/27		4,399		—			—		^{(2) (4)}
ATX Networks Corp.	Communications Equipment	8.50%	L + 7.50%	1.00%	09/01/26		4,370		4,370			4,370		^{^ (1) (3)}
Badger Sportswear, Inc.	Textiles, Apparel & Luxury Goods	5.75%	L + 4.50%	1.25%	09/11/23		7,119		7,086			6,905
Brillio, LLC	IT Services	5.75%	L + 4.75%	1.00%	02/06/25		10,870		10,476			10,870		^{(2) (3)}
Brillio, LLC	IT Services	5.75%	L + 4.75%	1.00%	02/06/25		1,823		1,803			1,823		^{(2) (3)}
Broadway Technology, LLC	Diversified Financial Services	7.50%	L + 6.50%	1.00%	01/08/26		25,970		25,514			25,450		^{(2) (3)}
Bullhorn, Inc.	Professional Services	6.75%	L + 5.75%	1.00%	09/30/26		26,630		25,583			26,363		^{(2) (3)}
Bullhorn, Inc.	Professional Services	6.75%	L + 5.75%	1.00%	09/30/26		1,232		1,215			1,220		^{(2) (3)}
Bullhorn, Inc.	Professional Services	6.75%	L + 5.75%	1.00%	09/30/26		552		531			547		^{(2) (3)}
Bullhorn, Inc.	Professional Services	6.75%	L + 5.75%	1.00%	09/30/26		440		423			436		^{(2) (3)}
Bullhorn, Inc.	Professional Services		L + 5.75%	1.00%	09/30/26		1,344		(18	)		(13	)	^{(2) (3) (4)}
Businessolver.com, Inc.	Health Care Technology	8.50%	L + 7.50%	1.00%	05/15/23		42,518		40,977			42,518		^{(2) (3)}
Businessolver.com, Inc.	Health Care Technology	8.50%	L + 7.50%	1.00%	05/15/23		11,147		11,026			11,147		^{(2) (3)}
BusinesSolver.com, Inc.	Health Care Technology	8.50%	L + 7.50%	1.00%	05/15/23		6,378		6,146			6,378		^{(2) (3)}
Businessolver.com, Inc.	Health Care Technology		L + 7.50%	1.00%	05/15/23		5,328		(70	)		—		^{(2) (3) (4)}
Capitol Imaging Acquisition Corp.	Health Care Providers & Services	7.50%	L + 6.50%	1.00%	10/01/26		18,062		17,706			17,881		^{(2) (3)}
Capitol Imaging Acquisition Corp.	Health Care Providers & Services	7.50%	L + 6.50%	1.00%	10/01/26		808		777			800		^{(2) (3)}
Capitol Imaging Acquisition Corp.	Health Care Providers & Services		L + 6.50%	1.00%	10/01/25		180		(3	)		(2	)	^{(2) (3) (4)}
CFS Management, LLC (dba Center for Sight Management)	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	07/01/24		19,880		19,313			19,631		^{(2) (3)}
CFS Management, LLC (dba Center for Sight Management)	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	07/01/24		3,450		3,312			3,407		^{(2) (3)}
CFS Management, LLC (dba Center for Sight Management)	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	07/01/24		2,017		580			580		^{(2) (3) (4)}
Chronicle Bidco Inc. (dba Lexitas)	Professional Services	7.00%	L + 6.00%	1.00%	11/14/25		16,997		16,192			16,997		^{(2) (3)}
Chronicle Bidco Inc. (dba Lexitas)	Professional Services	7.00%	L + 6.00%	1.00%	11/14/25		11,286		11,047			11,286		^{(2) (3)}
Chronicle Bidco Inc. (dba Lexitas)	Professional Services	7.00%	L + 6.00%	1.00%	11/14/25		11,100		7,669			7,836		^{(2) (3) (4)}
Chronicle Bidco Inc. (dba Lexitas)	Professional Services	7.00%	L + 6.00%	1.00%	11/14/25		7,160		6,819			7,160		^{(2) (3)}
Chronicle Bidco Inc. (dba Lexitas)	Professional Services		L + 6.00%	1.00%	11/14/25		2,180		(44	)		—		^{(2) (3) (4)}
CivicPlus LLC	Software	7.00%	L + 6.25%	0.75%	08/24/27		6,300		6,176			6,174		⁽²⁾
CivicPlus LLC	Software		L + 6.25%	0.75%	08/24/27		592		(12	)		(12	)	^{(2) (4)}

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of September 30, 2021 (continued)

(in thousands, except share and per share amounts)

(Unaudited)

Investment *#	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
CivicPlus LLC	Software		L + 6.25%	0.75%	08/24/27	$	2,960	$	(29	)	$	(30	)	^{(2) (4)}
Convene 237 Park Avenue, LLC (dba Convene)	Real Estate Mgmt. & Development	11.00%	L + 9.50% (incl. 2.00% PIK)	1.50%	08/30/24		56,846		51,829			44,340		^{(2) (3)}
Convene 237 Park Avenue, LLC (dba Convene)	Real Estate Mgmt. & Development	11.00%	L + 9.50% (incl. 2.00% PIK)	1.50%	08/30/24		16,710		15,231			13,034		^{(2) (3)}
CORA Health Holdings Corp	Health Care Providers & Services	6.75%	L + 5.75%	1.00%	06/15/27		22,720		22,393			22,436		^{(2) (3)}
CORA Health Holdings Corp	Health Care Providers & Services		L + 5.75%	1.00%	06/15/27		8,897		(63	)		(111	)	^{(2) (3) (4)}
Cordeagle US Finco, Inc. (aka Condeco)	Software	7.75%	L + 6.75%	1.00%	07/30/27		15,993		15,681			15,673		^{(1) (2)}
Cordeagle US Finco, Inc. (aka Condeco)	Software		L + 6.75%	1.00%	07/30/27		2,461		(48	)		(49	)	^{(1) (2) (4)}
CorePower Yoga LLC	Diversified Consumer Services	8.00%	L + 7.00% (incl. 5.00% PIK)	1.00%	05/14/25		24,665		22,257			20,534		^{(2) (3)}
CorePower Yoga LLC	Diversified Consumer Services		L + 7.00% (incl. 5.00% PIK)	1.00%	05/14/25		1,687		(132	)		(283	)	^{(2) (3) (4)}
CST Buyer Company (dba Intoxalock)	Diversified Consumer Services	7.00%	L + 6.00%	1.00%	10/03/25		28,301		27,434			28,159		^{(2) (3)}
CST Buyer Company (dba Intoxalock)	Diversified Consumer Services	7.00%	L + 6.00%	1.00%	10/27/25		14,967		14,682			14,892		^{(2) (3)}
CST Buyer Company (dba Intoxalock)	Diversified Consumer Services		L + 6.00%	1.00%	10/03/25		2,170		(12	)		(11	)	^{(2) (3) (4)}
DECA Dental Holdings LLC	Health Care Providers & Services	6.50%	L + 5.75%	0.75%	08/28/28		21,670		21,241			21,236		⁽²⁾
DECA Dental Holdings LLC	Health Care Providers & Services		L + 5.75%	0.75%	08/26/27		1,711		(34	)		(34	)	^{(2) (4)}
DECA Dental Holdings LLC	Health Care Providers & Services		L + 5.75%	0.75%	08/28/28		7,413		(73	)		(74	)	^{(2) (4)}
Diligent Corporation	Professional Services	7.25%	L + 6.25%	1.00%	08/04/25	€	38,158		42,893			44,532		^{(2) (3)}
Diligent Corporation	Professional Services	7.25%	L + 6.25%	1.00%	08/04/25		24,664		23,666			24,849		^{(2) (3)}
Diligent Corporation	Professional Services		L + 6.25%	1.00%	08/04/25		3,100		(56	)		23		^{(2) (3) (4)}
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		7,037		6,582			6,861		^{(2) (3)}
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		1,500		1,461			1,463		^{(2) (3)}
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		1,380		1,312			1,345		^{(2) (3)}
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		562		547			548		^{(2) (3)}
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		930		483			498		^{(2) (3) (4)}
Elemica Parent, Inc.	Chemicals		L + 6.00%	1.00%	09/18/25		380		(5	)		(9	)	^{(2) (3) (4)}
Eptam Plastics, Ltd.	Health Care Equipment & Supplies	6.50%	L + 5.50%	1.00%	12/06/25		10,502		10,056			10,371		^{(2) (3)}
Eptam Plastics, Ltd.	Health Care Equipment & Supplies	6.50%	L + 5.50%	1.00%	12/06/25		4,940		4,860			4,878		^{(2) (3)}
Eptam Plastics, Ltd.	Health Care Equipment & Supplies	6.50%	L + 5.50%	1.00%	12/06/25		4,526		4,424			4,469		^{(2) (3)}
Eptam Plastics, Ltd.	Health Care Equipment & Supplies	6.50%	L + 5.50%	1.00%	12/06/25		2,269		812			879		^{(2) (3) (4)}
ESO Solutions, Inc	Health Care Technology	8.00%	L + 7.00%	1.00%	05/03/27		39,908		39,148			39,209		^{(2) (3)}
ESO Solutions, Inc	Health Care Technology		L + 7.00%	1.00%	05/03/27		3,620		(68	)		(63	)	^{(2) (3) (4)}
Experity, Inc.	Health Care Technology	6.25%	L + 5.50%	0.75%	07/22/27		37,767		37,587			37,582		⁽²⁾
Experity, Inc.	Health Care Technology		L + 5.50%	0.75%	07/22/27		3,332		(16	)		(16	)	^{(2) (4)}
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	6.75%	L + 5.75% (incl. 0.25% PIK)	1.00%	08/21/23		15,766		15,084			15,688		⁽³⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	6.75%	L + 5.75% (incl. 0.25% PIK)	1.00%	08/21/23		4,021		3,794			4,001		⁽³⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	6.75%	L + 5.75% (incl. 0.25% PIK)	1.00%	08/21/23		3,151		3,015			3,135		⁽³⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	6.75%	L + 5.75% (incl. 0.25% PIK)	1.00%	08/21/23		3,024		2,852			3,008		⁽³⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	6.75%	L + 5.75% (incl. 0.25% PIK)	1.00%	08/21/23		3,008		2,838			2,993		⁽³⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	6.75%	L + 5.75% (incl. 0.25% PIK)	1.00%	08/21/23		1,992		1,906			1,982		⁽³⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure		L + 5.75% (incl. 0.25% PIK)	1.00%	08/21/23		118		(2	)		(1	)	^{(3) (4)}
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure		L + 5.75% (incl. 0.25% PIK)	1.00%	08/21/23		2,093		(40	)		(10	)	^{(3) (4)}
Gainsight, Inc.	Software	7.00%	L + 6.25%	0.75%	07/30/27		30,420		29,900			29,888		⁽²⁾
Gainsight, Inc.	Software		L + 6.25%	0.75%	07/30/27		5,320		(90	)		(93	)	^{(2) (4)}
GHA Buyer Inc. (dba Cedar Gate)	Health Care Technology	9.00%	L + 7.00%	2.00%	06/24/25		14,888		14,635			14,627		^{(2) (3)}
GHA Buyer Inc. (dba Cedar Gate)	Health Care Technology	9.00%	L + 7.00%	2.00%	06/24/25		2,800		2,566			2,563		^{(2) (3) (4)}
GHA Buyer Inc. (dba Cedar Gate)	Health Care Technology		L + 7.00%	2.00%	06/24/25		1,880		(31	)		(33	)	^{(2) (3) (4)}
GovDelivery Holdings, LLC (dba Granicus, Inc.)	Software	7.25%	L + 6.25%	1.00%	01/29/27		29,440		28,767			28,704		⁽²⁾
GovDelivery Holdings, LLC (dba Granicus, Inc.)	Software	7.00%	L + 6.00%	1.00%	01/29/27		3,800		2,237			2,200		^{(2) (4)}
GovDelivery Holdings, LLC (dba Granicus, Inc.)	Software		L + 6.25%	1.00%	01/29/27		2,583		(35	)		(65	)	^{(2) (4)}
Governmentjobs.com, Inc. (dba NeoGov)	Software	7.50%	L + 6.50%	1.00%	02/05/26		47,457		45,534			46,745		^{(2) (3)}
Governmentjobs.com, Inc. (dba NeoGov)	Software	8.00%	L + 7.00%	1.00%	02/05/26		23,975		23,556			24,035		^{(2) (3)}

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of September 30, 2021 (continued)

(in thousands, except share and per share amounts)

(Unaudited)

Investment *#	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
Governmentjobs.com, Inc. (dba NeoGov)	Software	7.50%	L + 6.50%	1.00%	02/05/26	$	6,328	$	383		$	380		^{(2) (3) (4)}
GS AcquisitionCo, Inc. (dba Insightsoftware)	Diversified Financial Services	6.75%	L + 5.75%	1.00%	05/22/26		9,607		9,465			9,535		⁽²⁾
GS AcquisitionCo, Inc. (dba Insightsoftware)	Diversified Financial Services	6.75%	L + 5.75%	1.00%	05/22/26		8,026		7,905			7,966		⁽²⁾
GS AcquisitionCo, Inc. (dba Insightsoftware)	Diversified Financial Services	6.75%	L + 5.75%	1.00%	05/22/26		679		675			674		⁽²⁾
GS AcquisitionCo, Inc. (dba Insightsoftware)	Diversified Financial Services		L + 5.75%	1.00%	05/22/26		982		(14	)		(7	)	^{(2) (4)}
Halo Branded Solutions, Inc.	Commercial Services & Supplies	5.50%	L + 4.50%	1.00%	06/30/25		6,374		6,335			5,909
Heartland Home Services	Diversified Consumer Services		L + 6.00%	1.00%	12/15/26		15,017		(73	)		(150	)	^{(2) (3) (4)}
Helios Buyer, Inc. (dba Heartland)	Diversified Consumer Services	7.00%	L + 6.00%	1.00%	12/15/26		19,229		18,925			19,037		^{(2) (3)}
Helios Buyer, Inc. (dba Heartland)	Diversified Consumer Services	7.00%	L + 6.00%	1.00%	12/15/26		7,923		7,889			7,844		^{(2) (3)}
Helios Buyer, Inc. (dba Heartland)	Diversified Consumer Services	7.06%	L + 6.00%	1.00%	12/15/26		2,482		2,042			2,060		^{(2) (3) (4)}
Hollander Sleep & Décor (dba SureFit)	Household Products	10.75%	L + 9.75%	1.00%	07/13/23		40,348		38,011			39,137		^{(2) (3)}
Honor HN Buyer, Inc	Health Care Providers & Services		L + 6.00%	1.00%	10/15/27		25,761		—			—		^{(2) (4)}
Honor HN Buyer, Inc	Health Care Providers & Services		L + 6.00%	1.00%	10/15/27		14,079		—			—		^{(2) (4)}
Honor HN Buyer, Inc	Health Care Providers & Services		L + 6.00%	1.00%	10/15/27		2,816		—			—		^{(2) (4)}
HowlCO LLC (dba Lone Wolf)	Real Estate Mgmt. & Development	7.00%	L + 6.00%	1.00%	10/23/26		35,402		34,869			35,048		^{(1) (2) (3)}
HowlCO LLC (dba Lone Wolf)	Real Estate Mgmt. & Development	7.00%	L + 6.00%	1.00%	10/23/26		11,457		11,344			11,342		^{(1) (2) (3)}
HowlCO LLC (dba Lone Wolf)	Real Estate Mgmt. & Development	7.00%	L + 6.00%	1.00%	10/23/26		10,859		10,757			10,751		^{(1) (2) (3)}
HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)	Hotels, Restaurants & Leisure	7.75%	L + 6.75%	1.00%	07/09/25		57,514		53,891			55,501		^{(2) (3)}
HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)	Hotels, Restaurants & Leisure		L + 6.75%	1.00%	07/09/25		4,688		(181	)		(164	)	^{(2) (3) (4)}
iCIMS, Inc.	Software	7.50%	L + 6.50%	1.00%	09/12/24		72,489		69,943			72,489		^{(2) (3)}
iCIMS, Inc.	Software	7.50%	L + 6.50%	1.00%	09/12/24		13,350		12,874			13,350		^{(2) (3)}
iCIMS, Inc.	Software		L + 6.50%	1.00%	09/12/24		4,531		4,475			4,531		^{(2) (3)}
Instructure Holdings	Diversified Consumer Services	6.50%	L + 5.50%	1.00%	03/24/26		40,623		39,228			40,623		^{(2) (3)}
Instructure Holdings	Diversified Consumer Services		L + 5.50%	1.00%	03/24/26		5,000		(43	)		—		^{(2) (3) (4)}
Internet Truckstop Group, LLC (dba Truckstop)	Transportation Infrastructure	6.75%	L + 5.75%	1.00%	04/02/25		53,626		51,383			53,223		^{(2) (3)}
Internet Truckstop Group, LLC (dba Truckstop)	Transportation Infrastructure		L + 5.75%	1.00%	04/02/25		4,400		(77	)		(33	)	^{(2) (3) (4)}
Iracore International Holdings, Inc.	Energy Equipment & Services	10.00%	L + 9.00%	1.00%	04/12/24		2,361		2,361			2,361		^{^ (3)}
Jill Acquisition LLC (dba J. Jill)	Specialty Retail	6.00%	L + 5.00%	1.00%	05/08/24		5,844		5,797			4,997
Kawa Solar Holdings Limited	Construction & Engineering				12/31/21		3,917		3,603			1,328		^{^ (1) (3) (5)}
Kawa Solar Holdings Limited	Construction & Engineering				12/31/21		3,318		800			—		^{^ (1) (3) (5)}
Lithium Technologies, Inc.	Interactive Media & Services	9.00%	L + 8.00%	1.00%	10/03/22		89,013		86,166			87,233		^{(2) (3)}
Lithium Technologies, Inc.	Interactive Media & Services		L + 8.00%	1.00%	10/03/22		5,110		(86	)		(102	)	^{(2) (3) (4)}
Mailgun Technologies, Inc.	Interactive Media & Services	6.00%	L + 5.00%	1.00%	03/26/25		38,379		37,261			38,379		^{(2) (3)}
Mailgun Technologies, Inc.	Interactive Media & Services	6.00%	L + 5.00%	1.00%	03/26/25		3,030		2,974			3,030		^{(2) (3)}
Mailgun Technologies, Inc.	Interactive Media & Services		L + 5.00%	1.00%	03/26/25		2,441		—			—		^{(2) (3) (4)}
MedeAnalytics, Inc.	Health Care Technology	7.50%	L + 6.50%	1.00%	10/09/26		950		905			936		^{(2) (3)}
Mervin Manufacturing, Inc.	Leisure Products	8.50%	L + 7.50%	1.00%	09/30/22		10,695		10,695			10,588		⁽³⁾
MMIT Holdings, LLC (dba Managed Markets Insight & Technology)	Health Care Technology	7.25%	L + 6.25%	1.00%	09/15/27		73,401		65,149			65,141		^{(2) (4)}
MMIT Holdings, LLC (dba Managed Markets Insight & Technology)	Health Care Technology		L + 6.25%	1.00%	09/15/27		5,923		(118	)		(118	)	^{(2) (4)}
MRI Software LLC	Real Estate Mgmt. & Development	6.50%	L + 5.50%	1.00%	02/10/26		23,114		22,055			23,027
MRI Software LLC	Real Estate Mgmt. & Development		L + 5.50%	1.00%	02/10/26		403		(10	)		(2	)	⁽⁴⁾
MRI Software LLC	Real Estate Mgmt. & Development		L + 5.50%	1.00%	02/10/26		1,612		(33	)		(6	)	⁽⁴⁾
MRI Software LLC	Real Estate Mgmt. & Development		L + 5.50%	1.00%	02/10/26		6,600		(15	)		(25	)	⁽⁴⁾
One GI LLC	Health Care Providers & Services	8.00%	L + 7.00%	1.00%	12/22/25		22,933		22,529			22,933		^{(2) (3)}
One GI LLC	Health Care Providers & Services	8.00%	L + 7.00%	1.00%	12/22/25		9,429		9,265			9,429		^{(2) (3)}
One GI LLC	Health Care Providers & Services		L + 7.00%	1.00%	12/22/25		2,500		(42	)		—		^{(2) (3) (4)}
Output Services Group, Inc.	Diversified Consumer Services	5.50%	L + 4.50%	1.00%	03/27/24		3,872		3,863			3,304
Picture Head Midco LLC	Entertainment	8.25%	L + 7.25% (incl. 0.50% PIK)	1.00%	08/31/23		45,851		43,057			43,673		^{(2) (3)}
PlanSource Holdings, Inc.	Health Care Technology	7.25%	L + 6.25%	1.00%	04/22/25		56,720		54,121			56,720		^{(2) (3)}
PlanSource Holdings, Inc.	Health Care Technology	7.25%	L + 6.25%	1.00%	04/22/25		7,824		3,744			3,912		^{(2) (3) (4)}

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of September 30, 2021 (continued)

(in thousands, except share and per share amounts)

(Unaudited)

Investment *#	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
Pluralsight, Inc	Professional Services	9.00%	L + 8.00%	1.00%	04/06/27	$	75,915	$	74,481		$	74,396		^{(2) (3)}
Pluralsight, Inc	Professional Services		L + 8.00%	1.00%	04/06/27		5,100		(94	)		(102	)	^{(2) (3) (4)}
Power Stop, LLC	Auto Components	4.58%	L + 4.50%		10/19/25		17,991		17,125			17,811		⁽²⁾
Premier Care Dental Management, LLC	Health Care Providers & Services	6.50%	L + 5.75%	0.75%	08/05/28		18,823		18,454			18,447		⁽²⁾
Premier Care Dental Management, LLC	Health Care Providers & Services		L + 5.75%	0.75%	08/05/28		10,175		(50	)		(51	)	^{(2) (4)}
Premier Care Dental Management, LLC	Health Care Providers & Services		L + 5.75%	0.75%	08/05/27		3,052		(59	)		(61	)	^{(2) (4)}
Premier Imaging, LLC (dba Lucid Health)	Health Care Providers & Services	6.75%	L + 5.75%	1.00%	01/02/25		27,277		25,968			26,868		^{(2) (3)}
Premier Imaging, LLC (dba Lucid Health)	Health Care Providers & Services	6.75%	L + 5.75%	1.00%	01/02/25		7,616		7,516			7,502		^{(2) (3)}
Professional Physical Therapy	Health Care Providers & Services	9.00%	L + 8.00% (incl. 2.00% PIK)	1.00%	12/16/22		5,940		5,648			5,524		⁽³⁾
Project Eagle Holdings, LLC (dba Exostar)	Aerospace & Defense	7.75%	L + 6.75%	1.00%	07/06/26		35,808		35,088			35,092		⁽²⁾
Project Eagle Holdings, LLC (dba Exostar)	Aerospace & Defense		L + 6.75%	1.00%	07/06/26		75		(2	)		(1	)	^{(2) (4)}
Prophix Software Inc.(dba Pound Bidco)	Diversified Financial Services	7.50%	L + 6.50%	1.00%	01/30/26		18,948		18,612			18,948		^{(1) (2) (3)}
Prophix Software Inc.(dba Pound Bidco)	Diversified Financial Services		L + 6.50%	1.00%	01/30/26		3,445		(60	)		—		^{(1) (2) (3) (4)}
PT Intermediate Holdings III, LLC (dba Parts Town)	Trading Companies & Distributors	6.50%	L + 5.50%	1.00%	10/15/25		30,413		28,638			30,337		⁽²⁾
PT Intermediate Holdings III, LLC (dba Parts Town)	Trading Companies & Distributors		L + 5.50%	1.00%	10/15/25		1,847		(9	)		(5	)	^{(2) (4)}
Purfoods, LLC	Health Care Providers & Services	7.00%	L + 6.00%	1.00%	08/12/26		594		570			594		^{(2) (3)}
Purfoods, LLC	Health Care Providers & Services	7.00%	L + 6.00%	1.00%	08/12/26		400		194			200		^{(2) (3) (4)}
Riverpoint Medical, LLC	Health Care Equipment & Supplies	5.50%	L + 4.50%	1.00%	06/21/25		22,009		21,006			21,734		^{(2) (3)}
Riverpoint Medical, LLC	Health Care Equipment & Supplies	6.75%	L + 5.75%	1.00%	06/21/25		1,667		1,646			1,646		^{(2) (3)}
Riverpoint Medical, LLC	Health Care Equipment & Supplies		L + 4.50%	1.00%	06/21/25		4,094		(78	)		(51	)	^{(2) (3) (4)}
Rodeo Buyer Company (dba Absorb Software)	Professional Services	7.25%	L + 6.25%	1.00%	05/25/27		21,167		20,763			20,743		^{(1) (2) (3)}
Rodeo Buyer Company (dba Absorb Software)	Professional Services		L + 6.25%	1.00%	05/25/27		3,387		(64	)		(68	)	^{(1) (2) (3) (4)}
SPay, Inc. (dba Stack Sports)	Interactive Media & Services	10.25%	L + 9.25% (incl. 3.50% PIK)	1.00%	06/17/24		27,670		25,656			26,010		^{(2) (3)}
SPay, Inc. (dba Stack Sports)	Interactive Media & Services	10.25%	L + 9.25% (incl. 3.50% PIK)	1.00%	06/17/24		1,981		1,834			1,862		^{(2) (3)}
SPay, Inc. (dba Stack Sports)	Interactive Media & Services	10.25%	L + 9.25% (incl. 3.50% PIK)	1.00%	06/17/24		991		918			931		^{(2) (3)}
StarCompliance Intermediate, LLC	Diversified Financial Services	7.75%	L + 6.75%	1.00%	01/12/27		15,600		15,318			15,288		^{(2) (3)}
StarCompliance Intermediate, LLC	Diversified Financial Services		L + 6.75%	1.00%	01/12/27		2,500		(44	)		(50	)	^{(2) (3) (4)}
Sundance Group Holdings, Inc. (dba NetDocuments)	Software	7.75%	L + 6.75%	1.00%	07/02/27		41,043		40,428			40,407		⁽²⁾
Sundance Group Holdings, Inc. (dba NetDocuments)	Software		L + 6.75%	1.00%	07/02/27		4,925		(73	)		(76	)	^{(2) (4)}
Sundance Group Holdings, Inc. (dba NetDocuments)	Software		L + 6.75%	1.00%	07/02/27		12,313		(92	)		(96	)	^{(2) (4)}
Sunstar Insurance Group, LLC	Insurance	6.75%	L + 5.75%	1.00%	10/09/26		20,634		4,377			4,359		^{(2) (3) (4)}
Sunstar Insurance Group, LLC	Insurance	6.75%	L + 5.75%	1.00%	10/09/26		4,086		4,033			4,046		^{(2) (3)}
Sunstar Insurance Group, LLC	Insurance	6.75%	L + 5.75%	1.00%	10/09/26		343		337			339		^{(2) (3)}
Sunstar Insurance Group, LLC	Insurance		L + 5.75%	1.00%	10/09/26		111		(2	)		(1	)	^{(2) (3) (4)}
Superman Holdings, LLC (dba Foundation Software)	Construction & Engineering	9.00%	L + 8.00%	1.00%	08/31/27		964		925			964		^{(2) (3)}
Superman Holdings, LLC (dba Foundation Software)	Construction & Engineering		L + 8.00%	1.00%	08/31/26		122		(3	)		—		^{(2) (3) (4)}
Sweep Purchaser LLC	Commercial Services & Supplies	6.75%	L + 5.75%	1.00%	11/30/26		28,465		27,961			28,180		^{(2) (3)}
Sweep Purchaser LLC	Commercial Services & Supplies	6.75%	L + 5.75%	1.00%	11/30/26		9,036		8,875			8,946		^{(2) (3)}
Sweep Purchaser LLC	Commercial Services & Supplies	6.75%	L + 5.75%	1.00%	11/30/26		7,246		6,049			6,101		^{(2) (3) (4)}
Sweep Purchaser LLC	Commercial Services & Supplies	7.61%	L + 5.75%	1.00%	11/30/26		4,541		1,375			1,408		^{(2) (3) (4)}
Syntellis Performance Solutions, LLC (dba Axiom)	Health Care Technology	8.00%	L + 7.00%	1.00%	08/02/27		831		791			808		^{(2) (3)}
The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)	Health Care Providers & Services	6.75%	L + 5.75%	1.00%	08/15/25		26,394		25,148			25,998		^{(2) (3)}
The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)	Health Care Providers & Services	8.00%	P + 4.75%	1.00%	08/15/25		4,565		580			616		^{(2) (3) (4)}
Thrasio, LLC	Internet & Direct Marketing Retail	8.00%	L + 7.00%	1.00%	12/18/26		29,666		29,255			29,666		^{(2) (3)}
Thrasio, LLC	Internet & Direct Marketing Retail	8.00%	L + 7.00%	1.00%	12/18/26		9,965		9,734			9,965		^{(2) (3)}
Thrasio, LLC	Internet & Direct Marketing Retail		L + 7.00%	1.00%	12/18/26		14,686		(73	)		—		^{(2) (3) (4)}
Total Vision LLC	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	07/15/26		5,070		2,462			2,484		^{(2) (4)}
Total Vision LLC	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	07/15/26		2,524		2,475			2,473		⁽²⁾
Total Vision LLC	Health Care Providers & Services		L + 5.50%	1.00%	07/15/26		1,270		(24	)		(25	)	^{(2) (4)}
Tronair Parent Inc.	Air Freight & Logistics	7.25%	L + 6.25% (incl. 0.50% PIK)	1.00%	09/08/23		6,374		6,324			5,584

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of September 30, 2021 (continued)

(in thousands, except share and per share amounts)

(Unaudited)

Investment *#	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
USN Opco LLC (dba Global Nephrology Solutions)	Health Care Providers & Services	6.25%	L + 5.25%	1.00%	12/21/26	$	21,928	$	21,537		$	21,709		^{(2) (3)}
USN Opco LLC (dba Global Nephrology Solutions)	Health Care Providers & Services	6.25%	L + 5.25%	1.00%	12/21/26		7,600		1,702			1,710		^{(2) (3) (4)}
USN Opco LLC (dba Global Nephrology Solutions)	Health Care Providers & Services		L + 5.25%	1.00%	12/21/26		3,023		(53	)		(30	)	^{(2) (3) (4)}
Viant Medical Holdings, Inc.	Health Care Equipment & Supplies	7.25%	L + 6.25%	1.00%	07/02/25		31,543		29,879			31,386		⁽²⁾
Volt Bidco, Inc. (aka Power Factors)	Independent Power and Renewable Electricity Producers	7.50%	L + 6.50%	1.00%	08/11/27		22,800		22,352			22,344		⁽²⁾
Volt Bidco, Inc. (aka Power Factors)	Independent Power and Renewable Electricity Producers		L + 6.50%	1.00%	08/11/27		2,618		—			—		^{(2) (4)}
Volt Bidco, Inc. (aka Power Factors)	Independent Power and Renewable Electricity Producers		L + 6.50%	1.00%	08/11/27		2,181		(43	)		(44	)	^{(2) (4)}
VRC Companies, LLC (dba Vital Records Control)	Commercial Services & Supplies	6.25%	L + 5.50%	0.75%	06/29/27		28,245		27,834			27,821		⁽²⁾
VRC Companies, LLC (dba Vital Records Control)	Commercial Services & Supplies	6.25%	L + 5.50%	0.75%	06/29/27		4,719		283			281		^{(2) (4)}
VRC Companies, LLC (dba Vital Records Control)	Commercial Services & Supplies		L + 5.50%	0.75%	06/29/27		944		(14	)		(14	)	^{(2) (4)}
WebPT, Inc.	Health Care Technology	7.75%	L + 6.75%	1.00%	08/28/24		25,126		23,972			24,874		^{(2) (3)}
WebPT, Inc.	Health Care Technology	7.75%	L + 6.75%	1.00%	08/28/24		2,617		725			759		^{(2) (3) (4)}
Wellness AcquisitionCo, Inc. (dba SPINS)	IT Services	6.50%	L + 5.50%	1.00%	01/20/27		20,050		19,687			20,050		^{(2) (3)}
Wellness AcquisitionCo, Inc. (dba SPINS)	IT Services		L + 5.50%	1.00%	01/20/27		2,600		(46	)		—		^{(2) (3) (4)}
Wine.com, LLC	Beverages	8.00%	L + 7.00%	1.00%	11/14/24		15,400		14,951			15,400		^{(2) (3)}
Wine.com, LLC	Beverages	8.00%	L + 7.00%	1.00%	11/14/24		3,700		3,636			3,700		^{(2) (3)}
WorkForce Software, LLC	Software	6.50%	L + 5.50%	1.00%	07/31/25		21,740		20,839			21,305		^{(2) (3)}
WorkForce Software, LLC	Software	7.50%	L + 6.50%	1.00%	07/31/25		1,894		978			972		^{(2) (3) (4)}
Xactly Corporation	IT Services	8.25%	L + 7.25%	1.00%	07/31/23		62,025		60,336			62,025		^{(2) (3)}
Xactly Corporation	IT Services		L + 7.25%	1.00%	07/31/23		3,874		(44	)		—		^{(2) (3) (4)}
Zarya Intermediate, LLC (dba iOFFICE)	Real Estate Mgmt. & Development	7.50%	L + 6.50%	1.00%	07/01/27		35,480		34,794			34,770		⁽²⁾
Zarya Intermediate, LLC (dba iOFFICE)	Real Estate Mgmt. & Development	7.50%	L + 6.50%	1.00%	07/01/27		27,870		27,321			27,313		⁽²⁾
Zarya Intermediate, LLC (dba iOFFICE)	Real Estate Mgmt. & Development		L + 6.50%	1.00%	07/01/27		6,757		(131	)		(135	)	^{(2) (4)}
Zodiac Intermediate, LLC (dba Zipari)	Health Care Technology	8.50%	L + 7.50%	1.00%	12/21/26		50,230		49,030			49,100		^{(2) (3)}
Zodiac Intermediate, LLC (dba Zipari)	Health Care Technology	8.50%	L + 7.50%	1.00%	12/22/25		7,500		4,831			4,831		^{(2) (3) (4)}
Total 1st Lien/Senior Secured Debt									2,596,091			2,622,896
1st Lien/Last-Out Unitranche (7) - 10.01%
Doxim, Inc.	Diversified Financial Services	7.00%	L + 6.00%	1.00%	02/28/24	$	38,967	$	37,310		$	38,577		^{(2) (3)}
Doxim, Inc.	Diversified Financial Services	7.75%	L + 6.75%	1.00%	02/28/24		25,000		24,507			24,500		^{(2) (3)}
Doxim, Inc.	Diversified Financial Services	7.00%	L + 6.00%	1.00%	02/28/24		22,863		21,642			22,635		^{(2) (3)}
Doxim, Inc.	Diversified Financial Services	8.00%	L + 7.00%	1.00%	02/28/24		6,751		6,611			6,649		^{(2) (3)}
Doxim, Inc.	Diversified Financial Services	9.00%	L + 8.00%	1.00%	02/28/24		5,242		5,125			5,281		^{(2) (3)}
Doxim, Inc.	Diversified Financial Services	9.00%	L + 8.00%	1.00%	02/28/24		3,928		3,851			3,958		^{(2) (3)}
Smarsh, Inc.	Interactive Media & Services	9.25%	L + 8.25%	1.00%	11/20/25		60,886		58,281			60,581		^{(2) (3)}
Total 1st Lien/Last-Out Unitranche									157,327			162,181
2nd Lien/Senior Secured Debt - 16.93%
Animal Supply Intermediate, LLC	Distributors	7.00%	7.00% PIK		11/14/25	$	8,931	$	8,462		$	7,056		^{^ (3)}
Bolttech Mannings, Inc.	Commercial Services & Supplies	8.12%	L + 8.00% PIK		11/20/22		17,878		17,766			17,342		^{^^ (3)}
Chase Industries, Inc. (dba Senneca Holdings)	Building Products		10.00% PIK		11/11/25		12,150		9,714			3,584		^{(2) (3) (7)}
Chase Industries, Inc. (dba Senneca Holdings)	Building Products		11.00% PIK		05/11/26		12,150		—			—		^{(2) (3) (7)}
Genesis Acquisition Co. (dba ProCare Software)	Diversified Financial Services	7.65%	L + 7.50%		07/31/25		17,000		15,726			16,278		^{(2) (3)}
Genesis Acquisition Co. (dba ProCare Software)	Diversified Financial Services	7.62%	L + 7.50%		07/31/25		4,939		4,777			4,729		^{(2) (3)}
Genesis Acquisition Co. (dba ProCare Software)	Diversified Financial Services	7.65%	L + 7.50%		07/31/25		4,300		3,978			4,117		^{(2) (3)}
IHS Intermediate Inc. (dba Interactive Health Solutions)	Health Care Providers & Services		L + 8.25%	1.00%	07/20/22		10,000		9,902			—		^{(3) (7)}
Intelligent Medical Objects, Inc.	Health Care Technology	9.50%	L + 8.50%	1.00%	12/22/24		29,200		27,789			28,908		^{(2) (3)}
MPI Engineered Technologies, LLC	Auto Components	12.00%			07/15/25		14,428		14,428			13,130		⁽³⁾
MPI Products LLC	Auto Components				07/15/25		7,412		—			—		^{(3) (5)}
National Spine and Pain Centers, LLC	Health Care Providers & Services	9.25%	L + 8.25%	1.00%	12/02/24		36,500		34,946			35,496		^{(2) (3)}
Odyssey Logistics & Technology Corporation	Road & Rail	9.00%	L + 8.00%	1.00%	10/12/25		45,348		40,179			43,081		⁽²⁾
Spectrum Plastics Group, Inc.	Containers & Packaging	8.00%	L + 7.00%	1.00%	01/31/26		12,525		11,328			11,439		⁽²⁾
YI, LLC (dba Young Innovations)	Health Care Equipment & Supplies	8.75%	L + 7.75%	1.00%	11/07/25		36,844		33,910			36,107		^{(2) (3)}
Zep Inc.	Chemicals	9.25%	L + 8.25%	1.00%	08/11/25		54,300		48,159			53,078		⁽²⁾
Total 2nd Lien/Senior Secured Debt									281,064			274,345
Unsecured Debt - 0.11%
ATX Networks Corp.	Communications Equipment	10.00%	10.00% PIK		09/01/28	$	1,748	$	1,435		$	1,433		^{^ (1) (3)}
Conergy Asia & ME Pte. LTD.	Construction & Engineering				06/30/22		1,266		1,055			376		^{^ (1) (3) (5)}
Total Unsecured Debt									2,490			1,809

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of September 30, 2021 (continued)

(in thousands, except share and per share amounts)

(Unaudited)

Investment *#	Industry	Interest Rate	Initial Acquisition Date⁽⁸⁾	Par/Shares (++)		Cost		Fair Value		Footnotes
Preferred Stock - 1.25%
Broadway Parent, LLC	Diversified Financial Services		01/25/21		4,000,000	$	4,019	$	4,304	^{(2) (3) (5)}
Conergy Asia Holdings, Ltd.	Construction & Engineering		08/23/17		600,000		600		—	^{^ (1) (3) (5)}
Foundation Software	Construction & Engineering		08/31/20		22		21		24	^{(2) (3) (5)}
Kawa Solar Holdings Limited	Construction & Engineering	8.00% PIK	10/25/16		72,698		778		—	^{^ (1) (3) (7)}
MedeAnalytics, Inc.	Health Care Technology		10/09/20		42,600		41		42	^{(2) (3) (5)}
Wine.com, LLC	Beverages		03/03/21		124,040		3,067		3,243	^{(2) (3) (5)}
Wine.com, LLC	Beverages		11/14/18		535,226		8,225		12,562	^{(2) (3) (5)}
Total Preferred Stock							16,751		20,175
Common Stock - 1.89%
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings)	Software		03/10/21		29,326	$	2,933	$	2,991	^{(2) (3) (5)}
Animal Supply Holdings, LLC	Distributors		08/14/20		37,500		126		—	^{^ (3) (5)}
Animal Supply Holdings, LLC	Distributors		08/14/20		83,333		13,745		—	^{^ (3) (5)}
ATX Parent Holdings, LLC - Class A Units	Communications Equipment		09/01/21		332		167		167	^{^ (1) (3)}
Bolttech Mannings, Inc.	Commercial Services & Supplies		12/22/17		309,142		14,885		3,153	^{^^ (3) (5)}
Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Class B	Health Care Providers & Services		03/30/18		20,183		2,916		3,916	^{^^^ (2) (3)}
Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Performance Units	Health Care Providers & Services		03/30/18		19,048		514		1,281	^{^^^ (1) (2) (3) (5)}
Conergy Asia Holdings, Ltd.	Construction & Engineering		07/31/17		2,000		4,700		—	^{^ (1) (3) (5)}
Country Fresh Holding Company Inc.	Food Products		04/29/19		1,514		889		—	^{(2) (3) (5)}
Elah Holdings, Inc.	Capital Markets		05/09/18		111,650		5,238		5,396	^{^ (2) (3) (5)}
Exostar LLC - Class B	Aerospace & Defense		07/06/20		31,407		—		24	^{(2) (3) (5)}
Foundation Software - Class B	Construction & Engineering		08/31/20		11,826		—		8	^{(2) (3) (5)}
Iracore International Holdings, Inc.	Energy Equipment & Services		04/13/17		28,898		7,003		6,102	^{^ (3) (5)}
Jill Acquisition LLC (dba J. Jill)	Specialty Retail		09/30/20		18,869		56		328	⁽⁵⁾
Kawa Solar Holdings Limited	Construction & Engineering		08/17/16		1,399,556		—		—	^{^ (1) (3) (5)}
National Spine and Pain Centers, LLC	Health Care Providers & Services		06/02/17		1,100		883		678	^{(2) (3) (5)}
Prairie Provident Resources, Inc.	Oil, Gas & Consumable Fuels				3,579,988		9,237		244	^{(1) (5)}
Total Vision LLC	Health Care Providers & Services		07/15/21		72,571		1,270		1,270	^{(2) (5)}
Volt Bidco, Inc. (aka Power Factors)	Independent Power and Renewable Electricity Producers		08/11/21		2,908		2,908		2,908	^{(2) (5)}
Yasso, Inc.	Food Products		03/23/17		1,640		1,368		2,176	^{(2) (3) (5)}
Total Common Stock							68,838		30,642
Warrants - 0.00%
Animal Supply Holdings, LLC	Distributors		08/14/20		1	$	756	$	76	^{^ (3) (5) (9)}
KDOR Holdings Inc. (dba Senneca Holdings)	Building Products		06/22/20		30		—		—	^{(2) (3) (5)}
KDOR Holdings Inc. (dba Senneca Holdings)	Building Products		05/29/20		1,406		—		—	^{(2) (3) (5)}
KDOR Holdings Inc. (dba Senneca Holdings)	Building Products		05/29/20		147		—		—	^{(2) (3) (5)}
Total Warrants							756		76
Total Investments - 192.09%						$	3,123,317	$	3,112,124

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of September 30, 2021

(in thousands, except share and per share amounts)

(Unaudited)

^*	Assets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt”.
⁽⁺⁾	Represents the actual interest rate for partially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by the larger of the floor or the reference to either LIBOR ("L") or alternate base rate (commonly based on the U.S. Prime Rate ("P"), unless otherwise noted) at the borrower’s option, which reset periodically based on the terms of the credit agreement. L loans are typically indexed to 12 month, 6 month, 3 month, 2 month, 1 month or 1 week L rates. As of September 30, 2021, rates for the 12 month, 6 month, 3 month, 2 month, 1 month and 1 week L are 0.24%, 0.16%, 0.13%, 0.11%, 0.08% and 0.07%, respectively. As of September 30, 2021, P was 3.25%, and Canadian Prime rate ("CDN P") was 2.45%. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at September 30, 2021.
⁽⁺⁺⁾	Par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars ("$") unless otherwise noted, Euro ("€") or Canadian dollar ("CAD").
^#	Percentages are based on net assets.
^{^}	As defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”), the investment is deemed to be an “affiliated person” of the Company because the Company owns, either directly or indirectly, 5% or more of the portfolio company’s outstanding voting securities. See Note 3 “Significant Agreements and Related Party Transactions”.
^{^^}	As defined in the Investment Company Act, the investment is deemed to be a “controlled affiliated person” of the Company because the Company owns, either directly or indirectly, 25% or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. See Note 3 “Significant Agreements and Related Party Transactions”.
^{^^^}	The investment is otherwise deemed to be an “affiliated person” of the Company. See Note 3 “Significant Agreements and Related Party Transactions”.
⁽¹⁾	The investment is not a qualifying asset under Section 55(a) of the Investment Company Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company’s total assets. As of September 30, 2021 the aggregate fair value of these securities is $130,892 or 3.94% of the Company’s total assets.
⁽²⁾	Represent co-investments made with the Company’s affiliates in accordance with the terms of the exemptive relief received from the U.S. Securities and Exchange Commission. See Note 3 “Significant Agreements and Related Party Transactions”.
⁽³⁾	The fair value of the investment was determined using significant unobservable inputs. See Note 5 “Fair Value Measurement”.
⁽⁴⁾	Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. The negative cost, if applicable, is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount on the loan. See Note 8 "Commitments and Contingencies".
⁽⁵⁾	Non-income producing security.
⁽⁶⁾	In exchange for the greater risk of loss, the “last-out” portion of the Company's unitranche loan investment generally earns a higher interest rate than the “first-out” portions. The “first-out” portion would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion.
⁽⁷⁾	The investment is on non-accrual status. See Note 2 "Significant Accounting Policies".
⁽⁸⁾	Securities exempt from registration under the Securities Act of 1933, and may be deemed to be “restricted securities”. As of September 30, 2021, the aggregate fair value of these securities is $50,649 or 3.13% of the Company's net assets. The initial acquisition dates have been included for such securities.
⁽⁹⁾	Right to purchase up to $8,851 of 1st Lien Senior Secured Debt, $7,483 of 2nd Lien Senior Secured Debt and 68,796 shares of Class A Units, which expires November 2021.

PIK – Payment-In-Kind

ADDITIONAL INFORMATION

Foreign currency forward contracts

Counterparty	Currency Purchased	Currency Sold	Settlement	Unrealized Appreciation (Depreciation)
Bank of America, N.A.	Euro 83	U.S. Dollar 98	10/05/21	$	(3	)
Bank of America, N.A.	U.S. Dollar 400	Euro 350	10/05/21		(6	)
Bank of America, N.A.	U.S. Dollar 294	Euro 258	10/05/21		(5	)
Bank of America, N.A.	U.S. Dollar 624	Euro 525	01/06/22		14
Bank of America, N.A.	U.S. Dollar 611	Euro 514	04/06/22		14
Bank of America, N.A.	U.S. Dollar 619	Euro 520	07/06/22		14
Bank of America, N.A.	U.S. Dollar 627	Euro 525	10/06/22		13
				$	41

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of December 31, 2020

(in thousands, except share and per share amounts)

Investment *	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost				Fair Value				Footnotes
1st Lien/Senior Secured Debt^{* #} - 156.46%
1272775 B.C. LTD. (dba Everest Clinical Research)	Professional Services	6.50%	L + 5.50%	1.00%	11/06/26	$	9,430		$	9,292			$	9,289			^{(1) (2)}
1272775 B.C. LTD. (dba Everest Clinical Research)	Professional Services		L + 5.50%	1.00%	11/06/26		1,260			(18	)			(19	)		^{(1) (2) (3)}
3SI Security Systems, Inc.	Commercial Services & Supplies	6.75%	L + 5.75%	1.00%	06/16/23		14,556			14,465				14,483			⁽⁴⁾
3SI Security Systems, Inc.	Commercial Services & Supplies	6.75%	L + 5.75%	1.00%	06/16/23		2,216			2,075				2,205			⁽⁴⁾
A Place For Mom, Inc.	Diversified Consumer Services	4.75%	L + 3.75%	1.00%	08/10/24		8,752			8,746				8,052
Acquia, Inc.	Software	8.00%	L + 7.00%	1.00%	10/31/25		30,561			28,977				30,026			^{(2) (4)}
Acquia, Inc.	Software		L + 7.00%	1.00%	10/31/25		3,268			(77	)			(57	)		^{(2) (3) (4)}
Ansira Partners, Inc.	Professional Services	7.50%	L + 6.50% PIK	1.00%	12/20/24		4,748			4,726				3,988
Ansira Partners, Inc.	Professional Services	7.50%	L + 6.50% PIK	1.00%	12/20/24		292			291				245
Apptio, Inc.	IT Services	8.25%	L + 7.25%	1.00%	01/10/25		79,154			75,824				77,967			^{(2) (4)}
Apptio, Inc.	IT Services		L + 7.25%	1.00%	01/10/25		5,385			(75	)			(81	)		^{(2) (3) (4)}
Associations, Inc.	Real Estate Mgmt. & Development	8.00%	L + 7.00% (incl. 3.00% PIK)	1.00%	07/30/24		33,860			32,095				33,013			^{(2) (4)}
Associations, Inc.	Real Estate Mgmt. & Development	8.00%	L + 7.00% (incl. 3.00% PIK)	1.00%	07/30/24		7,396			7,102				7,104			^{(2) (3) (4)}
Associations, Inc.	Real Estate Mgmt. & Development	7.00%	L + 6.00%	1.00%	07/30/24		1,422			1,348				1,387			^{(2) (4)}
ATX Networks Corp.	Communications Equipment	8.75%	L + 7.75% (incl. 1.50% PIK)	1.00%	12/31/23		7,183			7,162				6,321
ATX Networks Corp.	Communications Equipment	8.75%	L + 7.75% (incl. 1.50% PIK)	1.00%	12/31/23		457			452				402
Badger Sportswear, Inc.	Textiles, Apparel & Luxury Goods	6.25%	L + 5.00%	1.00%	09/11/23		7,150			7,106				6,292
Barbri, Inc.	Diversified Consumer Services	5.00%	L + 4.00%	1.00%	12/01/23		6,243			6,227				5,931
BJH Holdings III Corp. (dba Jack’s Family Restaurants)	Hotels, Restaurants & Leisure	6.25%	L + 5.25%	1.00%	08/19/25		14,904			14,065				14,270			⁽²⁾
Blacksmith Applications, Inc.	Software	7.50%	L + 6.50%	1.00%	12/02/26		25,100			24,542				24,535			⁽²⁾
Blacksmith Applications, Inc.	Software		L + 6.50%	1.00%	12/02/26		2,000			(44	)			(45	)		^{(2) (3)}
Brillio, LLC	IT Services	5.75%	L + 4.75%	1.00%	02/06/25		10,953			10,478				10,871			^{(2) (4)}
Brillio, LLC	IT Services	5.75%	L + 4.75%	1.00%	02/06/25		3,710			1,808				1,827			^{(2) (3) (4)}
Bullhorn, Inc.	Professional Services	6.75%	L + 5.75%	1.00%	09/30/26		26,833			25,653				26,430			^{(2) (4)}
Bullhorn, Inc.	Professional Services	6.75%	L + 5.75%	1.00%	09/30/26		556			532				548			^{(2) (4)}
Bullhorn, Inc.	Professional Services	6.75%	L + 5.75%	1.00%	09/30/26		444			424				437			^{(2) (4)}
Bullhorn, Inc.	Professional Services		L + 5.75%	1.00%	09/30/26		1,232			(19	)			(18	)		^{(2) (3) (4)}
Bullhorn, Inc.	Professional Services		L + 5.75%	1.00%	09/30/26		1,344			(21	)			(20	)		^{(2) (3) (4)}
Businessolver.com, Inc.	Health Care Technology	8.50%	L + 7.50%	1.00%	05/15/23		42,625			40,448				42,092			^{(2) (4)}
Businessolver.com, Inc.	Health Care Technology	8.50%	L + 7.50%	1.00%	05/15/23		11,175			11,003				11,035			^{(2) (4)}
Businessolver.com, Inc.	Health Care Technology	8.50%	L + 7.50%	1.00%	05/15/23		6,394			6,066				6,314			^{(2) (4)}
Businessolver.com, Inc.	Health Care Technology		L + 7.50%	1.00%	05/15/23		5,328			(101	)			(67	)		^{(2) (3) (4)}
Capitol Imaging Acquisition Corp.	Health Care Providers & Services	7.50%	L + 6.50%	1.00%	10/01/26		814			779				798			⁽²⁾
Capitol Imaging Acquisition Corp.	Health Care Providers & Services	8.75%	P + 5.50%		10/01/25		180			19				19			^{(2) (3)}
CFS Management, LLC (dba Center for Sight Management)	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	07/01/24		11,671			11,090				11,409			^{(2) (4)}
CFS Management, LLC (dba Center for Sight Management)	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	07/01/24		3,476			3,303				3,398			^{(2) (4)}
Chronicle Bidco Inc. (dba Lexitas)	Professional Services	7.00%	L + 6.00%	1.00%	11/14/25		17,127			16,194				16,699			⁽²⁾
Chronicle Bidco Inc. (dba Lexitas)	Professional Services	7.00%	L + 6.00%	1.00%	11/14/25		11,372			11,095				11,087			⁽²⁾
Chronicle Bidco Inc. (dba Lexitas)	Professional Services	7.00%	L + 6.00%	1.00%	11/14/25		7,214			6,820				7,034			⁽²⁾
Chronicle Bidco Inc. (dba Lexitas)	Professional Services	7.00%	L + 6.00%	1.00%	11/14/25		6,318			89				(7	)		^{(2) (3)}
Chronicle Bidco Inc. (dba Lexitas)	Professional Services		L + 6.00%	1.00%	11/14/25		2,180			(52	)			(55	)		^{(2) (3)}
ConnectWise, LLC	IT Services	6.25%	L + 5.25%	1.00%	02/28/25		33,186			31,844				32,854			^{(2) (4)}
ConnectWise, LLC	IT Services	6.25%	L + 5.25%	1.00%	02/28/25		2,561			609				615			^{(2) (3) (4)}
Convene 237 Park Avenue, LLC (dba Convene)	Real Estate Mgmt. & Development	9.00%	L + 7.50%	1.50%	08/30/24		52,200			46,177				41,760			^{(2) (4)}
Convene 237 Park Avenue, LLC (dba Convene)	Real Estate Mgmt. & Development	9.00%	L + 7.50%	1.50%	08/30/24		15,340			13,563				12,272			^{(2) (4)}

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of December 31, 2020 (continued)

(in thousands, except share and per share amounts)

Investment *	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
CorePower Yoga LLC	Diversified Consumer Services	7.00%	L + 6.00% (incl. 1.25% PIK)	1.00%	05/14/25	$	24,108	$	21,328		$	20,250		⁽²⁾
CorePower Yoga LLC	Diversified Consumer Services	7.00%	L + 6.00% (incl. 1.25% PIK)	1.00%	05/14/25		1,687		1,534			1,417		⁽²⁾
CST Buyer Company (dba Intoxalock)	Diversified Consumer Services	7.00%	L + 6.00%	1.00%	10/03/25		28,301		27,301			27,664		^{(2) (4)}
CST Buyer Company (dba Intoxalock)	Diversified Consumer Services	7.00%	L + 6.00%	1.00%	11/03/25		15,080		14,747			14,741		^{(2) (4)}
CST Buyer Company (dba Intoxalock)	Diversified Consumer Services		L + 6.00%	1.00%	10/03/25		2,170		(14	)		(49	)	^{(2) (3) (4)}
DDS USA Holding, Inc.	Health Care Equipment & Supplies	6.75%	L + 5.75%	1.00%	06/30/22		9,116		8,829			9,048		^{(2) (4)}
DDS USA Holding, Inc.	Health Care Equipment & Supplies	7.06%	L + 5.75%	1.00%	06/30/22		7,807		7,561			7,749		^{(2) (4)}
DDS USA Holding, Inc.	Health Care Equipment & Supplies		L + 5.75%	1.00%	06/30/22		2,612		(16	)		(20	)	^{(2) (3) (4)}
Diligent Corporation	Professional Services	7.25%	L + 6.25%	1.00%	08/04/25	€	38,448		42,915			45,913		^{(2) (4)}
Diligent Corporation	Professional Services	7.25%	L + 6.25%	1.00%	08/04/25		24,851		23,683			24,292		^{(2) (4)}
Diligent Corporation	Professional Services		L + 6.25%	1.00%	08/04/25		3,100		(66	)		(70	)	^{(2) (3) (4)}
DocuTAP, Inc.	Health Care Technology	6.50%	L + 5.50%	1.00%	05/12/25		58,566		55,580			57,395		^{(2) (4)}
E2open, LLC	Software	6.75%	L + 5.75%	1.00%	11/26/24		40,093		37,959			39,917		⁽²⁾
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		7,091		6,561			6,879		^{(2) (4)}
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		1,390		1,311			1,348		^{(2) (4)}
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		930		720			737		^{(2) (3) (4)}
Elemica Parent, Inc.	Chemicals	7.00%	L + 6.00%	1.00%	09/18/25		566		549			549		^{(2) (4)}
Elemica Parent, Inc.	Chemicals		L + 6.00%	1.00%	09/18/25		380		(6	)		(11	)	^{(2) (3) (4)}
Elemica Parent, Inc.	Chemicals		L + 6.00%	1.00%	09/18/25		1,508		(22	)		(45	)	^{(2) (3) (4)}
Empirix, Inc.	Diversified Telecommunication Services	7.25%	L + 6.25%	1.00%	09/25/24		53,053		50,468			51,594		^{(2) (4)}
Empirix, Inc.	Diversified Telecommunication Services		L + 6.25%	1.00%	09/25/23		3,100		(63	)		(85	)	^{(2) (3) (4)}
Eptam Plastics, Ltd.	Health Care Equipment & Supplies	6.50%	L + 5.50%	1.00%	12/06/25		10,582		10,065			10,371		^{(2) (4)}
Eptam Plastics, Ltd.	Health Care Equipment & Supplies	6.50%	L + 5.50%	1.00%	12/06/25		2,269		1,931			1,996		^{(2) (3) (4)}
Eptam Plastics, Ltd.	Health Care Equipment & Supplies		L + 5.50%	1.00%	12/06/25		4,537		(83	)		(91	)	^{(2) (3) (4)}
Fenergo Finance 3 Limited	Diversified Financial Services	7.00%	L + 6.00%	1.00%	09/05/24	€	43,100		48,582			51,995		^{(1) (2) (4)}
Fenergo Finance 3 Limited	Diversified Financial Services		L + 6.00%	1.00%	09/05/24		2,865		(33	)		(36	)	^{(1) (2) (3) (4)}
Fenergo Finance 3 Limited	Diversified Financial Services		L + 6.00%	1.00%	09/05/24	€	3,700		(8	)		(57	)	^{(1) (2) (3) (4)}
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	8.00%	L + 7.00% (incl. 1.50% PIK)	1.00%	08/21/23		15,721		14,793			15,249		⁽⁴⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	8.00%	L + 7.00% (incl. 1.50% PIK)	1.00%	08/21/23		4,009		3,700			3,889		⁽⁴⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	8.00%	L + 7.00% (incl. 1.50% PIK)	1.00%	08/21/23		3,141		2,956			3,047		⁽⁴⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	8.00%	L + 7.00% (incl. 1.50% PIK)	1.00%	08/21/23		3,014		2,781			2,924		⁽⁴⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	8.00%	L + 7.00% (incl. 1.50% PIK)	1.00%	08/21/23		2,999		2,767			2,909		⁽⁴⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure	8.00%	L + 7.00% (incl. 1.50% PIK)	1.00%	08/21/23		1,986		1,869			1,926		⁽⁴⁾
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure		L + 7.00% (incl. 1.50% PIK)	1.00%	08/21/23		118		(3	)		(4	)	^{(3) (4)}
FWR Holding Corporation (dba First Watch Restaurants)	Hotels, Restaurants & Leisure		L + 7.00% (incl. 1.50% PIK)	1.00%	08/21/23		2,093		(56	)		(63	)	^{(3) (4)}

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of December 31, 2020 (continued)

(in thousands, except share and per share amounts)

Investment *	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
Gastro Health Holdco, LLC	Health Care Providers & Services	8.00%	L + 7.00%	1.00%	09/04/24	$	23,415	$	22,104		$	22,888		^{(2) (4)}
Gastro Health Holdco, LLC	Health Care Providers & Services	8.00%	L + 7.00%	1.00%	09/04/24		12,138		11,459			11,865		^{(2) (4)}
Gastro Health Holdco, LLC	Health Care Providers & Services	8.00%	L + 7.00%	1.00%	09/04/24		11,699		11,053			11,436		^{(2) (4)}
Gastro Health Holdco, LLC	Health Care Providers & Services	9.25%	L + 7.00%	1.00%	09/04/23		4,900		1,702			1,727		^{(2) (3) (4)}
GH Holding Company (dba Grace Hill)	Real Estate Mgmt. & Development	4.65%	L + 4.50%		02/28/23		7,294		7,277			7,166		⁽⁴⁾
GHA Buyer Inc. (dba Cedar Gate)	Health Care Technology	8.00%	L + 6.00%	2.00%	06/24/25		15,000		14,703			14,700		⁽²⁾
GHA Buyer Inc. (dba Cedar Gate)	Health Care Technology	8.00%	L + 6.00%	2.00%	06/24/25		2,820		2,604			2,604		^{(2) (3)}
GHA Buyer Inc. (dba Cedar Gate)	Health Care Technology		L + 6.00%	2.00%	06/24/25		1,880		(37	)		(38	)	^{(2) (3)}
GI Revelation Acquisition LLC (dba Consilio)	IT Services	5.15%	L + 5.00%		04/16/25		4,634		4,619			4,542
GK Holdings, Inc. (dba Global Knowledge)	IT Services		L + 8.00%	1.00%	01/20/21		8,460		8,457			8,206		^{(4) (5)}
GlobalTranz Enterprises, Inc.	Road & Rail	5.15%	L + 5.00%		05/15/26		18,933		16,423			17,419		⁽²⁾
Governmentjobs.com, Inc. (dba NeoGov)	Software	7.50%	L + 6.50%	1.00%	02/05/26		47,457		45,262			46,508		^{(2) (4)}
Governmentjobs.com, Inc. (dba NeoGov)	Software	8.00%	L + 7.00%	1.00%	02/05/26		23,975		23,497			24,035		^{(2) (4)}
Governmentjobs.com, Inc. (dba NeoGov)	Software	7.50%	L + 6.50%	1.00%	02/05/26		6,328		368			348		^{(2) (3) (4)}
Granicus, Inc.	Software	8.00%	L + 7.00%	1.00%	08/21/26		22,763		21,576			22,308		⁽²⁾
Granicus, Inc.	Software	8.00%	L + 7.00%	1.00%	08/21/26		1,996		1,947			1,956		⁽²⁾
Granicus, Inc.	Software		L + 7.00%	1.00%	08/21/26		1,563		(37	)		(31	)	^{(2) (3)}
GS AcquisitionCo, Inc. (dba Insightsoftware)	Diversified Financial Services	6.75%	L + 5.75%	1.00%	05/24/24		9,680		9,537			9,607		⁽²⁾
GS AcquisitionCo, Inc. (dba Insightsoftware)	Diversified Financial Services	6.75%	L + 5.75%	1.00%	05/24/24		8,066		3,944			3,973		^{(2) (3)}
GS AcquisitionCo, Inc. (dba Insightsoftware)	Diversified Financial Services		L + 5.75%	1.00%	05/24/24		807		(12	)		(6	)	^{(2) (3)}
Halo Branded Solutions, Inc.	Commercial Services & Supplies	5.50%	L + 4.50%	1.00%	06/30/25		6,424		6,378			5,910
Helios Buyer, Inc. (dba Heartland)	Diversified Consumer Services	7.00%	L + 6.00%	1.00%	12/15/26		14,645		14,354			14,352		⁽²⁾
Helios Buyer, Inc. (dba Heartland)	Diversified Consumer Services	7.00%	L + 6.00%	1.00%	12/15/26		2,482		179			179		^{(2) (3)}
Helios Buyer, Inc. (dba Heartland)	Diversified Consumer Services		L + 6.00%	1.00%	12/15/26		7,943		(39	)		(40	)	^{(2) (3)}
HowlCO LLC (dba Lone Wolf)	Real Estate Mgmt. & Development	7.00%	L + 6.00%	1.00%	10/23/26		28,047		27,499			27,486		^{(1) (2)}
HowlCO LLC (dba Lone Wolf)	Real Estate Mgmt. & Development	7.00%	L + 6.00%	1.00%	10/23/26		4,808		4,713			4,808		^{(1) (2)}
HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)	Hotels, Restaurants & Leisure	7.75%	L + 6.75%	1.00%	07/09/25		57,658		53,441			53,910		^{(2) (4)}
HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)	Hotels, Restaurants & Leisure		L + 6.75%	1.00%	07/09/25		4,688		(216	)		(305	)	^{(2) (3) (4)}
Hygiena Borrower LLC	Life Sciences Tools & Services	5.00%	L + 4.00%	1.00%	08/26/22		17,191		16,822			17,105
Hygiena Borrower LLC	Life Sciences Tools & Services		L + 4.00%	1.00%	08/26/22		1,863		(16	)		(9	)	⁽³⁾
iCIMS, Inc.	Software	7.50%	L + 6.50%	1.00%	09/12/24		72,489		69,394			71,402		^{(2) (4)}
iCIMS, Inc.	Software	7.50%	L + 6.50%	1.00%	09/12/24		13,350		12,772			13,150		^{(2) (4)}
iCIMS, Inc.	Software	7.50%	L + 6.50%	1.00%	09/12/24		4,531		4,463			4,463		^{(2) (4)}
Infinity Sales Group	Media	11.50%	L + 10.50%	1.00%	11/23/22		25,579		25,579			26,474		⁽⁴⁾
Instructure Holdings	Diversified Consumer Services	8.00%	L + 7.00%	1.00%	03/24/26		64,164		61,665			63,522		^{(2) (4)}
Instructure Holdings	Diversified Consumer Services		L + 7.00%	1.00%	03/24/26		5,000		(51	)		(50	)	^{(2) (3) (4)}
Integral Ad Science, Inc.	Interactive Media & Services	8.25%	L + 7.25% (incl. 1.25% PIK)	1.00%	07/19/24		62,851		59,525			61,594		^{(2) (4)}
Integral Ad Science, Inc.	Interactive Media & Services		L + 6.00%	1.00%	07/19/23		4,402		(108	)		(88	)	^{(2) (3) (4)}
Internet Truckstop Group, LLC (dba Truckstop)	Transportation Infrastructure	6.50%	L + 5.50%	1.00%	04/02/25		54,037		51,511			52,956		^{(2) (4)}
Internet Truckstop Group, LLC (dba Truckstop)	Transportation Infrastructure		L + 5.50%	1.00%	04/02/25		4,400		(82	)		(88	)	^{(2) (3) (4)}

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of December 31, 2020 (continued)

(in thousands, except share and per share amounts)

Investment *	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
Iracore International Holdings, Inc.	Energy Equipment & Services	10.00%	L + 9.00%	1.00%	04/12/21	$	2,361	$	2,361		$	2,361		^{^ (4)}
Jill Acquisition LLC (dba J. Jill)	Specialty Retail	6.00%	L + 5.00%	1.00%	05/08/24		6,622		6,554			4,503
Kawa Solar Holdings Limited	Construction & Engineering				12/31/21		3,917		3,603			1,359		^{^ (1) (4) (6)}
Kawa Solar Holdings Limited	Construction & Engineering				12/31/21		3,318		800			—		^{^ (1) (4) (6)}
Lithium Technologies, Inc.	Interactive Media & Services	9.00%	L + 8.00%	1.00%	10/03/22		89,013		84,252			85,230		^{(2) (4)}
Lithium Technologies, Inc.	Interactive Media & Services	9.00%	L + 8.00%	1.00%	10/03/22		5,110		1,896			1,827		^{(2) (3) (4)}
Mailgun Technologies, Inc.	Interactive Media & Services	6.00%	L + 5.00%	1.00%	03/26/25		38,673		37,340			38,673		^{(2) (4)}
Mailgun Technologies, Inc.	Interactive Media & Services		L + 5.00%	1.00%	03/26/25		2,441		—			—		^{(2) (3) (4)}
MedeAnalytics, Inc.	Health Care Technology	7.50%	L + 6.50%	1.00%	10/09/26		957		907			929		^{(2) (4)}
Mervin Manufacturing, Inc.	Leisure Products	8.50%	L + 7.50%	1.00%	09/30/22		10,777		10,776			10,346		⁽⁴⁾
MMIT Holdings, LLC (dba Managed Markets Insight & Technology)	Health Care Technology	6.50%	L + 5.50%	1.00%	11/15/24		49,936		47,843			49,187		^{(2) (4)}
MMIT Holdings, LLC (dba Managed Markets Insight & Technology)	Health Care Technology	6.50%	L + 5.50%	1.00%	11/15/24		7,713		4,520			4,512		^{(2) (3) (4)}
MRI Software LLC	Real Estate Mgmt. & Development	6.50%	L + 5.50%	1.00%	02/10/26		23,030		21,825			22,358
MRI Software LLC	Real Estate Mgmt. & Development		L + 5.50%	1.00%	02/10/26		661		(17	)		(19	)	⁽³⁾
MRI Software LLC	Real Estate Mgmt. & Development		L + 5.50%	1.00%	02/10/26		1,612		(39	)		(47	)	⁽³⁾
Netvoyage Corporation (dba NetDocuments)	Software	8.00%	L + 7.00%	1.00%	03/22/24		16,284		15,596			15,958		^{(2) (4)}
Netvoyage Corporation (dba NetDocuments)	Software	8.00%	L + 7.00%	1.00%	03/22/24		9,875		9,362			9,677		^{(2) (4)}
Netvoyage Corporation (dba NetDocuments)	Software	8.00%	L + 7.00%	1.00%	03/22/24		1,672		1,602			1,639		^{(2) (4)}
Netvoyage Corporation (dba NetDocuments)	Software		L + 7.00%	1.00%	03/24/22		1,264		(20	)		(25	)	^{(2) (3) (4)}
One GI LLC	Health Care Providers & Services	8.00%	L + 7.00%	1.00%	12/22/25		9,500		9,311			9,310		⁽²⁾
One GI LLC	Health Care Providers & Services	8.00%	L + 7.00%	1.00%	12/22/25		23,100		1,262			1,276		^{(2) (3)}
One GI LLC	Health Care Providers & Services		L + 7.00%	1.00%	12/22/25		2,500		(50	)		(50	)	^{(2) (3)}
Output Services Group, Inc.	Diversified Consumer Services	5.50%	L + 4.50%	1.00%	03/27/24		3,902		3,891			2,848
Pharmalogic Holdings Corp.	Health Care Equipment & Supplies	6.25%	P + 3.00%		06/11/23		3,205		3,201			3,093		⁽⁴⁾
Pharmalogic Holdings Corp.	Health Care Equipment & Supplies	6.25%	P + 3.00%		06/11/23		1,742		1,740			1,681		⁽⁴⁾
Pharmalogic Holdings Corp.	Health Care Equipment & Supplies	6.25%	P + 3.00%		06/11/23		1,712		1,706			1,652		⁽⁴⁾
Pharmalogic Holdings Corp.	Health Care Equipment & Supplies	6.25%	P + 3.00%		06/11/23		920		919			888		⁽⁴⁾
Picture Head Midco LLC	Entertainment	8.25%	L + 7.25% (incl. 0.50% PIK)	1.00%	08/31/23		45,848		42,105			41,722		^{(2) (4)}
PlanSource Holdings, Inc.	Health Care Technology	7.25%	L + 6.25%	1.00%	04/22/25		56,720		53,667			55,727		^{(2) (4)}
PlanSource Holdings, Inc.	Health Care Technology		L + 6.25%	1.00%	04/22/25		7,824		(201	)		(137	)	^{(2) (3) (4)}
Power Stop, LLC	Auto Components	4.65%	L + 4.50%		10/19/25		18,130		17,116			17,699		⁽²⁾
Premier Imaging, LLC (dba Lucid Health)	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	01/02/25		28,736		27,082			27,659		^{(2) (4)}
Professional Physical Therapy	Health Care Providers & Services	9.50%	L + 8.50% (incl. 2.50% PIK)	1.00%	12/16/22		5,871		5,402			5,167		⁽⁴⁾
Project Eagle Holdings, LLC (dba Exostar)	Aerospace & Defense	9.25%	L + 8.25%	1.00%	07/06/26		902		859			882		^{(2) (4)}
Project Eagle Holdings, LLC (dba Exostar)	Aerospace & Defense		L + 8.25%	1.00%	07/06/26		75		(2	)		(2	)	^{(2) (3) (4)}
PT Intermediate Holdings III, LLC (dba Parts Town)	Trading Companies & Distributors	6.50%	L + 5.50%	1.00%	10/15/25		28,789		26,740			26,774		⁽²⁾
Purfoods, LLC	Health Care Providers & Services	7.25%	L + 6.25%	1.00%	08/12/26		599		571			590		^{(2) (4)}

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of December 31, 2020 (continued)

(in thousands, except share and per share amounts)

Investment *	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost			Fair Value			Footnotes
Purfoods, LLC	Health Care Providers & Services		L + 6.25%	1.00%	08/12/26	$	400	$	(5	)	$	(6	)	^{(2) (3) (4)}
Riverpoint Medical, LLC	Health Care Equipment & Supplies	5.50%	L + 4.50%	1.00%	06/21/25		22,178		21,055			21,624		^{(2) (4)}
Riverpoint Medical, LLC	Health Care Equipment & Supplies		L + 4.50%	1.00%	06/21/25		4,094		(94	)		(102	)	^{(2) (3) (4)}
Selectquote, Inc.	Insurance	7.00%	L + 6.00%	1.00%	11/05/24		20,265		19,560			20,265		⁽²⁾
SF Home Décor, LLC (dba SureFit Home Décor)	Household Products	10.75%	L + 9.75%	1.00%	07/13/22		42,160		38,927			40,790		^{(2) (4)}
SPay, Inc. (dba Stack Sports)	Interactive Media & Services	8.75%	L + 7.75% (incl. 2.00% PIK)	1.00%	06/17/24		26,157		23,672			23,149		^{(2) (4)}
SPay, Inc. (dba Stack Sports)	Interactive Media & Services	8.75%	L + 7.75% (incl. 2.00% PIK)	1.00%	06/17/24		1,899		1,719			1,681		^{(2) (4)}
SPay, Inc. (dba Stack Sports)	Interactive Media & Services	8.75%	L + 7.75% (incl. 2.00% PIK)	1.00%	06/17/24		951		861			841		^{(2) (4)}
Sunstar Insurance Group, LLC	Insurance	6.50%	L + 5.50%	1.00%	10/09/26		543		520			532		⁽²⁾
Sunstar Insurance Group, LLC	Insurance		L + 5.50%	1.00%	10/09/26		111		(2	)		(2	)	^{(2) (3)}
Sunstar Insurance Group, LLC	Insurance		L + 5.50%	1.00%	10/09/26		344		(7	)		(7	)	^{(2) (3)}
Superman Holdings, LLC (dba Foundation Software)	Construction & Engineering	10.25%	P + 7.00%		08/31/27		855		814			833		^{(2) (4)}
Superman Holdings, LLC (dba Foundation Software)	Construction & Engineering		P + 7.00%		08/31/26		122		(3	)		(3	)	^{(2) (3) (4)}
Sweep Purchaser LLC	Commercial Services & Supplies	6.75%	L + 5.75%	1.00%	11/30/26		28,608		28,042			28,036		⁽²⁾
Sweep Purchaser LLC	Commercial Services & Supplies		L + 5.75%	1.00%	11/30/26		9,082		(90	)		(91	)	^{(2) (3)}
Sweep Purchaser LLC	Commercial Services & Supplies		L + 5.75%	1.00%	11/30/26		4,541		(90	)		(91	)	^{(2) (3)}
Syntellis Performance Solutions, LLC (dba Axiom)	Health Care Technology	9.00%	L + 8.00%	1.00%	08/02/27		837		793			812		^{(2) (4)}
The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)	Health Care Providers & Services	6.25%	L + 5.25%	1.00%	08/15/25		26,596		25,205			25,732		^{(2) (4)}
The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)	Health Care Providers & Services		L + 5.25%	1.00%	08/15/25		4,565		(112	)		(148	)	^{(2) (3) (4)}
Thrasio, LLC	Internet & Direct Marketing Retail	8.00%	L + 7.00%	1.00%	12/18/26		15,130		14,753			14,752		⁽²⁾
Thrasio, LLC	Internet & Direct Marketing Retail		L + 7.00%	1.00%	12/18/26		9,990		(124	)		(125	)	^{(2) (3)}
Tronair Parent Inc.	Air Freight & Logistics	5.75%	L + 4.75%	1.00%	09/08/23		6,703		6,674			5,463
U.S. Acute Care Solutions, LLC	Health Care Providers & Services	7.00%	L + 6.00%	1.00%	05/17/21		6,271		6,265			5,832
US Med Acquisition, Inc.	Health Care Equipment & Supplies	9.00%	L + 8.00%	1.00%	02/14/23		29,334		29,145			28,894		⁽⁴⁾
USN Opco LLC (dba Global Nephrology Solutions)	Health Care Providers & Services	6.50%	L + 5.50%	1.00%	12/21/26		22,038		21,599			21,597		⁽²⁾
USN Opco LLC (dba Global Nephrology Solutions)	Health Care Providers & Services		L + 5.50%	1.00%	12/21/26		3,023		(60	)		(60	)	^{(2) (3)}
USN Opco LLC (dba Global Nephrology Solutions)	Health Care Providers & Services		L + 5.50%	1.00%	12/21/26		7,600		(76	)		(76	)	^{(2) (3)}
Viant Medical Holdings, Inc.	Health Care Equipment & Supplies	7.25%	L + 6.25%	1.00%	07/02/25		31,785		29,831			30,990		⁽²⁾
Villa Bidco Inc (dba Authority Brands)	Diversified Consumer Services	6.75%	L + 5.75%	1.00%	03/21/25		26,754		25,488			26,219		^{(2) (4)}
Villa Bidco Inc (dba Authority Brands)	Diversified Consumer Services	8.00%	P + 4.75%		03/21/25		2,162		257			255		^{(2) (3) (4)}
VRC Companies, LLC (dba Vital Records Control)	Commercial Services & Supplies	7.50%	L + 6.50%	1.00%	03/31/23		28,403		27,744			28,190		⁽⁴⁾
VRC Companies, LLC (dba Vital Records Control)	Commercial Services & Supplies		P + 5.50%		03/31/22		1,131		(7	)		(8	)	^{(3) (4)}
WebPT, Inc.	Health Care Technology	7.75%	L + 6.75%	1.00%	08/28/24		25,126		23,720			24,372		^{(2) (4)}
WebPT, Inc.	Health Care Technology	7.75%	L + 6.75%	1.00%	08/28/24		2,617		710			707		^{(2) (3) (4)}
WebPT, Inc.	Health Care Technology		L + 6.75%	1.00%	08/28/24		3,141		(80	)		(94	)	^{(2) (3) (4)}
Wellness AcquisitionCo, Inc. (dba SPINS)	IT Services		L + 5.75%	1.00%	01/20/27		20,100		—			—		^{(2) (3)}
Wellness AcquisitionCo, Inc. (dba SPINS)	IT Services		L + 5.75%	1.00%	01/20/27		2,600		—			—		^{(2) (3)}
Wine.com, LLC	Beverages	8.00%	L + 7.00%	1.00%	11/14/24		15,400		14,861			15,400		^{(2) (4)}
WorkForce Software, LLC	Software	7.50%	L + 6.50%	1.00%	07/31/25		21,616		20,569			21,292		^{(2) (4)}
WorkForce Software, LLC	Software		L + 6.50%	1.00%	07/31/25		1,894		(39	)		(28	)	^{(2) (3) (4)}
Wrike, Inc.	Professional Services	7.75%	L + 6.75%	1.00%	12/31/24		54,964		53,081			54,964		^{(2) (4)}
Wrike, Inc.	Professional Services		L + 6.75%	1.00%	12/31/24		3,900		(21	)		—		^{(2) (3) (4)}
Xactly Corporation	IT Services	8.25%	L + 7.25%	1.00%	07/29/22		62,025		59,755			61,560		^{(2) (4)}
Xactly Corporation	IT Services		L + 7.25%	1.00%	07/29/22		3,874		(44	)		(29	)	^{(2) (3) (4)}
Yasso, Inc.	Food Products	8.75%	L + 7.75%	1.00%	03/23/22		15,264		14,906			15,264		^{(2) (4)}
Zodiac Intermediate, LLC (dba Zipari)	Health Care Technology	8.50%	L + 7.50%	1.00%	12/21/26		50,230		48,900			48,894		⁽²⁾
Zodiac Intermediate, LLC (dba Zipari)	Health Care Technology		L + 7.50%	1.00%	12/22/25		7,500		(198	)		(200	)	^{(2) (3)}
Total 1st Lien/Senior Secured Debt									2,489,285			2,526,969

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of December 31, 2020 (continued)

(in thousands, except share and per share amounts)

Investment *	Industry	Interest Rate (+)	Reference Rate and Spread (+)	Floor (+)	Maturity	Par/Shares (++)		Cost		Fair Value		Footnotes
1st Lien/Last-Out Unitranche⁽⁷⁾ - 8.87%
Doxim, Inc.	Diversified Financial Services	7.00%	L + 6.00%	1.00%	02/28/24	$	39,200	$	37,078	$	38,220	^{(2) (4)}
Doxim, Inc.	Diversified Financial Services	7.00%	L + 6.00%	1.00%	02/28/24		23,000		21,435		22,425	^{(2) (4)}
Doxim, Inc.	Diversified Financial Services	9.00%	L + 8.00%	1.00%	02/28/24		5,300		5,150		5,167	^{(2) (4)}
Doxim, Inc.	Diversified Financial Services	9.00%	L + 8.00%	1.00%	02/28/24		3,971		3,873		3,872	^{(2) (4)}
RugsUSA, LLC	Household Products	7.00%	L + 6.00%	1.00%	04/30/23		13,949		13,507		13,879	^{(2) (4)}
Smarsh, Inc.	Interactive Media & Services	9.25%	L + 8.25%	1.00%	11/20/25		60,886		57,917		59,668	⁽²⁾
Total 1st Lien/Last-Out Unitranche									138,960		143,231
2nd Lien/Senior Secured Debt - 28.34%
American Dental Partners, Inc.	Health Care Providers & Services	9.50%	L + 8.50%	1.00%	09/25/23		11,070		10,370		10,406	^{(2) (4)}
Animal Supply Intermediate, LLC	Distributors	7.00%	7.00% PIK		11/14/25		8,471		7,926		7,352	^{^ (4)}
Bolttech Mannings, Inc.	Commercial Services & Supplies	8.23%	L + 8.00% PIK		11/20/22		13,697		13,515		13,423	^{^^ (4)}
Chase Industries, Inc. (dba Senneca Holdings)	Building Products	10.00%	10.00% PIK		11/11/25		12,150		9,521		9,234	^{(2) (4)}
Chase Industries, Inc. (dba Senneca Holdings)	Building Products		11.00% PIK		05/11/26		12,150	—		—		^{(2) (4) (5)}
ERC Finance, LLC (dba Eating Recovery Center)	Health Care Providers & Services	9.22%	L + 8.22%	1.00%	09/22/25		45,200		42,860		44,522	^{(2) (4)}
Genesis Acquisition Co. (dba ProCare Software)	Diversified Financial Services	7.73%	L + 7.50%		07/31/25		17,000		15,523		15,470	^{(2) (4)}
Genesis Acquisition Co. (dba ProCare Software)	Diversified Financial Services	7.73%	L + 7.50%		07/31/25		4,300		3,927		3,913	^{(2) (4)}
GK Holdings, Inc. (dba Global Knowledge)	IT Services		L + 12.25%	1.00%	01/20/22		3,000		2,977		1,650	^{(4) (5)}
Hygiena Borrower LLC	Life Sciences Tools & Services	8.75%	L + 7.75%	1.00%	08/26/23		4,510		4,283		4,454	⁽⁴⁾
Hygiena Borrower LLC	Life Sciences Tools & Services	8.75%	L + 7.75%	1.00%	08/26/23		236		224		233	⁽⁴⁾
IHS Intermediate Inc. (dba Interactive Health Solutions)	Health Care Providers & Services		L + 8.25%	1.00%	07/20/22		10,000		9,902	—		^{(4) (5)}
Intelligent Medical Objects, Inc.	Health Care Technology	9.50%	L + 8.50%	1.00%	12/22/24		21,900		20,307		21,353	^{(2) (4)}
Market Track, LLC	Media	8.75%	L + 7.75%	1.00%	06/05/25		42,200		39,989		40,512	^{(2) (4)}
MPI Engineered Technologies, LLC	Auto Components	12.00%	12.00% PIK		07/15/25		13,996		13,996		12,666	⁽⁴⁾
MPI Products LLC	Auto Components				07/15/25		7,412	—		—		^{(4) (6)}
National Spine and Pain Centers, LLC	Health Care Providers & Services	9.25%	L + 8.25%	1.00%	12/02/24		36,500		34,647		35,222	^{(2) (4)}
Odyssey Logistics & Technology Corporation	Road & Rail	9.00%	L + 8.00%	1.00%	10/12/25		45,348		39,486		38,886	⁽²⁾
SMB Shipping Logistics, LLC (dba Worldwide Express)	Air Freight & Logistics	9.00%	L + 8.00%	1.00%	02/03/25		66,667		63,579		63,333	^{(2) (4)}
Spectrum Plastics Group, Inc.	Containers & Packaging	8.00%	L + 7.00%	1.00%	01/31/26		12,525		11,176		10,975	⁽²⁾
USRP Holdings, Inc. (dba U.S. Retirement Partners)	Insurance	9.75%	L + 8.75%	1.00%	09/29/25		9,700		8,744		9,239	^{(2) (4)}
USRP Holdings, Inc. (dba U.S. Retirement Partners)	Insurance	9.75%	L + 8.75%	1.00%	09/29/25		1,584		1,428		1,509	^{(2) (4)}
Xcellence, Inc. (dba Xact Data Discovery)	IT Services	9.75%	L + 8.75%	1.00%	06/22/24		26,100		23,744		25,708	^{(2) (4)}
YI, LLC (dba Young Innovations)	Health Care Equipment & Supplies	8.75%	L + 7.75%	1.00%	11/07/25		36,844		33,502		35,002	^{(2) (4)}
Zep Inc.	Chemicals	9.25%	L + 8.25%	1.00%	08/11/25		54,300		47,292		52,671	⁽²⁾
Total 2nd Lien/Senior Secured Debt									458,918		457,733
Unsecured Debt - 0.02%
Conergy Asia & ME Pte. LTD.	Construction & Engineering				06/30/21		1,266		1,055		334	^{^ (1) (4) (6)}
Total Unsecured Debt									1,055		334

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of December 31, 2020 (continued)

(in thousands, except share and per share amounts)

Investment *	Industry	Interest Rate	Initial Acquisition Date⁽⁸⁾	Par/Shares (++)		Cost		Fair Value		Footnotes
Preferred Stock - 2.98%
CB-HDT Holdings, Inc. (dba Hunter Defense Technologies)	Aerospace & Defense		07/01/16		1,108,333		10,185		34,591	^{^ (4) (6)}
Conergy Asia Holdings, Ltd.	Construction & Engineering		08/23/17		600,000		600	—		^{^ (1) (4) (6)}
Exostar LLC - Class A	Aerospace & Defense		07/06/20		20		20		21	^{(2) (4) (6)}
Foundation Software	Construction & Engineering		08/31/20		22		21		23	^{(2) (4) (6)}
Kawa Solar Holdings Limited	Construction & Engineering	8.00% PIK	10/25/16		68,505		778	—		^{^ (1) (4) (5)}
MedeAnalytics, Inc.	Health Care Technology		10/09/20		42,600		42		43	⁽²⁾
Wine.com, LLC	Beverages		11/14/18		535,226		8,225		13,402	^{(2) (4) (6)}
Total Preferred Stock							19,871		48,080
Common Stock - 4.05%
Animal Supply Holdings, LLC	Distributors		08/14/20		83,333		13,745		8,462	^{^ (4)}
Animal Supply Holdings, LLC	Distributors		08/14/20		37,500		126	—		^{^ (4)}
Bolttech Mannings, Inc.	Commercial Services & Supplies		12/22/17		309,142		14,885		6,387	^{^^ (4) (6)}
CB-HDT Holdings, Inc. (dba Hunter Defense Technologies)	Aerospace & Defense		07/01/16		453,383		2,393		14,150	^{^ (4) (6)}
Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Class B	Health Care Providers & Services		03/30/18		20,183		2,916		3,498	^{^^^ (2) (4)}
Collaborative Imaging Holdco, LLC (dba Texas Radiology Associates) - Performance Units	Health Care Providers & Services		03/30/18		19,048		514		867	^{^^^ (1) (2) (4) (6)}
Conergy Asia Holdings, Ltd.	Construction & Engineering		07/31/17		2,000		4,700	—		^{^ (1) (4) (6)}
Country Fresh Holding Company Inc.	Food Products		04/29/19		1,514		888		10	^{(2) (4) (6)}
Elah Holdings, Inc.	Capital Markets		05/09/18		111,650		5,238		5,396	^{^ (2) (4) (6)}
Exostar LLC - Class B	Aerospace & Defense		07/06/20		31,407	—			8	^{(2) (4) (6)}
Foundation Software - Class B	Construction & Engineering		08/31/20		11,826	—		—		^{(2) (4) (6)}
Iracore International Holdings, Inc.	Energy Equipment & Services		04/13/17		28,898		7,003		7,817	^{^ (4) (6)}
Jill Acquisition LLC (dba J. Jill)	Specialty Retail		09/30/20		18,869		56		70
Kawa Solar Holdings Limited	Construction & Engineering		08/17/16		1,399,556	—		—		^{^ (1) (4) (6)}
National Spine and Pain Centers, LLC	Health Care Providers & Services		06/02/17		1,100		883		669	^{(2) (4) (6)}
Prairie Provident Resources, Inc.	Oil, Gas & Consumable Fuels				3,579,988		9,237		41	^{(1) (6)}
Wrike, Inc.	Professional Services		12/31/18		8,434,304		9,783		16,784	^{(2) (4) (6)}
Yasso, Inc.	Food Products		03/23/17		1,640		1,368		1,236	^{(2) (4) (6)}
Total Common Stock							73,735		65,395
Warrants - 0.06%
Animal Supply Holdings, LLC	Distributors		08/14/20		1		756		1,024	^{^ (4) (9)}
KDOR Holdings Inc. (dba Senneca Holdings)	Building Products		06/22/20		147	—		—		^{(2) (4)}
KDOR Holdings Inc. (dba Senneca Holdings)	Building Products		05/29/20		1,406	—		—		^{(2) (4)}
KDOR Holdings Inc. (dba Senneca Holdings)	Building Products		05/29/20		30	—		—		^{(2) (4)}
Total Warrants							756		1,024
Total Investments - 200.78%						$	3,182,580	$	3,242,766

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Consolidated Schedule of Investments as of December 31, 2020 (continued)

(in thousands, except share and per share amounts)

^*	Assets are pledged as collateral for the Revolving Credit Facility. See Note 6 “Debt”.
⁽⁺⁾	Represents the actual interest rate for partially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by the larger of the floor or the reference to either LIBOR ("L") or alternate base rate (commonly based on the Prime Rate ("P")), at the borrower’s option, which reset periodically based on the terms of the credit agreement. L loans are typically indexed to 12 month, 6 month, 3 month, 2 month, 1 month or 1 week L rates. As of December 31, 2020, rates for the 12 month, 6 month, 3 month, 2 month, 1 month and 1 week L are 0.34%, 0.26%, 0.24%, 0.19%, 0.14% and 0.10%. As of December 31, 2020, P was 3.25%. For investments with multiple reference rates or alternate base rates, the interest rate shown is the weighted average interest rate in effect at December 31, 2020.
⁽⁺⁺⁾	The total par amount is presented for debt investments, while the number of shares or units owned is presented for equity investments. Par amount is denominated in U.S. Dollars ("$") unless otherwise noted, Euro ("€").
^#	Percentages are based on net assets.
^{^}	As defined in the Investment Company Act, the investment is deemed to be an “affiliated person” of the Company because the Company owns, either directly or indirectly, 5% or more of the portfolio company’s outstanding voting securities. See Note 3 “Significant Agreements and Related Party Transactions”.
^{^^}	As defined in the Investment Company Act, the investment is deemed to be a “controlled affiliated person” of the Company because the Company owns, either directly or indirectly, 25% or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. See Note 3 “Significant Agreements and Related Party Transactions”.
^{^^^}	The investment is otherwise deemed to be an “affiliated person” of the Company. See Note 3 “Significant Agreements and Related Party Transactions”.
⁽¹⁾	The investment is not a qualifying asset under Section 55(a) of the Investment Company Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company’s total assets. As of December 31, 2020 the aggregate fair value of these securities is $96,067 or 2.90% of the Company’s total assets.
⁽²⁾	Represent co-investments made with the Company’s affiliates in accordance with the terms of the exemptive relief received from the U.S. Securities and Exchange Commission. See Note 3 “Significant Agreements and Related Party Transactions”.
⁽³⁾	Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. The negative cost, if applicable, is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value, if applicable, is the result of the capitalized discount on the loan. See Note 8 "Commitments and Contingencies".
⁽⁴⁾	The fair value of the investment was determined using significant unobservable inputs. See Note 5 “Fair Value Measurement”.
⁽⁵⁾	The investment is on non-accrual status. See Note 2 “Significant Accounting Policies”.
⁽⁶⁾	Non-income producing security.
⁽⁷⁾	In exchange for the greater risk of loss, the “last-out” portion of the Company's unitranche loan investment generally earns a higher interest rate than the “first-out” portions. The “first-out” portion would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion.
⁽⁸⁾	Securities exempt from registration under the Securities Act of 1933, and may be deemed to be “restricted securities”. As of December 31, 2020, the aggregate fair value of these securities is $114,458 or 7.09% of the Company's net assets. The initial acquisition dates have been included for such securities.

⁽⁹⁾	Right to purchase up to $8,851 of 1st Lien Senior Secured Debt, $7,483 of 2nd Lien Senior Secured Debt and 68,796 shares of Class A Units, which expires November 2021.

PIK – Payment-In-Kind

ADDITIONAL INFORMATION

Foreign currency forward contracts

Counterparty	Currency Purchased	Currency Sold	Settlement	Unrealized Appreciation (Depreciation)
Bank of America, N.A.	U.S. Dollar 528	Euro 468	01/05/21	$	(45	)
Bank of America, N.A.	U.S. Dollar 716	Euro 635	01/05/21		(60	)
Bank of America, N.A.	U.S. Dollar 702	Euro 620	04/06/21		(57	)
Bank of America, N.A.	U.S. Dollar 517	Euro 457	04/06/21		(42	)
Bank of America, N.A.	U.S. Dollar 701	Euro 617	07/06/21		(56	)
Bank of America, N.A.	U.S. Dollar 517	Euro 455	07/06/21		(41	)
Bank of America, N.A.	U.S. Dollar 400	Euro 350	10/05/21		(31	)
Bank of America, N.A.	U.S. Dollar 294	Euro 258	10/05/21		(23	)
				$	(355	)

The accompanying notes are part of these unaudited consolidated financial statements.

Table of Contents

Goldman Sachs BDC, Inc.

Notes to the Consolidated Financial Statements

(in thousands, except share and per share amounts)

(Unaudited)

1.ORGANIZATION

Goldman Sachs BDC, Inc. (the “Company,” which term refers to either Goldman Sachs BDC, Inc. or Goldman Sachs BDC, Inc. together with its consolidated subsidiaries, as the context may require) was initially established as Goldman Sachs Liberty Harbor Capital, LLC, a single member Delaware limited liability company (“SMLLC”), on September 26, 2012 and commenced operations on November 15, 2012 with The Goldman Sachs Group, Inc. (“Group Inc.”) as its sole member. On March 29, 2013, the Company elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Effective April 1, 2013, the Company converted from a SMLLC to a Delaware corporation. In addition, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2013.

The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including first lien debt, unitranche loans, including last-out portions of such loans, and second lien debt, and unsecured debt, including mezzanine debt, as well as through select equity investments.

Goldman Sachs Asset Management, L.P. (“GSAM”), a Delaware limited partnership and an affiliate of Goldman Sachs & Co. LLC (including its predecessors, “GS & Co.”), is the investment adviser (the “Investment Adviser”) of the Company. The term “Goldman Sachs” refers to Group Inc., together with GS & Co., GSAM and its other subsidiaries.

On March 23, 2015, the Company completed its initial public offering and the Company’s common stock began trading on the New York Stock Exchange under the symbol “GSBD.”

The Company has formed wholly owned subsidiaries, which are structured as Delaware limited liability companies, to hold certain equity or equity-like investments in portfolio companies.

The Merger with Goldman Sachs Middle Market Lending Corp.

On October 12, 2020, the Company completed its merger (the “Merger”) with Goldman Sachs Middle Market Lending Corp. (“GS MMLC”) pursuant to the Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 11, 2020. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of GS MMLC common stock was converted into the right to receive, for each share of GS MMLC common stock, that number of shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), with a net asset value (“NAV”) equal to the NAV per share of GS MMLC common stock, in each case calculated as of October 9, 2020. As a result of the Merger, the Company issued an aggregate of 61,037,311 shares of Common Stock to former GS MMLC stockholders. For further information, see Note 12 “Merger with GS MMLC.”

2.	SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The Company’s functional currency is U.S. dollars (“USD”) and these consolidated financial statements have been prepared in that currency. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to Regulation S-X. This requires the Company to make certain estimates and assumptions that may affect the amounts reported on the consolidated financial statements and accompanying notes. These consolidated financial statements reflect normal and recurring adjustments that in the opinion of the Company are necessary for the fair statement of the results for the periods presented. Actual results may differ from the estimates and assumptions included on the consolidated financial statements.

Certain financial information that is included in annual consolidated financial statements, including certain financial statement disclosures, prepared in accordance with GAAP, is not required for interim reporting purposes and has been condensed or omitted herein. These consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes related thereto for the year ended December 31, 2020, included in the Company’s annual report on Form 10-K, which was filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 25, 2021. The results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the full fiscal year, any other interim period or any future year or period.

Certain prior period information has been reclassified to conform to the current period presentation. The reclassification has no effect on the Company’s consolidated financial position or the consolidated results of operations as previously reported.

As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies (“ASC 946”) issued by the Financial Accounting Standards Board (“FASB”).

Table of Contents

Basis of Consolidation

As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. Accordingly, the Company consolidated the financial position and results of operations of its wholly owned subsidiaries, BDC Blocker I, LLC (formerly known as My-On BDC Blocker, LLC), GSBD Blocker II, LLC, GSBD Wine I, LLC, GSBD Blocker III LLC, GSBD Blocker IV LLC, MMLC Blocker I, LLC, MMLC Blocker II, LLC, MMLC Wine I, LLC, and MMLC Blocker III LLC. All significant intercompany transactions and balances have been eliminated in consolidation.

Revenue Recognition

The Company records its investment transactions on a trade date basis, which is the date when the Company assumes the risks for gains and losses related to that instrument. Realized gains and losses are based on the specific identification method.

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis. Discounts and premiums to par value on investments purchased are accreted and amortized into interest income over the life of the respective investment using the effective interest method. Loan origination fees, original issue discount (“OID”) and market discounts or premiums are capitalized and amortized into interest income using the effective interest method or straight-line method, as applicable. Exit fees that are receivable upon repayment of a loan or debt security are amortized into interest income over the life of the respective investment. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income, for which the Company has earned the following:

	For the Three Months Ended				For the Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Prepayment premiums	$	838	$	464	$	1,512	$	564
Accelerated amortization of upfront loan origination fees and unamortized discounts	$	25,331	$	173	$	43,543	$	779

Fees received from portfolio companies (directors’ fees, consulting fees, administrative fees, tax advisory fees and other similar compensation) are paid to the Company, unless, to the extent required by applicable law or exemptive relief, if any, therefrom, the Company only receives its allocable portion of such fees when invested in the same portfolio company as another account managed by the Investment Adviser.

Dividend income on preferred equity investments is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity investments is recorded on the record date for private portfolio companies and on the ex-dividend date for publicly traded portfolio companies. Interest and dividend income are presented net of withholding tax, if any.

Certain investments may have contractual payment-in-kind (“PIK”) interest or dividends. PIK represents accrued interest or accumulated dividends that are added to the principal amount or shares (if equity) of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or upon the investment being called by the issuer. PIK is recorded as interest or dividend income, as applicable. If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest or dividends are generally reversed through interest or dividend income.

Certain structuring fees, amendment fees, syndication fees and commitment fees are recorded as other income when earned. Administrative agent fees received by the Company are recorded as other income when the services are rendered over time.

Non-Accrual Investments

Investments are placed on non-accrual status when it is probable that principal, interest or dividends will not be collected according to the contractual terms. Accrued interest or dividends generally are reversed when an investment is placed on non-accrual status. Interest or dividend payments received on non-accrual investments may be recognized as income or applied to principal depending upon management’s judgment. Non-accrual investments are restored to accrual status when past due principal and interest or dividends are paid and, in management’s judgment, principal and interest or dividend payments are likely to remain current. The Company may make exceptions to this treatment if an investment has sufficient collateral value and is in the process of collection. As of September 30, 2021, the Company had certain investments held in three portfolio companies on non-accrual status, which represented 0.7% and 0.1% of the total investments (excluding investments in money market funds, if any) at amortized cost and at fair value. As of December 31, 2020, the Company had certain investments held in four portfolio companies on non-accrual status, which represented 0.7% and 0.3% of the total investments (excluding investments in money market funds, if any) at amortized cost and at fair value.

Table of Contents

Investments

The Company carries its investments in accordance with ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), issued by the FASB, which defines fair value, establishes a framework for measuring fair value and requires disclosures about fair value measurements. Fair value is generally based on quoted market prices provided by independent pricing services, broker or dealer quotations or alternative price sources. In the absence of quoted market prices, broker or dealer quotations or alternative price sources, investments are measured at fair value as determined by the board of directors (the “Board of Directors”) within the meaning of the Investment Company Act.

Due to the inherent uncertainties of valuation, certain estimated fair values may differ significantly from the values that would have been realized had a ready market for these investments existed, and these differences could be material. See Note 5 “Fair Value Measurement”.

The Company generally invests in illiquid securities, including debt and equity investments, of middle-market companies. The Board of Directors has delegated to the Investment Adviser day-to-day responsibility for implementing and maintaining internal controls and procedures related to the valuation of the Company’s portfolio investments. Under valuation procedures adopted by the Board of Directors, market quotations are generally used to assess the value of the investments for which market quotations are readily available. The Investment Adviser obtains these market quotations from independent pricing services or at the bid prices obtained from at least two brokers or dealers, if available; otherwise from a principal market maker or a primary market dealer. To assess the continuing appropriateness of pricing sources and methodologies, the Investment Adviser regularly performs price verification procedures and issues challenges as necessary to independent pricing services or brokers, and any differences are reviewed in accordance with the valuation procedures. If the Board of Directors or Investment Adviser has a bona fide reason to believe any such market quotation does not reflect the fair value of an investment, it may independently value such investment in accordance with valuation procedures for investments for which market quotations are not readily available.

With respect to investments for which market quotations are not readily available, or for which market quotations are deemed not reflective of the fair value, the valuation procedures adopted by the Board of Directors contemplate a multi-step valuation process each quarter, as described below:

(1)

The quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;

(2)

The Board of Directors also engages independent valuation firms (the “Independent Valuation Advisors”) to provide independent valuations of the investments for which market quotations are not readily available, or are readily available but deemed not reflective of the fair value of an investment. The Independent Valuation Advisors independently value such investments using quantitative and qualitative information provided by the investment professionals of the Investment Adviser and the portfolio companies as well as any market quotations obtained from independent pricing services, brokers, dealers or market dealers. The Independent Valuation Advisors also provide analyses to support their valuation methodology and calculations. The Independent Valuation Advisors provide an opinion on a final range of values on such investments to the Board of Directors or the Audit Committee. The Independent Valuation Advisors define fair value in accordance with ASC 820 and utilize valuation approaches including the market approach, the income approach or both. A portion of the portfolio is reviewed on a quarterly basis, and all investments in the portfolio for which market quotations are not readily available, or are readily available, but deemed not reflective of the fair value of an investment, are reviewed at least annually by an Independent Valuation Advisor;

(3)

The Independent Valuation Advisors’ preliminary valuations are reviewed by the Investment Adviser and the Valuation Oversight Group (“VOG”), a team that is part of the Controllers Department within the Finance Division of Goldman Sachs. The Independent Valuation Advisors’ valuation ranges are compared to the Investment Adviser’s valuations to ensure the Investment Adviser’s valuations are reasonable. VOG presents the valuations to the Asset Management Private Investment Valuation and Side Pocket Working Group of the Asset Management Valuation Committee, which is comprised of representatives from GSAM who are independent of the investment decision making process;

(4)

The Asset Management Valuation Committee ratifies fair valuations and makes recommendations to the Audit Committee of the Board of Directors;

(5)

The Audit Committee of the Board of Directors reviews valuation information provided by the Asset Management Division Valuation Committee, the Investment Adviser and the Independent Valuation Advisors. The Audit Committee then assesses such valuation recommendations; and

(6)

The Board of Directors discusses the valuations and, within the meaning of the Investment Company Act, determines the fair value of the investments in good faith, based on the inputs of the Investment Adviser, the Independent Valuation Advisors and the Audit Committee.

Money Market Funds

Investments in money market funds are valued at NAV per share. See Note 3 “Significant Agreements and Related Party Transactions.”

Table of Contents

Cash

Cash consists of deposits held at a custodian bank. As of September 30, 2021 and December 31, 2020, the Company held an aggregate cash balance of $171,600 and $32,137. Foreign currency of $2,243 and $1,831 (acquisition cost of $2,389 and $1,765) is included in cash as of September 30, 2021 and December 31, 2020.

Foreign Currency Translation

Amounts denominated in foreign currencies are translated into USD on the following basis: (i) investments and other assets and liabilities denominated in foreign currencies are translated into USD based upon currency exchange rates effective on the last business day of the period; and (ii) purchases and sales of investments, borrowings and repayments of such borrowings, income, and expenses denominated in foreign currencies are translated into USD based upon currency exchange rates prevailing on the transaction dates.

The Company does not isolate the portion of the results of operations resulting from changes in foreign exchange rates on investments from fluctuations arising from changes in market prices of securities held. Such fluctuations are included within the net realized and unrealized gains or losses on investments. Fluctuations arising from the translation of non-investment assets and liabilities are included with the net change in unrealized gains (losses) on foreign currency translations on the Consolidated Statements of Operations.

Foreign security and currency translations may involve certain considerations and risks not typically associated with investing in U.S. companies and U.S. government securities. These risks include, but are not limited to, currency fluctuations and revaluations and future adverse political, social and economic developments, which could cause investments in foreign markets to be less liquid and prices more volatile than those of comparable U.S. companies or U.S. government securities.

Derivatives

The Company may enter into foreign currency forward contracts to reduce the Company’s exposure to foreign currency exchange rate fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another, at a pre-determined price at a future date. Forward foreign currency contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts are recorded on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Notional amounts of foreign currency forward contract assets and liabilities are presented separately on the Consolidated Schedules of Investments. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting and as such, the Company recognizes its derivatives at fair value with changes in the net unrealized appreciation (depreciation) on foreign currency forward contracts recorded on the Consolidated Statements of Operations.

Income Taxes

The Company recognizes tax positions in its consolidated financial statements only when it is more likely than not that the position will be sustained upon examination by the relevant taxing authority based on the technical merits of the position. A position that meets this standard is measured at the largest amount of benefit that will more likely than not be realized upon settlement. The Company reports any interest expense related to income tax matters in income tax expense, and any income tax penalties under expenses on the Consolidated Statements of Operations.

The Company’s tax positions have been reviewed based on applicable statutes of limitation for tax assessments, which may vary by jurisdiction, and based on such review, the Company has concluded that no additional provision for income tax is required on the consolidated financial statements. The Company is subject to potential examination by certain taxing authorities in various jurisdictions. The Company’s tax positions are subject to ongoing interpretation of laws and regulations by taxing authorities.

The Company has elected to be treated as a RIC commencing with its taxable year ended December 31, 2013. So long as the Company maintains its status as a RIC, it will generally not be required to pay corporate-level U.S. federal income tax on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. As a result, any U.S. federal income tax liability related to income earned and distributed by the Company represents obligations of the Company’s stockholders and will not be reflected on the consolidated financial statements of the Company.

To maintain its tax treatment as a RIC, the Company must meet specified source-of-income and asset diversification requirements and timely distribute to its stockholders for each taxable year at least 90% of its investment company taxable income (generally, its net ordinary income plus the excess of its realized net short-term capital gains over realized net long-term capital losses, determined without regard to the dividends paid deduction). In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income as required. For the three and nine months ended September 30, 2021, the Company accrued excise taxes of $308 and $924. As of September 30, 2021, $1,026 of accrued excise taxes remained payable. For the three and nine months ended September 30, 2020, the Company accrued excise taxes of $389 and $1,205.

Table of Contents

Certain of the Company’s consolidated subsidiaries are subject to U.S. federal and state corporate-level income taxes. Income tax expense, if any, is included under the income category for which it applies on the Consolidated Statements of Operations.

Distributions

Distributions from net investment income and net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with GAAP. The Company may pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce the stockholder’s tax basis in its shares. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent they are charged or credited to paid-in capital in excess of par or distributable earnings, as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Company’s annual RIC tax return. Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a distribution is determined by the Board of Directors each quarter and is generally based upon the earnings estimated by the Investment Adviser. The Company may pay distributions to its stockholders in a year in excess of its net ordinary income and capital gains for that year and, accordingly, a portion of such distributions may constitute a return of capital for U.S. federal income tax purposes. The Company intends to timely distribute to its stockholders substantially all of its annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and may carry forward taxable income for distribution in the following year and pay any applicable tax. The specific tax characteristics of the Company’s distributions will be reported to stockholders after the end of the calendar year. All distributions will be subject to available funds, and no assurance can be given that the Company will be able to declare such distributions in future periods.

The Company has a dividend reinvestment plan that provides for reinvestment of all cash distributions declared by the Board of Directors unless a stockholder elects to “opt out” of the plan. As a result, if the Board of Directors declares a cash distribution, then the stockholders who have not “opted out” of the dividend reinvestment plan will have their cash distributions automatically reinvested in additional shares of common stock, rather than receiving the cash distribution. Stockholders who receive distributions in the form of shares of common stock will generally be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions and, for this purpose, stockholders receiving distributions in the form of stock will generally be treated as receiving distributions equal to the fair market value of the stock received through the plan; however, since their cash distributions will be reinvested, those stockholders will not receive cash with which to pay any applicable taxes. Due to regulatory considerations, Group Inc. has opted out of the dividend reinvestment plan, and GS & Co. has opted out of the dividend reinvestment plan in respect of shares of the Company’s common stock acquired through its 10b5-1 plan.

Deferred Financing and Debt Issuance Costs

Deferred financing and debt issuance costs consist of fees and expenses paid in connection with the closing of and amendments to the Company’s senior secured revolving credit agreement (as amended, the “Revolving Credit Facility”) with Truist Bank, as administrative agent, and Bank of America, N.A., as syndication agent, the offering of the Company’s 4.50% Convertible Notes due 2022 (the “Convertible Notes”), the offering of the Company’s 3.75% Notes due 2025 (the “2025 Notes”), and the offering of the Company’s 2.875% Notes due 2026 (the “2026 Notes”). The aforementioned costs are amortized using the straight-line method over each instrument’s term. Deferred financing costs related to the Revolving Credit Facility are presented separately as an asset on the Company’s Consolidated Statements of Assets and Liabilities. Deferred debt issuance costs related to the Convertible Notes, the 2025 Notes, and the 2026 Notes are presented net against the outstanding debt balance on the Consolidated Statements of Assets and Liabilities.

3.	SIGNIFICANT AGREEMENTS AND RELATED PARTY TRANSACTIONS

Investment Management Agreement

The Company has entered into an investment management agreement (the “Investment Management Agreement”) with the Investment Adviser, pursuant to which the Investment Adviser manages the Company’s investment program and related activities.

Management Fee

The Company pays the Investment Adviser a management fee (the “Management Fee”), accrued and payable quarterly in arrears. The Management Fee is calculated at an annual rate of 1.00% (0.25% per quarter) of the average value of the Company’s gross assets (excluding cash or cash equivalents but including assets purchased with borrowed amounts) at the end of each of the two most recently completed calendar quarters. The Management Fee for any partial quarter will be appropriately prorated.

For the three and nine months ended September 30, 2021, Management Fees amounted to $7,962 and $24,241 and the Investment Adviser voluntarily agreed to waive $0 and $500 of Management Fees. As of September 30, 2021, $7,962 remained payable. For the three and nine months ended September 30, 2020, Management Fees amounted to $3,618 and $10,901.

Table of Contents

Incentive Fee

The incentive fee (the “Incentive Fee”) consists of two components that are determined independent of each other, with the result that one component may be payable even if the other is not. The Incentive Fee is calculated as follows:

A portion of the Incentive Fee is based on income and a portion is based on capital gains, each as described below. The Investment Adviser is entitled to receive the Incentive Fee based on income if Ordinary Income (as defined below) exceeds a quarterly “hurdle rate” of 1.75%. For this purpose, the hurdle is computed by reference to the Company’s NAV and does not take into account changes in the market price of the Company’s common stock.

The Incentive Fee based on income is determined and paid quarterly in arrears at the end of each calendar quarter by reference to the Company’s aggregate net investment income, as adjusted as described below, from the calendar quarter then ending and the eleven preceding calendar quarters (such period the “Trailing Twelve Quarters”). The Incentive Fee based on capital gains is determined and paid annually in arrears at the end of each calendar year by reference to an “Annual Period,” which means the period beginning on January 1 of each calendar year and ending on December 31 of such calendar year or, in the case of the first and last year, the appropriate portion thereof.

The hurdle amount for the Incentive Fee based on income is determined on a quarterly basis and is equal to 1.75% multiplied by the Company’s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The hurdle amount is calculated after making appropriate adjustments for subscriptions (which includes all of the Company’s issuances of shares of its common stock, including issuances pursuant to its dividend reinvestment plan) and distributions that occurred during the relevant Trailing Twelve Quarters. The Incentive Fee for any partial period will be appropriately prorated.

i. Quarterly Incentive Fee Based on Income

For the portion of the Incentive Fee based on income, the Company pays the Investment Adviser a quarterly Incentive Fee based on the amount by which (A) aggregate net investment income (“Ordinary Income”) in respect of the relevant Trailing Twelve Quarters exceeds (B) the hurdle amount for such Trailing Twelve Quarters. The amount of the excess of (A) over (B) described in this paragraph for such Trailing Twelve Quarters is referred to as the “Excess Income Amount”. Ordinary Income is net of all fees and expenses, including the Management Fee but excluding any Incentive Fee.

The Incentive Fee based on income for each quarter is determined as follows:

•

No Incentive Fee based on income is payable to the Investment Adviser for any calendar quarter for which there is no Excess Income Amount;

•

100% of the Ordinary Income, if any, that exceeds the hurdle amount, but is less than or equal to an amount, referred to as the “Catch-up Amount,” determined as the sum of 2.1875% multiplied by the Company’s NAV at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters is included in the calculation of the Incentive Fee based on income; and

•

20% of the Ordinary Income that exceeds the Catch-up Amount is included in the calculation of the Incentive Fee based on income.

The amount of the Incentive Fee based on income that is paid to the Investment Adviser for a particular quarter equals the excess of the Incentive Fee so calculated minus the aggregate Incentive Fees based on income that were paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters but not in excess of the Incentive Fee Cap (as described below).

The Incentive Fee based on income that is paid to the Investment Adviser for a particular quarter is subject to a cap (the “Incentive Fee Cap”). The Incentive Fee Cap for any quarter is an amount equal to (a) 20% of the Cumulative Net Return (as defined below) during the relevant Trailing Twelve Quarters minus (b) the aggregate Incentive Fees based on income that were paid in respect of the first eleven calendar quarters (or the portion thereof) included in the relevant Trailing Twelve Quarters.

“Cumulative Net Return” means (x) the Ordinary Income in respect of the relevant Trailing Twelve Quarters minus (y) any Net Capital Loss, if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company pays no Incentive Fee based on income to the Investment Adviser for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the Incentive Fee based on income that is payable to the Investment Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company pays an Incentive Fee based on income to the Investment Adviser equal to the Incentive Fee Cap for such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the Incentive Fee based on income that is payable to the Investment Adviser for such quarter (before giving effect to the Incentive Fee Cap) calculated as described above, the Company pays an Incentive Fee based on income to the Investment Adviser equal to the Incentive Fee calculated as described above for such quarter without regard to the Incentive Fee Cap.

Table of Contents

“Net Capital Loss” in respect of a particular period means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in such period and (ii) aggregate capital gains, whether realized or unrealized, in such period.

ii. Annual Incentive Fee Based on Capital Gains

The portion of the Incentive Fee based on capital gains is calculated on an annual basis. For each Annual Period, the Company pays the Investment Adviser an amount equal to (A) 20% of the difference, if positive, of the sum of the Company’s aggregate realized capital gains, if any, computed net of the Company’s aggregate realized capital losses, if any, and the Company’s aggregate unrealized capital depreciation, in each case from April 1, 2013 until the end of such Annual Period minus (B) the cumulative amount of Incentive Fees based on capital gains previously paid to the Investment Adviser from April 1, 2013. For the avoidance of doubt, unrealized capital appreciation is excluded from the calculation in clause (A) above.

The Company accrues, but does not pay, a portion of the Incentive Fee based on capital gains with respect to net unrealized appreciation. Under GAAP, the Company is required to accrue an Incentive Fee based on capital gains that includes net realized capital gains and losses and net unrealized capital appreciation and depreciation on investments held at the end of each period. In calculating the accrual for the Incentive Fee based on capital gains, the Company considers the cumulative aggregate unrealized capital appreciation in the calculation, since an Incentive Fee based on capital gains would be payable if such unrealized capital appreciation were realized, even though such unrealized capital appreciation is not permitted to be considered in calculating the fee payable under the Investment Management Agreement. This accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital appreciation or depreciation. If such amount is positive at the end of a period, then the Company records a capital gains incentive fee equal to 20% of such amount, minus the aggregate amount of actual Incentive Fees based on capital gains paid in all prior periods. If such amount is negative, then there is no accrual for such period. There can be no assurance that such unrealized capital appreciation will be realized in the future.

For the three and nine months ended September 30, 2021, Incentive Fees based on income amounted to $9,326 and $32,551. As of September 30, 2021, $7,885 remained payable. For the three and nine months ended September 30, 2020, the Company incurred Incentive Fees based on income of $737 and $737. For the three and nine months ended September 30, 2021 and 2020, the Company did not accrue or pay any Incentive Fees based on capital gains.

In connection with the Merger, GSAM has agreed to waive a portion of its Incentive Fee based on income to the extent incurred, for a period of nine quarters, commencing with the quarter ended December 31, 2019 and through and including the quarter ending December 31, 2021, otherwise payable by the Company under the Investment Management Agreement by and between the Company and GSAM, as applicable, for each such quarter in an amount sufficient to ensure that the Company’s net investment income per weighted share outstanding for such quarter is at least $0.48 per share. For the three and nine months ended September 30, 2021, GSAM waived $0 and $4,543 of Incentive Fees. Additionally, GSAM voluntarily agreed to waive $1,441 and $19,149 of Incentive Fees for the three and nine months ended September 30, 2021 attributable to the purchase discount resulting from the Merger. For the three and nine months ended September 30, 2020, the Company did not incur an Incentive Fee based on income.

Administration and Custodian Fees

The Company has entered into an administration agreement with State Street Bank and Trust Company (the “Administrator”) under which the Administrator provides various accounting and administrative services to the Company. The Company pays the Administrator fees for its services as it determines to be commercially reasonable in its sole discretion. The Company also reimburses the Administrator for all reasonable expenses. To the extent that the Administrator outsources any of its functions, the Administrator pays any compensation associated with such functions. The Administrator also serves as the Company’s custodian (the “Custodian”).

For the three and nine months ended September 30, 2021, the Company incurred expenses for services provided by the Administrator and the Custodian of $483 and $1,439. As of September 30, 2021, $798 remained payable. For the three and nine months ended September 30, 2020, the Company incurred expenses for services provided by the Administrator and the Custodian of $224 and $685.

Transfer Agent Fees

The Company has entered into a transfer agency and services agreement pursuant to which Computershare Trust Company, N.A. serves as the Company’s transfer agent (the “Transfer Agent”), dividend agent and registrar. For the three and nine months ended September 30, 2021, the Company incurred expenses for services provided by the Transfer Agent of $12 and $27. As of September 30, 2021, $0 remained payable. For the three and nine months ended September 30, 2020, the Company incurred expenses for services provided by the Transfer Agent of $5 and $13.

Common Stock Repurchase Plans

In February 2019, the Board of Directors approved a 10b5-1 stock repurchase plan, which provided for the Company to repurchase up to $25,000 of shares of its common stock if the stock traded below the most recently announced NAV per share, subject to limitations. The plan took effect on March 18, 2019, was temporarily suspended on December 9, 2019 and expired on March 18, 2020. The Company did not repurchase any of its common stock pursuant to the plan or otherwise.

In November 2020, the Board of Directors authorized the adoption of a new common stock repurchase plan (the “10b5-1 Plan”), which provides for the Company to repurchase up to $75,000 of shares of the Company’s common stock if the stock trades below the most recently announced quarter-end NAV per share, subject to limitations. Under the 10b5-1 Plan, no purchases will be made if such purchases would cause the Company’s Debt/Equity Ratio to exceed the lower of (a) 1.30 or (b) the Maximum Debt/Equity Ratio. In the 10b5-1 Plan,

Table of Contents

“Debt/Equity Ratio” means the sum of debt on the Consolidated Statements of Assets and Liabilities and the total notional value of the Company’s unfunded commitments divided by net assets, as of the most recent reported financial statement end date, and “Maximum Debt/Equity Ratio” means the sum of debt on the Consolidated Statements of Assets and Liabilities and committed uncalled debt divided by net assets, as of the most recent reported financial statement end date. The 10b5-1 Plan was adopted and took effect on November 9, 2020. The 10b5-1 Plan will expire on November 9, 2021. Purchases under the 10b5-1 Plan will be conducted on a programmatic basis in accordance with Rules 10b5-1 and 10b-18 under the Exchange Act and other applicable securities laws. The Company’s repurchase of its common stock under the 10b5-1 Plan or otherwise may result in the price of the Company’s common stock being higher than the price that otherwise might exist in the open market. The Company did not repurchase any of its common stock pursuant to the plan or otherwise.

Affiliates

Group Inc. owned 6.37% as of September 30, 2021 and 6.39% as of December 31, 2020, of the outstanding shares of the Company’s common stock. The table below presents the Company’s affiliated investments:

	Beginning Fair Value Balance		Gross Additions⁽¹⁾		Gross Reductions⁽²⁾			Net Realized Gain(Loss)		Net Change in Unrealized Appreciation (Depreciation)			Ending Fair Value Balance		Dividend, Interest, PIK and Other Income
For the Nine Months Ended September 30, 2021
Controlled Affiliates
Bolttech Mannings, Inc.	$	19,810	$	4,251	$	—		$	—	$	(3,566	)	$	20,495	$	1,077
Total Controlled Affiliates	$	19,810	$	4,251	$	—		$	—	$	(3,566	)	$	20,495	$	1,077
Non-Controlled Affiliates
Goldman Sachs Financial Square Government Fund	$	—	$	619,046	$	(619,046	)	$	—	$	—		$	—	$	1
Animal Supply Holdings, LLC		16,838		536		—			—		(10,242	)		7,132		537
ATX Networks Corp.		—		5,972		—			—		(2	)		5,970		51
CB-HDT Holdings, Inc. (dba Hunter Defense Technologies)		48,741		—		(48,494	)		35,916		(36,163	)		—		(6	)
Collaborative Imaging, LLC (dba Texas Radiology Associates)		4,365		—		—			—		832			5,197		227
Conergy Asia Holdings, Ltd.		334		—		—			—		42			376		—
Elah Holdings, Inc.		5,396		—		—			—		—			5,396		—
Iracore International Holdings, Inc.		10,178		—		—			—		(1,715	)		8,463		866
Kawa Solar Holdings Limited		1,359		—		—			—		(31	)		1,328		—
Total Non-Controlled Affiliates	$	87,211	$	625,554	$	(667,540	)	$	35,916	$	(47,279	)	$	33,862	$	1,676
Total Affiliates	$	107,021	$	629,805	$	(667,540	)	$	35,916	$	(50,845	)	$	54,357	$	2,753

For the Year Ended December 31, 2020
Controlled Affiliates
Animal Supply Holdings, LLC	$	50,685	$	212	$	(22,303	)	$	(35,984	)	$	7,390		$	—	$	333
Bolttech Mannings, Inc.		22,854		23,461		(20,401	)		(4,704	)		(1,400	)		19,810		1,504
Total Controlled Affiliates	$	73,539	$	23,673	$	(42,704	)	$	(40,688	)	$	5,990		$	19,810	$	1,837
Non-Controlled Affiliates
Goldman Sachs Financial Square Government Fund	$	—	$	538,011	$	(538,011	)	$	—		$	—		$	—	$	62
Accuity Delivery Systems, LLC		15,213		23,140		(40,050	)		3,765			(2,068	)		—		2,131
Animal Supply Holdings, LLC		—		22,553		—			—			(5,715	)		16,838		261
CB-HDT Holdings, Inc. (dba Hunter Defense Technologies)		32,248		691		(7,037	)		—			22,839			48,741		698
Collaborative Imaging, LLC (dba Texas Radiology Associates)		17,311		24,710		(37,875	)		(5	)		224			4,365		4,086
Conergy Asia Holdings, Ltd.		1,064		1,258		(1,055	)		(211	)		(722	)		334		27
Elah Holdings, Inc.		2,234		3,004		—			—			158			5,396		—
Iracore International Holdings, Inc.		10,884		—		(556	)		—			(150	)		10,178		302
Kawa Solar Holdings Limited		3,502		28		(1,879	)		(4	)		(288	)		1,359		—
Prairie Provident Resources, Inc.		124		—		(9,237	)		—			9,113			—		—
Total Non-Controlled Affiliates	$	82,580	$	613,395	$	(635,700	)	$	3,545		$	23,391		$	87,211	$	7,567
Total Affiliates	$	156,119	$	637,068	$	(678,404	)	$	(37,143	)	$	29,381		$	107,021	$	9,404

⁽¹⁾

Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.

⁽²⁾

Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

Table of Contents

Due to Affiliates

The Investment Adviser pays certain general and administrative expenses, including legal expenses, on behalf of the Company in the ordinary course of business. As of September 30, 2021 and December 31, 2020, there were $0 and $12 included within Accrued expenses and other liabilities paid by the Investment Adviser and its affiliates on behalf of the Company.

Co-investment Activity

In certain circumstances, negotiated co-investments by the Company and other funds managed by the Investment Adviser may be made only pursuant to an order from the SEC permitting the Company to do so. On January 4, 2017, the SEC granted exemptive relief (“Exemptive Relief”) that permits the Company to co-invest with Goldman Sachs Private Middle Market Credit LLC, GS MMLC (which was merged with the Company on October 12, 2020), Goldman Sachs Private Middle Market Credit II LLC and certain other funds that may be managed by GSAM, including the GSAM Credit Alternatives Team, after the date of the exemptive order, subject to certain conditions including that co-investments are made in a manner consistent with the Company’s investment objectives, positions, policies, strategies and restrictions, as well as regulatory requirements and pursuant to the conditions required by the Exemptive Relief, and are allocated fairly among participants. The GSAM Credit Alternatives Team is comprised of investment professionals dedicated to the Company’s investment strategy and other funds that share a similar investment strategy with the Company, who are responsible for identifying investment opportunities, conducting research and due diligence on prospective investments, negotiating and structuring the Company’s investments and monitoring and servicing the Company’s investments, together with investment professionals who are primarily focused on investment strategies in syndicated, liquid credit. Under the terms of the Exemptive Relief, a “required majority” (as defined in Section 57(o) of the Investment Company Act) of the Company’s independent directors must make certain conclusions in connection with a co-investment transaction, including that (1) the terms of the proposed transaction are reasonable and fair to the Company and the Company’s stockholders and do not involve overreaching in respect of the Company or its stockholders on the part of any person concerned, and (2) the transaction is consistent with the interests of the Company’s stockholders and is consistent with the then-current investment objectives and strategies of the Company. As a result of the Exemptive Relief, there could be significant overlap in the Company’s investment portfolio and the investment portfolios of the aforementioned funds and/or other funds established by the GSAM Credit Alternatives Team that could avail themselves of the Exemptive Relief.

4.	INVESTMENTS

The Company’s investments (excluding investments in money market funds, if any) consisted of the following:

	September 30, 2021				December 31, 2020
Investment Type	Cost		Fair Value		Cost		Fair Value
1st Lien/Senior Secured Debt	$	2,596,091	$	2,622,896	$	2,489,285	$	2,526,969
1st Lien/Last-Out Unitranche		157,327		162,181		138,960		143,231
2nd Lien/Senior Secured Debt		281,064		274,345		458,918		457,733
Unsecured Debt		2,490		1,809		1,055		334
Preferred Stock		16,751		20,175		19,871		48,080
Common Stock		68,838		30,642		73,735		65,395
Warrants		756		76		756		1,024
Total	$	3,123,317	$	3,112,124	$	3,182,580	$	3,242,766

Table of Contents

The industry composition of the Company’s investments at fair value and net assets was as follows:

	September 30, 2021						December 31, 2020
Industry	Fair Value			Net Assets			Fair Value			Net Assets
Software		12.8	%		24.6	%		10.1	%		20.2	%
Health Care Technology		12.5			24.1			10.5			21.1
Health Care Providers & Services		8.8			17.0			7.9			15.8
Professional Services		8.0			15.4			6.7			13.5
Diversified Financial Services		7.2			13.9			4.8			9.6
Interactive Media & Services		7.0			13.5			8.4			16.9
Real Estate Mgmt. & Development		6.4			12.3			4.9			9.7
IT Services		5.7			10.9			7.0			14.0
Diversified Consumer Services		4.6			8.9			5.7			11.5
Commercial Services & Supplies		3.7			7.1			3.0			6.1
Health Care Equipment & Supplies		3.6			6.9			4.7			9.5
Hotels, Restaurants & Leisure		2.8			5.3			3.0			6.0
Chemicals		2.0			3.9			1.9			3.8
Transportation Infrastructure		1.7			3.3			1.6			3.3
Entertainment		1.4			2.7			1.3			2.6
Road & Rail		1.4			2.7			1.7			3.5
Internet & Direct Marketing Retail		1.3			2.4			0.5			0.9
Household Products		1.3			2.4			1.7			3.4
Aerospace & Defense		1.1			2.2			1.5			3.1
Beverages		1.1			2.2			0.9			1.8
Auto Components		1.0			1.9			0.9			1.9
Trading Companies & Distributors		1.0			1.9			0.8			1.7
Independent Power and Renewable Electricity Producers		0.8			1.6			—			—
Containers & Packaging		0.4			0.7			0.3			0.7
Leisure Products		0.3			0.7			0.3			0.6
Insurance		0.3			0.5			1.0			1.9
Energy Equipment & Services		0.3			0.5			0.3			0.6
Distributors		0.2			0.4			0.5			1.0
Textiles, Apparel & Luxury Goods		0.2			0.4			0.2			0.4
Communications Equipment		0.2			0.4			0.2			0.4
Air Freight & Logistics		0.2			0.3			2.1			4.3
Capital Markets		0.2			0.3			0.2			0.3
Specialty Retail		0.2			0.3			0.1			0.3
Building Products		0.1			0.2			0.3			0.6
Construction & Engineering		0.1			0.2			0.1			0.2
Food Products		0.1			0.1			0.5			1.0
Oil, Gas & Consumable Fuels⁽¹⁾		—			—			—			—
Media		—			—			2.1			4.1
Life Sciences Tools & Services		—			—			0.7			1.3
Diversified Telecommunication Services		—			—			1.6			3.2
Total		100.0	%		192.1	%		100.0	%		200.8	%

⁽¹⁾	Amount rounds to 0.0%.

The geographic composition of the Company’s investments at fair value was as follows:

Geographic	September 30, 2021			December 31, 2020
United States		96.9	%		97.6	%
Canada		3.1			0.8
Ireland		—			1.6
Germany⁽¹⁾		—			—
Singapore⁽¹⁾		—			—
Total		100.0	%		100.0	%

⁽¹⁾	Amount rounds to 0.0%.

Table of Contents

5.	FAIR VALUE MEASUREMENT

The fair value of a financial instrument is the amount that would be received to sell an asset or would be paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price).

The fair value hierarchy under ASC 820 prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The levels used for classifying investments are not necessarily an indication of the risk associated with investing in these securities. The three levels of the fair value hierarchy are as follows:

Basis of Fair Value Measurement

Level 1 – Inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The types of financial instruments included in Level 1 include unrestricted securities, including equities and derivatives, listed in active markets.

Level 2 – Inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities and certain over-the-counter derivatives where the fair value is based on observable inputs.

Level 3 – Inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in this category include investments in privately held entities and certain over-the-counter derivatives where the fair value is based on unobservable inputs.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Note 2 “Significant Accounting Policies” should be read in conjunction with the information outlined below.

The table below presents the valuation techniques and the nature of significant inputs generally used in determining the fair value of Level 2 and Level 3 Instruments.

Level 2 Instruments		Valuation Techniques and Significant Inputs
Equity and Fixed Income		The types of instruments that trade in markets that are not considered to be active but are valued based on quoted market prices, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency include commercial paper, most government agency obligations, most corporate debt securities, certain mortgage-backed securities, certain bank loans, less liquid publicly listed equities, certain state and municipal obligations, certain money market instruments and certain loan commitments. Valuations of Level 2 Equity and Fixed Income instruments can be verified to quoted prices, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency. Consideration is given to the nature of the quotations (e.g. indicative or firm) and the relationship of recent market activity to the prices provided from alternative pricing sources.

Derivative Contracts		OTC derivatives (both centrally cleared and bilateral) are valued using market transactions and other market evidence whenever possible, including market-based inputs to models, calibration to market-clearing transactions, broker or dealer quotations, or other alternative pricing sources with reasonable levels of price transparency. Where models are used, the selection of a particular model to value an OTC derivative depends upon the contractual terms of, and specific risks inherent in, the instrument, as well as the availability of pricing information in the market. The Company generally uses similar models to value similar instruments. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit curves, measures of volatility, voluntary and involuntary prepayment rates, loss severity rates and correlations of such inputs. For OTC derivatives that trade in liquid markets, model inputs can generally be verified and model selection does not involve significant management judgment. OTC derivatives are classified within Level 2 of the fair value hierarchy when significant inputs are corroborated by market evidence.

Level 3 Instruments

Valuation Techniques and Significant Inputs

Bank Loans, Corporate Debt, and Other Debt

Obligations

Valuations are generally based on discounted cash flow techniques, for which the significant inputs are the amount and timing of expected future cash flows, market yields and recovery assumptions. The significant inputs are generally determined based on relative value analyses, which incorporate comparisons both to credit default swaps that reference the same underlying credit risk and to other debt instruments for the same issuer for which observable prices or broker quotes are available. Other valuation methodologies are used as appropriate including market comparables, transactions in similar instruments and recovery/liquidation analysis.

Table of Contents

Equity

Recent third-party investments or pending transactions are considered to be the best evidence for any change in fair value. When these are not available, the following valuation methodologies are used, as appropriate and available (i) Transactions in similar instruments; (ii) Discounted cash flow techniques; (iii) Third party appraisals; and (iv) Industry multiples and public comparables.

Evidence includes recent or pending reorganizations (for example, merger proposals, tender offers and debt restructurings) and significant changes in financial metrics, including (i) Current financial performance as compared to projected performance; (ii) Capitalization rates and multiples; and (iii) Market yields implied by transactions of similar or related assets.

The tables below present the ranges of significant unobservable inputs used to value the Company’s Level 3 assets as of September 30, 2021 and December 31, 2020. These ranges represent the significant unobservable inputs that were used in the valuation of each type of instrument, but they do not represent a range of values for any one instrument. For example, the lowest yield in 1st Lien/Senior Secured Debt is appropriate for valuing that specific debt investment, but may not be appropriate for valuing any other debt investments in this asset class. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the Company’s Level 3 assets.

Level 3 Instruments		Fair Value⁽¹⁾⁽²⁾	Valuation Techniques⁽³⁾	Significant Unobservable Inputs	Range of Significant Unobservable Inputs⁽⁴⁾	Weighted Average⁽⁵⁾
As of September 30, 2021
Bank Loans, Corporate Debt, and Other Debt Obligations
1st Lien/Senior Secured Debt	$	2,012,930	Discounted cash flows	Discount Rate	6.0% - 19.4%	8.8%
	$	1,328	Collateral analysis	Recovery Rate	—	33.9%
1st Lien/Last-Out Unitranche	$	162,181	Discounted cash flows	Discount Rate	8.7% - 9.8%	9.1%
2nd Lien/Senior Secured Debt	$	163,163	Discounted cash flows	Discount Rate	9.7% - 14.7%	10.7%
	$	3,584	Comparable multiples	EV/EBITDA⁽⁶⁾	—	9.8x
Unsecured Debt	$	1,433	Discounted cash flows	Discount Rate	—	12.9%
	$	376	Collateral analysis	Recovery Rate	—	29.7%
Equity
Preferred Stock	$	2,218	Comparable multiples	EV/EBITDA⁽⁶⁾	10.5x - 21.2x	20.9x
	$	17,957	Comparable multiples	EV/Revenue	1.5x - 6.4x	2.1x
Common Stock	$	10,593	Discounted cash flows	Discount Rate	17.6% - 31.2%	25.3%
	$	13,070	Comparable multiples	EV/EBITDA⁽⁶⁾	4.9x - 21.3x	10.1x
	$	2,229	Comparable multiples	EV/Revenue	0.7x - 2.3x	1.2x
Warrants	$	76	Comparable multiples	EV/EBITDA⁽⁶⁾	—	9.0x
As of December 31, 2020
Bank Loans, Corporate Debt, and Other Debt Obligations
1st Lien/Senior Secured Debt	$	1,933,798	Discounted cash flows	Discount Rate	5.7% - 16.6%	8.6%
	$	9,565	Collateral analysis	Recovery Rate	34.7% - 97.0%	88.1%
1st Lien/Last-Out Unitranche	$	83,563	Discounted cash flows	Discount Rate	7.3% - 10.0%	8.9%
2nd Lien/Senior Secured Debt	$	341,376	Discounted cash flows	Discount Rate	9.2% - 14.3%	10.4%
	$	1,650	Collateral analysis	Recovery Rate	—	55.0%
	$	12,175	Comparable multiples	EV/EBITDA⁽⁶⁾	8.0x - 10.5x	9.9x
Unsecured Debt	$	334	Collateral analysis	Recovery Rate	—	26.3%
Equity
Preferred Stock	$	34,635	Comparable multiples	EV/EBITDA⁽⁶⁾	7.3x - 16.0x	7.3x
	$	13,402	Comparable multiples	EV/Revenue	—	1.6x
Common Stock	$	9,761	Discounted cash flows	Discount Rate	14.0% - 31.5%	24.5%
	$	35,226	Comparable multiples	EV/EBITDA⁽⁶⁾	5.1x - 16.0x	7.1x
	$	20,297	Comparable multiples	EV/Revenue	0.3x - 15.1x	12.6x
Warrants	$	1,024	Comparable multiples	EV/EBITDA⁽⁶⁾	—	8.0x

⁽¹⁾

As of September 30, 2021, included within the fair value of Level 3 assets of $2,898,263 is an amount of $507,125 for which the Investment Adviser did not develop the unobservable inputs (examples include single source broker quotations, third party pricing, and prior transactions). The income approach was used in the determination of fair value for $2,339,707 or 82.2% of Level 3 bank loans, corporate debt, and other debt obligations.

⁽²⁾

As of December 31, 2020, included within the fair value of Level 3 assets of $3,050,769 is an amount of $553,963 for which the Investment Adviser did not develop the unobservable inputs (examples include single source broker quotations, third party pricing, and prior transactions). The income approach was used in the determination of fair value for $2,358,737 or 80.3% of Level 3 bank loans, corporate debt, and other debt obligations.

⁽³⁾	The fair value of any one instrument may be determined using multiple valuation techniques. For example, market comparable and discounted cash flows may be used together to determine fair value. Therefore, the Level 3 balance encompasses both of these techniques.

⁽⁴⁾	The range for an asset category consisting of a single investment, if any, is not meaningful and therefore has been excluded.

⁽⁵⁾

Weighted average for an asset category consisting of multiple investments is calculated by weighting the significant unobservable input by the relative fair value of the investment. Weighted average for an asset category consisting of a single investment represents the significant unobservable input used in the fair value of the investment.

⁽⁶⁾	Enterprise value of portfolio company as a multiple of earnings before interest, taxes, depreciation and amortization (“EBITDA”).

Table of Contents

As noted above, the income and market approaches were used in the determination of fair value of certain Level 3 assets as of September 30, 2021 and December 31, 2020. The significant unobservable inputs used in the income approach are the discount rate or market yield used to discount the estimated future cash flows expected to be received from the underlying investment, which include both future principal and interest payments. An increase in the discount rate or market yield would result in a decrease in the fair value. Included in the consideration and selection of discount rates or market yields is risk of default, rating of the investment, call provisions and comparable company investments. The significant unobservable inputs used in the market approach are based on market comparable transactions and market multiples of publicly traded comparable companies. Increases or decreases in market comparable transactions or market multiples would result in an increase or decrease, in the fair value.

The following is a summary of the Company’s assets categorized within the fair value hierarchy:

	September 30, 2021								December 31, 2020
Assets	Level 1		Level 2		Level 3		Total		Level 1		Level 2			Level 3		Total
1st Lien/Senior Secured Debt	$	—	$	105,691	$	2,517,205	$	2,622,896	$	—	$	142,025		$	2,384,944	$	2,526,969
1st Lien/Last-Out Unitranche		—		—		162,181		162,181		—		—			143,231		143,231
2nd Lien/Senior Secured Debt		—		107,598		166,747		274,345		—		49,861			407,872		457,733
Unsecured Debt		—		—		1,809		1,809		—		—			334		334
Preferred Stock		—		—		20,175		20,175		—		—			48,080		48,080
Common Stock		572		—		30,070		30,642		111		—			65,284		65,395
Warrants		—		—		76		76		—		—			1,024		1,024
Total Assets	$	572	$	213,289	$	2,898,263	$	3,112,124	$	111	$	191,886		$	3,050,769	$	3,242,766
Unrealized appreciation (depreciation) on the foreign currency forward contracts	$	—	$	41	$	—	$	41	$	—	$	(355	)	$	—	$	(355	)

The below table presents a summary of changes in fair value of Level 3 assets by investment type:

	Beginning Balance		Purchases⁽¹⁾		Net Realized Gain (Loss)			Net Change in Unrealized Appreciation (Depreciation)			Sales and Settlements⁽²⁾			Net Amortization of Premium/ Discount		Transfers In⁽³⁾		Transfers Out⁽³⁾			Ending Balance		Net Change in Unrealized Appreciation (Depreciation) for assets still held
For the Nine Months Ended September 30, 2021
1st Lien/Senior Secured Debt	$	2,384,944	$	988,448	$	(937	)	$	(11,352	)	$	(847,532	)	$	46,909	$	—	$	(43,275	)	$	2,517,205	$	7,799
1st Lien/Last-Out Unitranche		143,231		31,138		—			583			(14,477	)		1,706		—		—			162,181		955
2nd Lien/Senior Secured Debt		407,872		17,078		(1,203	)		(8,888	)		(209,051	)		13,610		—		(52,671	)		166,747		(5,520	)
Unsecured Debt		334		1,433		—			40			—			2		—		—			1,809		40
Preferred Stock		48,080		7,086		24,233			(24,786	)		(34,438	)		—		—		—			20,175		(379	)
Common Stock		65,284		7,278		19,223			(30,316	)		(31,399	)		—		—		—			30,070		(11,558	)
Warrants		1,024		—		—			(948	)		—			—		—		—			76		(948	)
Total Assets	$	3,050,769	$	1,052,461	$	41,316		$	(75,667	)	$	(1,136,897	)	$	62,227	$	—	$	(95,946	)	$	2,898,263	$	(9,611	)
For the Nine Months Ended September 30, 2020
1st Lien/Senior Secured Debt	$	1,000,087	$	115,010	$	25		$	(22,311	)	$	(68,023	)	$	3,018	$	6,702	$	(12,559	)	$	1,021,949	$	(22,554	)
1st Lien/Last-Out Unitranche		35,278		—		—			(150	)		(277	)		124		—		—			34,975		(150	)
2nd Lien/Senior Secured Debt		201,033		37,811		(10,571	)		(2,301	)		(33,907	)		404		—		(14,000	)		178,469		(8,692	)
Unsecured Debt		7,409		1,630		(211	)		(123	)		(1,558	)		64		—		—			7,211		(123	)
Preferred Stock		48,762		21		(6,624	)		17,361			(18,376	)		—		—		—			41,144		15,461
Common Stock		47,984		22,164		(29,230	)		6,651			—			—		—		—			47,569		1,185
Warrants		—		756		—			448			—			—		—		—			1,204		448
Total Assets	$	1,340,553	$	177,392	$	(46,611	)	$	(425	)	$	(122,141	)	$	3,610	$	6,702	$	(26,559	)	$	1,332,521	$	(14,425	)

⁽¹⁾	Purchases may include PIK, securities received in corporate actions and restructurings.

⁽²⁾	Sales and Settlements may include securities delivered in corporate actions and restructuring of investments.

⁽³⁾	Transfers in (out) of Level 3 are due to an increase (decrease) in the quantity and reliability of broker quotes obtained assessed by the Investment Adviser.

Debt Not Carried at Fair Value

Fair value is estimated by discounting remaining payments using applicable current market rates, which take into account changes in the Company’s marketplace credit ratings, or market quotes, if available. If the Company’s debt obligations were carried at fair value, the fair value and level would have been as follows:

		As of
	Level	September 30, 2021		December 31, 2020
Revolving Credit Facility	3	$	624,862	$	629,383
Convertible Notes	2	$	158,100	$	160,255
2025 Notes	2	$	382,855	$	381,807
2026 Notes	2	$	516,630	$	512,174

Table of Contents

DEBT

The Company is permitted to borrow amounts such that its asset coverage ratio, as defined in the Investment Company Act, is at least 150% after such borrowing (if certain requirements are met). As of September 30, 2021 and December 31, 2020, the Company’s asset coverage ratio based on the aggregate amount outstanding of senior securities was 199% and 198%.

The Company’s outstanding debt was as follows:

	As of
	September 30, 2021						December 31, 2020
	Aggregate Borrowing Amount Committed		Amount Available		Carrying Value⁽³⁾		Aggregate Borrowing Amount Committed		Amount Available		Carrying Value⁽³⁾
Revolving Credit Facility⁽¹⁾⁽²⁾	$	1,695,000	$	1,069,830	$	624,862	$	1,695,000	$	1,066,319	$	629,383
Convertible Notes		155,000		—		154,240		155,000		—		152,983
2025 Notes		360,000		—		355,381		360,000		—		354,331
2026 Notes		500,000		—		491,815		500,000		—		490,363
Total Debt	$	2,710,000	$	1,069,830	$	1,626,298	$	2,710,000	$	1,066,319	$	1,627,060

⁽¹⁾	Provides, under certain circumstances, a total borrowing capacity of $2,250,000.

⁽²⁾

The Company may borrow amounts in USD or certain other permitted currencies. Debt outstanding denominated in currencies other than USD has been converted to USD using the applicable foreign currency exchange rate as of the applicable reporting date. As of September 30, 2021, the Company had outstanding borrowings denominated in USD of $581,074, in Euros (EUR) of 37,700 and in Canadian Dollars (CAD) of 150. As of December 31, 2020, the Company had outstanding borrowings denominated in USD of $529,574 and in EUR of 81,700.

⁽³⁾	The carrying value is presented net of unamortized debt issuance costs and OID net of accretion as applicable.

The combined weighted average interest rate of the aggregate borrowings outstanding for the nine months ended September 30, 2021 and the year ended December 31, 2020 was 2.92% and 3.17%. The combined weighted average debt of the aggregate borrowings outstanding for the nine months ended September 30, 2021 and the year ended December 31, 2020 was $1,599,372 and $1,037,496.

Revolving Credit Facility

On September 19, 2013, the Company entered into a Revolving Credit Facility with various lenders. Truist Bank serves as administrative agent and Bank of America, N.A. serves as syndication agent under the Revolving Credit Facility. The Company has amended and restated the Revolving Credit Facility on October 3, 2014, November 4, 2015, December 16, 2016, February 21, 2018, September 17, 2018, February 25, 2020, November 20, 2020 and August 13, 2021.

The aggregate committed borrowing amount under the Revolving Credit Facility is $1,695,000. The Revolving Credit Facility includes an uncommitted accordion feature that allows the Company, under certain circumstances, to increase the borrowing capacity of the Revolving Credit Facility to up to $2,250,000.

Borrowings denominated in USD, including amounts drawn in respect of letters of credit, bear interest (at the Company’s election) of either (i) LIBOR plus a margin of either (x) 2.00%, (y) 1.875% (subject to maintenance of certain long-term corporate debt ratings) or (z) 1.75% (subject to certain borrowing base conditions) or (ii) an alternative base rate, which is the highest of 0%, the Prime Rate, the Federal Funds Effective Rate plus 0.50% and overnight LIBOR plus 1.00%, plus a margin of either (x) 1.00%, (y) 0.875% (subject to maintenance of certain long-term corporate debt ratings) or (z) 0.75% (subject to certain borrowing base conditions). Borrowings denominated in non-USD bear interest of LIBOR plus a margin of either 2.00%, 1.875% or 1.75% (subject to the conditions applicable to borrowings denominated in USD that bear interest based on LIBOR) plus, in the case of borrowings denominated in Pound Sterling (GBP) only, an additional 0.1193% credit adjustment spread. With respect to borrowings denominated in USD, the Company may elect either LIBOR, or an alternative base rate at the time of borrowing, and such borrowings may be converted from one benchmark to another at any time, subject to certain conditions. Interest is payable quarterly in arrears. The Company pays a fee of 0.375% per annum on committed but undrawn amounts under the Revolving Credit Facility, payable quarterly in arrears. Any amounts borrowed under the Revolving Credit Facility will mature, and all accrued and unpaid interest will be due and payable, on August 13, 2026.

The Revolving Credit Facility may be guaranteed by certain of the Company’s domestic subsidiaries, including any that are formed or acquired by the Company in the future. Proceeds from borrowings may be used for general corporate purposes, including the funding of portfolio investments.

Table of Contents

The Company’s obligations to the lenders under the Revolving Credit Facility are secured by a first priority security interest in substantially all of the Company’s portfolio of investments and cash, with certain exceptions. The Revolving Credit Facility contains certain covenants, including: (i) maintaining a minimum stockholder’s equity of $800,000 plus 25% of net proceeds of the sale of equity interests of the Company after February 25, 2020, (ii) maintaining a minimum asset coverage ratio of at least 150%, (iii) maintaining a minimum asset coverage ratio of 200% with respect to the consolidated assets (with certain limitations on the contribution of equity in financing subsidiaries as specified therein) of the Company and its subsidiary guarantors to the secured debt of the Company and its subsidiary guarantors, (iv) maintaining a minimum Company net worth of at least $700,000, (v) maintaining a minimum liquidity test of at least 10% of the covered debt amount during any period when the adjusted covered debt balance is greater than 90% of the adjusted borrowing base, each as defined in the Revolving Credit Facility, and (vi) complying with restrictions on industry concentrations in the Company’s investment portfolio. As of September 30, 2021, the Company is in compliance with these covenants.

Costs of $25,095 were incurred in connection with obtaining and amending the Revolving Credit Facility, which have been recorded as deferred financing costs on the Consolidated Statements of Assets and Liabilities and are being amortized over the life of the Revolving Credit Facility using the straight-line method. As of September 30, 2021 and December 31, 2020, deferred financing costs were $13,331 and $11,350.

The below table presents the summary information of the Revolving Credit Facility:

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Borrowing interest expense	$	2,583		$	2,100		$	8,769		$	8,385
Facility fees		1,187			426			3,209			1,130
Amortization of financing costs		700			473			2,079			1,345
Total	$	4,470		$	2,999		$	14,057		$	10,860
Weighted average interest rate		2.01	%		2.06	%		2.01	%		2.69	%
Average outstanding balance	$	510,169		$	405,022		$	584,372		$	417,087

Convertible Notes

On October 3, 2016, the Company closed an offering of $115,000 aggregate principal amount of unsecured Convertible Notes, which includes $15,000 aggregate principal amount issued pursuant to the initial purchasers’ exercise in full of an over-allotment option (the “Initial Convertible Notes”).

On July 2, 2018, the Company closed an additional offering of $40,000 aggregate principal amount of Convertible Notes (the “Additional Convertible Notes” and together with Initial Convertible Notes, the “Convertible Notes”). The Additional Convertible Notes have identical terms, are fungible with and are part of the Initial Convertible Notes.

The Convertible Notes were issued pursuant to an indenture between the Company and Wells Fargo Bank, National Association (“Wells Fargo”), as Trustee. Wells Fargo and/or its affiliates provide bank lending and distribution services to certain Goldman Sachs funds. The Convertible Notes bear interest at a rate of 4.50% per year, payable semi-annually in arrears on April 1 and October 1 of each year, commencing on April 1, 2017. The Convertible Notes will mature on April 1, 2022, unless repurchased or converted in accordance with their terms prior to such date. In certain circumstances, the Convertible Notes will be convertible into cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, based on a conversion rate of 41.1666 shares of the Company’s common stock per one thousand dollars principal amount of Convertible Notes, which is equivalent to a conversion price of approximately $24.29 per share of common stock, subject to customary anti-dilution adjustments and the other terms of the indenture governing the Convertible Notes. The conversion price of $24.29 is approximately 9.1% above the $22.26 per share closing price of the Company’s common stock on September 27, 2016 and 15.7% above the $20.99 per share closing price of our common stock on June 26, 2018. The Company will not have the right to redeem the Convertible Notes prior to maturity.

Holders may convert their notes at their option at any time prior to the close of business on the business day immediately preceding October 1, 2021 only under the following: (1) during any calendar quarter, if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollars principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events. On or after October 1, 2021, until the close of business on the scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the occurrence or nonoccurrence of any of the foregoing circumstances.

The Convertible Notes are accounted for in accordance with ASC Topic 470-20, Debt with Conversion and Other Options. Upon conversion of any of the Convertible Notes, the Company intends to pay the outstanding principal amount in cash and, to the extent that the conversion value exceeds the principal amount, has the option to pay the excess amount in cash or shares of the Company’s common stock (or a combination of cash and shares), subject to the requirements of the indenture governing the Convertible Notes. The Company has determined that the embedded conversion options in the Convertible Notes are not required to be separately accounted for as derivatives under ASC Topic 815, Derivatives and Hedging. At the time of issuance, the values of the debt and equity components of the Initial Convertible Notes and Additional Convertible Notes were approximately 99.4% and 0.6%, and 97.9% and 2.1%.

Table of Contents

The OID equal to the equity component of the Convertible Notes was recorded in “paid-in capital in excess of par” in the accompanying Consolidated Statements of Assets and Liabilities. The Company records interest expense comprised of both stated interest and amortization of the OID. At the time of issuance, the equity components of the Initial Convertible Notes and the Additional Convertible Notes were $743 and $836. Additionally, the issuance costs associated with the Convertible Notes were allocated to the debt and equity components in proportion to the allocation of the values at the time of issuance and accounted for as debt issuance costs and equity issuance costs.

The below table presents the components of the carrying value of the Convertible Notes:

	September 30, 2021			December 31, 2020
Principal amount of debt	$	155,000		$	155,000
OID, net of accretion		238			587
Unamortized debt issuance costs		522			1,430
Carrying Value	$	154,240		$	152,983
Stated interest rate		4.50	%		4.50	%
Effective interest rate (stated interest rate plus accretion of OID)		4.80	%		4.79	%

The below table presents the components of interest and other debt expenses related to the Convertible Notes:

	For the Three Months Ended				For the Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Borrowing interest expense	$	1,743	$	1,743	$	5,231	$	5,231
Accretion of OID		119		112		350		332
Amortization of debt issuance costs		306		306		908		911
Total	$	2,168	$	2,161	$	6,489	$	6,474

2025 Notes

On February 10, 2020, the Company closed an offering of $360,000 aggregate principal amount of unsecured notes. The 2025 Notes were issued pursuant to an indenture between the Company and Wells Fargo Bank, as Trustee. Wells Fargo Bank and/or its affiliates provide bank lending and distribution services to certain Goldman Sachs funds. The 2025 Notes bear interest at a rate of 3.75% per year, payable semi-annually, commencing on August 10, 2020. The 2025 Notes will mature on February 10, 2025 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the indenture.

The below table presents the components of the carrying value of the 2025 Notes:

	September 30, 2021			December 31, 2020
Principal amount of debt	$	360,000		$	360,000
Unamortized debt issuance costs		4,619			5,669
Carrying Value	$	355,381		$	354,331
Stated interest rate		3.75	%		3.75	%

The below table presents the components of interest and other debt expenses related to the 2025 Notes:

	For the Three Months Ended				For the Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Borrowing interest expense	$	3,375	$	3,375	$	10,125	$	8,663
Amortization of debt issuance costs		354		354		1,050		900
Total	$	3,729	$	3,729	$	11,175	$	9,563

2026 Notes

On November 24, 2020, the Company closed an offering of $500,000 aggregate principal amount of unsecured notes. The 2026 Notes were issued pursuant to an indenture between the Company and Wells Fargo Bank, as Trustee. Wells Fargo Bank and/or its affiliates provide bank lending and distribution services to certain Goldman Sachs funds. The 2026 Notes bear interest at a rate of 2.875% per year, payable semi-annually, commencing on July 15, 2021. The 2026 Notes will mature on January 15, 2026 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the indenture.

Table of Contents

The below table presents the components of the carrying value of the 2026 Notes:

	September 30, 2021			December 31, 2020
Principal amount of debt	$	500,000		$	500,000
Unamortized debt issuance costs		8,185			9,637
Carrying Value	$	491,815		$	490,363
Stated interest rate		2.875	%		2.875	%

The below table presents the components of interest and other debt expenses related to the 2026 Notes:

	For the Three Months Ended			For the Nine Months Ended
	September 30, 2021		September 30, 2020	September 30, 2021		September 30, 2020
Borrowing interest expense	$	3,593	N/A	$	10,781	N/A
Amortization of debt issuance costs		489	N/A		1,451	N/A
Total	$	4,082	N/A	$	12,232	N/A

7.	DERIVATIVES

The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies.

In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”) or a similar agreement with its derivative counterparties. An ISDA Master Agreement is a bilateral agreement between the Company and a counterparty that governs OTC derivatives, including foreign currency forward contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default (close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.

For financial reporting purposes, cash collateral that has been pledged to cover obligations of the Company and cash collateral received from the counterparty, if any, is included on the Consolidated Statements of Assets and Liabilities as due to/due from broker. The Company minimizes counterparty credit risk by only entering into agreements with counterparties that they believe to be of good standing and by monitoring the financial stability of those counterparties.

For the three and nine months ended September 30, 2021, the Company’s average USD notional exposure to foreign currency forward contracts was $2,934 and $2,933. For the three and nine months ended September 30, 2020, the Company’s average USD notional exposure to foreign currency forward contracts was $2,552 and $3,153.

The Company’s net exposure to foreign currency forward contracts by counterparty that are subject to ISDA Master Agreements or similar agreements presented on the Consolidated Statements of Assets and Liabilities was as follows:

	Gross Amount of Assets		Gross Amount of (Liabilities)			Net Amount of Assets or (Liabilities)			Collateral (Received) Pledged⁽¹⁾		Net Amounts ⁽²⁾
September 30, 2021
Bank of America, N.A.	$	55	$	(14	)	$	41		$	—	$	41
December 31, 2020
Bank of America, N.A.	$	—	$	(355	)	$	(355	)	$	—	$	(355	)

⁽¹⁾	Amount excludes excess cash collateral paid.

⁽²⁾	Net amount represents the net amount due (to) from counterparty in the event of a default based on the contractual setoff rights under the agreement. Net amount excludes any over-collateralized amounts.

The effect of transactions in derivative instruments on the Consolidated Statements of Operations was as follows:

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
Net realized gain (loss) on foreign currency forward contracts	$	(49	)	$	29		$	(220	)	$	109
Net change in unrealized appreciation (depreciation) on foreign currency forward contracts		122			(132	)		396			(131	)
Total net realized and unrealized gains (losses) on foreign currency forward contracts	$	73		$	(103	)	$	176		$	(22	)

Table of Contents

8.	COMMITMENTS AND CONTINGENCIES

Commitments

The Company may enter into investment commitments through signed commitment letters. In many circumstances, borrower acceptance and final terms are subject to transaction-related contingencies. These are disclosed as commitments upon execution of a final agreement. As of September 30, 2021, the Company believed that it had adequate financial resources to satisfy its unfunded commitments. The Company had the following unfunded commitments by investment types:

			Unfunded Commitment⁽²⁾						Fair Value⁽³⁾
	Commitment Expiration Date⁽¹⁾		September 30, 2021			December 31, 2020			September 30, 2021				December 31, 2020
1st Lien/Senior Secured Debt
GHA Buyer Inc. (dba Cedar Gate)	12/14/21	$		188	$		188	$		(3	)	$		(2	)
FWR Holding Corporation (dba First Watch Restaurants)	12/20/21			118			118			(1	)			(4	)
Elemica Parent, Inc.	12/31/21			380			380			(9	)			(11	)
MRI Software LLC	02/10/22			403			661			(2	)			(19	)
MRI Software LLC	03/24/22			6,600		—				(25	)		—
Chronicle Bidco Inc. (dba Lexitas)	04/23/22			3,264			6,166		—					(154	)
Xactly Corporation	07/29/22			3,874			3,874		—					(29	)
Volt Bidco, Inc. (aka Power Factors)	08/11/22			2,618		—			—				—
Purfoods, LLC	08/12/22			200			400		—					(6	)
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings)	09/10/22			3,046		—				(69	)		—
Lithium Technologies, Inc.	10/03/22			5,110			3,066			(102	)			(130	)
USN Opco LLC (dba Global Nephrology Solutions)	12/21/22			5,814			7,600			(58	)			(76	)
VRC Companies, LLC (dba Vital Records Control)	12/29/22			4,368		—				(66	)		—
Aria Systems, Inc.	12/30/22			4,160		—				(52	)		—
Heartland Home Services	01/30/23			15,017		—				(150	)		—
Sweep Purchaser LLC	02/12/23			1,072		—				(11	)		—
Thrasio, LLC	03/17/23			14,686		—			—				—
Sunstar Insurance Group, LLC	03/31/23			16,069		—				(161	)		—
GovDelivery Holdings, LLC (dba Granicus, Inc.)	04/21/23			1,505		—				(38	)		—
Businessolver.com, Inc.	05/15/23			5,328			5,328		—					(67	)
CORA Health Holdings Corp	06/15/23			8,897		—				(111	)		—
PT Intermediate Holdings III, LLC (dba Parts Town)	06/29/23			1,847		—				(5	)		—
Sundance Group Holdings, Inc. (dba NetDocuments)	07/02/23			12,313		—				(96	)		—
Total Vision LLC	07/15/23			2,535		—				(25	)		—
Premier Care Dental Management, LLC	08/05/23			10,175		—				(51	)		—
FWR Holding Corporation (dba First Watch Restaurants)	08/21/23			2,093			2,093			(10	)			(63	)
CivicPlus LLC	08/24/23			2,960		—				(30	)		—
DECA Dental Holdings LLC	08/26/23			7,413		—				(74	)		—
CFS Management, LLC (dba Center for Sight Management)	09/01/23			1,412		—				(18	)		—
Honor HN Buyer, Inc	10/15/23			13,798		—			—				—
Assembly Intermediate LLC	10/19/23			10,888		—			—				—
AQ Helios Buyer, Inc. (aka SurePoint)	07/01/24			11,560		—			—				—
WebPT, Inc.	08/28/24			1,832			1,832			(18	)			(55	)
Apptio, Inc.	01/10/25			3,231			5,385		—					(81	)
Mailgun Technologies, Inc.	03/26/25			2,441			2,441		—				—
Internet Truckstop Group, LLC (dba Truckstop)	04/02/25			4,400			4,400			(33	)			(88	)
PlanSource Holdings, Inc.	04/22/25			3,912			7,824		—					(137	)
CorePower Yoga LLC	05/14/25			1,687		—				(283	)		—
Riverpoint Medical, LLC	06/21/25			4,094			4,094			(51	)			(102	)
GHA Buyer Inc. (dba Cedar Gate)	06/24/25			1,880			1,880			(33	)			(38	)
HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)	07/09/25			4,688			4,688			(164	)			(305	)
WorkForce Software, LLC	07/31/25			884			1,894			(18	)			(28	)
Diligent Corporation	08/04/25			3,100			3,100			23				(70	)
The Center for Orthopedic and Research Excellence, Inc. (dba HOPCo)	08/15/25			3,880			4,565			(58	)			(148	)
Elemica Parent, Inc.	09/18/25			409			165			(10	)			(5	)
Capitol Imaging Acquisition Corp.	10/01/25			180			158			(2	)			(3	)
CST Buyer Company (dba Intoxalock)	10/03/25			2,170			2,170			(11	)			(49	)
Acquia, Inc.	10/31/25			3,007			3,268			(45	)			(57	)
Chronicle Bidco Inc. (dba Lexitas)	11/14/25			2,180			2,180		—					(55	)
Eptam Plastics, Ltd.	12/06/25			1,361			227			(17	)			(5	)
One GI LLC	12/22/25			2,500			2,500		—					(50	)
Zodiac Intermediate, LLC (dba Zipari)	12/22/25			2,500			7,500			(56	)			(200	)
Prophix Software Inc.(dba Pound Bidco)	01/30/26			3,445		—			—				—

Table of Contents

			Unfunded Commitment⁽²⁾						Fair Value⁽³⁾
	Commitment Expiration Date⁽¹⁾		September 30, 2021			December 31, 2020			September 30, 2021				December 31, 2020
Governmentjobs.com, Inc. (dba NeoGov)	02/05/26	$		5,853	$		5,853	$		(88	)	$		(117	)
MRI Software LLC	02/10/26			1,612			1,612			(6	)			(47	)
Instructure Holdings	03/24/26			5,000			5,000		—					(50	)
GS AcquisitionCo, Inc. (dba Insightsoftware)	05/22/26			982			807			(7	)			(6	)
AQ Helios Buyer, Inc. (aka SurePoint)	07/01/26			4,022		—				(80	)		—
Project Eagle Holdings, LLC (dba Exostar)	07/06/26			75			75			(1	)			(2	)
Total Vision LLC	07/15/26			1,270		—				(25	)		—
Superman Holdings, LLC (dba Foundation Software)	08/31/26			122			122		—					(3	)
Bullhorn, Inc.	09/30/26			1,344			1,344			(13	)			(20	)
Sunstar Insurance Group, LLC	10/09/26			111			111			(1	)			(2	)
1272775 B.C. LTD. (dba Everest Clinical Research)	11/06/26			1,151			1,260			(17	)			(19	)
Sweep Purchaser LLC	11/30/26			3,087			4,541			(31	)			(91	)
Helios Buyer, Inc. (dba Heartland)	12/15/26			396			2,254			(4	)			(45	)
USN Opco LLC (dba Global Nephrology Solutions)	12/21/26			3,023			3,023			(30	)			(60	)
StarCompliance Intermediate, LLC	01/12/27			2,500		—				(50	)		—
Wellness AcquisitionCo, Inc. (dba SPINS)	01/20/27			2,600			2,548		—				—
GovDelivery Holdings, LLC (dba Granicus, Inc.)	01/29/27			2,583		—				(65	)		—
Abacus Data Holdings, Inc. (dba Clutch Intermediate Holdings)	03/10/27			1,037		—				(23	)		—
Pluralsight, Inc	04/06/27			5,100		—				(102	)		—
ESO Solutions, Inc	05/03/27			3,620		—				(63	)		—
Rodeo Buyer Company (dba Absorb Software)	05/25/27			3,387		—				(68	)		—
VRC Companies, LLC (dba Vital Records Control)	06/29/27			944		—				(14	)		—
Zarya Intermediate, LLC (dba iOFFICE)	07/01/27			6,757		—				(135	)		—
Sundance Group Holdings, Inc. (dba NetDocuments)	07/02/27			4,925		—				(76	)		—
Experity, Inc.	07/22/27			3,332		—				(16	)		—
Cordeagle US Finco, Inc. (aka Condeco)	07/30/27			2,461		—				(49	)		—
Gainsight, Inc.	07/30/27			5,320		—				(93	)		—
Premier Care Dental Management, LLC	08/05/27			3,052		—				(61	)		—
Volt Bidco, Inc. (aka Power Factors)	08/11/27			2,181		—				(44	)		—
CivicPlus LLC	08/24/27			592		—				(12	)		—
DECA Dental Holdings LLC	08/26/27			1,711		—				(34	)		—
MMIT Holdings, LLC (dba Managed Markets Insight & Technology)	09/15/27			5,923		—				(118	)		—
MMIT Holdings, LLC (dba Managed Markets Insight & Technology)	09/15/27			6,791		—			—				—
Honor HN Buyer, Inc	10/15/27			2,760		—			—				—
Honor HN Buyer, Inc	10/15/27			25,245		—			—				—
Assembly Intermediate LLC	10/19/27			43,111		—			—				—
Assembly Intermediate LLC	10/19/27			4,311		—			—				—
Brillio, LLC	02/06/21			—			1,855		—					(14	)
One GI LLC	06/22/21			—			21,593		—					(216	)
Associations, Inc.	07/30/21			—			107		—					(3	)
WebPT, Inc.	08/28/21			—			3,141		—					(94	)
Bullhorn, Inc.	10/01/21			—			1,232		—					(18	)
GS AcquisitionCo, Inc. (dba Insightsoftware)	12/02/21			—			4,033		—					(30	)
Eptam Plastics, Ltd.	12/06/21			—			4,537		—					(91	)
Elemica Parent, Inc.	12/15/21			—			1,508		—					(45	)
Netvoyage Corporation (dba NetDocuments)	03/24/22			—			1,264		—					(25	)
VRC Companies, LLC (dba Vital Records Control)	03/31/22			—			1,131		—					(8	)
Helios Buyer, Inc. (dba Heartland)	06/15/22			—			7,943		—					(40	)
Thrasio, LLC	06/18/22			—			9,990		—					(125	)
DDS USA Holding, Inc.	06/30/22			—			2,612		—					(20	)
Hygiena Borrower LLC	08/26/22			—			1,863		—					(9	)
Sunstar Insurance Group, LLC	10/09/22			—			344		—					(7	)
Sweep Purchaser LLC	11/30/22			—			9,082		—					(91	)
Integral Ad Science, Inc.	07/19/23			—			4,402		—					(88	)
Gastro Health Holdco, LLC	09/04/23			—			3,063		—					(69	)
Empirix, Inc.	09/25/23			—			3,100		—					(85	)
Fenergo Finance 3 Limited	09/05/24			—			4,520		—					(57	)
Fenergo Finance 3 Limited	09/05/24			—			2,865		—					(36	)
MMIT Holdings, LLC (dba Managed Markets Insight & Technology)	11/15/24			—			3,085		—					(46	)
Wrike, Inc.	12/31/24			—			3,900		—				—
ConnectWise, LLC	02/28/25			—			1,920		—					(19	)
Villa Bidco Inc (dba Authority Brands)	03/21/25			—			1,864		—					(37	)

Table of Contents

			Unfunded Commitment⁽²⁾						Fair Value⁽³⁾
	Commitment Expiration Date⁽¹⁾		September 30, 2021			December 31, 2020			September 30, 2021				December 31, 2020
Granicus, Inc.	08/21/26			—			1,563		—					(31	)
Blacksmith Applications, Inc.	12/02/26			—			2,000		—					(45	)
Wellness AcquisitionCo, Inc. (dba SPINS)	01/20/27			—			19,698		—				—
Total 1st Lien/Senior Secured Debt		$		401,783	$		242,910	$		(3,269	)	$		(3,848	)
Total		$		401,783	$		242,910	$		(3,269	)	$		(3,848	)

⁽¹⁾	Commitments are generally subject to borrowers meeting certain criteria such as compliance with covenants and certain operational metrics. These amounts may remain outstanding until the commitment period of an applicable loan expires, which may be shorter than its maturity.

⁽²⁾	Unfunded commitments denominated in currencies other than USD have been converted to USD using the exchange rate as of the applicable reporting date.

⁽³⁾	The fair value is reflected as investments, at fair value on the Consolidated Statements of Assets and Liabilities.

Contingencies

In the normal course of business, the Company enters into contracts that provide a variety of general indemnifications. Any exposure to the Company under these arrangements could involve future claims that may be made against the Company. Currently, no such claims exist or are expected to arise and, accordingly, the Company has not accrued any liability in connection with such indemnifications.

9.	NET ASSETS

Equity Issuances

There were no sales of the Company’s common stock during the three and nine months ended September 30, 2021 and 2020.

Distributions

The Company has adopted a dividend reinvestment plan that provides for reinvestment of all cash distributions declared by the Board of Directors, unless a stockholder elects to “opt out” of the plan. As a result, if the Board of Directors declares a cash distribution, then the stockholders who have not “opted out” of the dividend reinvestment plan will have their cash distributions automatically reinvested in additional shares of common stock, rather than receiving the cash distribution. The shares distributed by the Transfer Agent in the Company’s dividend reinvestment plan are either through (i) newly issued shares or (ii) acquired by the Transfer Agent through the purchase of outstanding shares on the open market. If, on the payment date for any distribution, the most recently computed NAV per share as of the dividend payment date is equal to or less than the closing market price plus estimated per share fees, the Transfer Agent will invest the distribution amount in newly issued shares. Otherwise, the Transfer Agent will invest the dividend amount in shares acquired by purchasing shares on the open market. The following table summarizes the distributions declared on shares of the Company’s common stock and shares distributed pursuant to the dividend reinvestment plan to stockholders who had not opted out of the dividend reinvestment plan:

Date Declared	Record Date	Payment Date	Amount Per Share		Shares
For the Nine Months Ended September 30, 2021
November 4, 2020 (special)	February 15, 2021	March 15, 2021	$	0.05		6,849
February 24, 2021	March 31, 2021	April 27, 2021	$	0.45		68,092
November 4, 2020 (special)	May 14, 2021	June 15, 2021	$	0.05		8,852
May 4, 2021	June 30, 2021	July 27, 2021	$	0.45		69,917
November 4, 2020 (special)	August 16, 2021	September 15, 2021	$	0.05		7,717
August 5, 2021	September 30, 2021	October 27, 2021	$	0.45		65,213
For the Nine Months Ended September 30, 2020
February 19, 2020	March 31, 2020	April 15, 2020	$	0.45	37,741*
May 5, 2020	June 30, 2020	July 15, 2020	$	0.45		46,407
August 4, 2020	September 30, 2020	October 15, 2020	$	0.45		49,015

^*	In accordance with the Company’s dividend reinvestment plan, shares were purchased in the open market.

10.EARNINGS PER SHARE

The following information sets forth the computation of basic and diluted earnings per share:

	For the Three Months Ended				For the Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Net increase in net assets from operations	$	38,033	$	32,440	$	153,473	$	3,478
Weighted average shares outstanding		101,727,464		40,440,982		101,654,241		40,413,082
Basic and diluted earnings per share	$	0.37	$	0.80	$	1.51	$	0.09

Table of Contents

For the purpose of calculating diluted earnings per common share, the average closing price of the Company’s common stock for the three and nine months ended September 30, 2021 and 2020 was less than the conversion price for the Convertible Notes outstanding as of September 30, 2021 and 2020. Therefore, for the three and nine months ended September 30, 2021 and 2020, diluted earnings per share equal basic earnings per share because the underlying shares for the intrinsic value of the embedded options in the Convertible Notes were not dilutive.

11.	FINANCIAL HIGHLIGHTS

Below presents the schedule of financial highlights of the Company:

	For the Nine Months Ended
	September 30, 2021			September 30, 2020
Per Share Data:⁽¹⁾
NAV, beginning of period	$	15.91		$	16.75
Net investment income		1.77			1.35
Net realized and unrealized gains (losses)⁽²⁾		(0.26	)		(1.26	)
Net increase in net assets from operations		1.51			0.09
Distributions declared from net investment income		(1.50	)		(1.35	)
Total increase (decrease) in net assets		0.01			(1.26	)
NAV, end of period	$	15.92		$	15.49
Market price, end of period	$	18.35		$	15.04
Shares outstanding, end of period		101,753,598			40,448,044
Weighted average shares outstanding		101,654,241			40,413,082
Total return based on NAV⁽³⁾		8.47	%		1.34	%
Total return based on market value⁽⁴⁾		4.04	%		(22.55	)%
Supplemental Data/Ratio⁽⁵⁾:
Net assets, end of period	$	1,620,089		$	626,423
Ratio of net expenses to average net assets		6.84	%		8.48	%
Ratio of net expenses before voluntary waivers to average net assets		8.46	%		9.30	%
Ratio of net expenses (without incentive fees and interest and other debt expenses) to average net assets		2.49	%		2.68	%
Ratio of interest and other debt expenses to average net assets		3.62	%		5.80	%
Ratio of net incentive fees to average net assets		0.73	%		—
Ratio of total expenses to average net assets		8.83	%		9.46	%
Ratio of net investment income to average net assets		14.81	%		11.80	%
Portfolio turnover		33	%		12	%

⁽¹⁾	The per share data was derived by using the weighted average shares outstanding during the applicable period, except for distributions declared, which reflects the actual amount per share for the applicable period.

⁽²⁾	The amount shown may not correspond with the aggregate amount paid for the period as it includes the effect of the timing of the distribution.

⁽³⁾	Calculated as the change in NAV per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s dividend reinvestment plan.

⁽⁴⁾	Calculated as the change in market value per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s dividend reinvestment plan.

⁽⁵⁾	Ratios are annualized.

12. MERGER WITH GS MMLC

On October 12, 2020, the Company completed its merger with GS MMLC pursuant to the Merger Agreement, dated as of June 11, 2020. The Company was the accounting survivor of the Merger. At the effective time of the Merger, each outstanding share of GS MMLC common stock was converted into the right to receive, for each share of GS MMLC common stock, that number of shares of the Company’s common stock, par value $0.001 per share, with a NAV equal to the NAV per share of GS MMLC common stock, in each case calculated as of October 9, 2020. As a result, the Company issued an aggregate of 61,037,311 shares of Common Stock to the former GS MMLC stockholders.

The Merger was accounted for as an asset acquisition in accordance with ASC 805-50, Business Combinations—Related Issues. The consideration paid to GS MMLC’s stockholders was less than the aggregate fair values of the assets acquired and liabilities assumed, which resulted in a purchase discount (the “purchase discount”). The purchase discount was allocated to the cost of GS MMLC investments acquired by the Company on a pro-rata basis based on their relative fair values as of the closing date. Immediately following the Merger with GS MMLC, the investments were marked to their respective fair values and, as a result, the purchase discount allocated to the cost basis of the investments acquired was immediately recognized as unrealized appreciation on the Consolidated Statement of Operations. The purchase discount allocated to the loan investments acquired will amortize over the life of each respective loan through interest income with a corresponding adjustment recorded as unrealized depreciation on such loans acquired through their ultimate disposition. The purchase discount allocated to equity investments acquired will not amortize over the life of such investments through interest income and, assuming no subsequent change to the fair value of the equity investments acquired and disposition of such equity investments at fair value, the

Table of Contents

Company will recognize a realized gain with a corresponding reversal of the unrealized appreciation on disposition of such equity investments acquired. The Merger was considered a tax-free reorganization and the Company has elected to carry forward the historical cost basis of the GS MMLC investments for tax purposes.

The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger:

Common stock issued by the Company⁽¹⁾	$	866,201
Total purchase price	$	866,201
Assets acquired:
Investments, at fair value (amortized cost of $1,741,300)	$	1,691,263
Cash and cash equivalents		177,576
Other assets		18,986
Total assets acquired	$	1,887,825
Liabilities assumed:
Debt	$	843,701
Distribution payable		75,000
Other liabilities⁽²⁾		18,963
Total liabilities assumed	$	937,664
Net assets acquired	$	950,161
Total purchase discount	$	(83,960)

⁽¹⁾

Based on the market price at closing of $15.26, adjusted for a discount to reflect the impact of transfer restrictions applicable to the shares of the Company’s Common Stock issued to GS MMLC stockholders pursuant to the terms of the Merger, and the 61,037,311 shares of common stock issued by the Company.

⁽²⁾

Includes $4,159 of management fees and $6,672 of incentive fees accrued by GS MMLC pursuant to an investment management agreement between GS MMLC and Investment Adviser, which was terminated upon the closing of the Merger. The payable for these fees was assumed by the Company and paid by the Company to the Investment Adviser in November 2020.

13.	SUBSEQUENT EVENTS

Subsequent events after the date of the Consolidated Statements of Assets and Liabilities have been evaluated through the date the unaudited consolidated financial statements were issued. Other than the items discussed below, the Company has concluded that there is no impact requiring adjustment or disclosure on the consolidated financial statements.

On November 4, 2021, the Board of Directors declared a quarterly distribution of $0.45 per share payable on January 27, 2022 to holders of record as of December 31, 2021.

Table of Contents

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and other parts of this report contain forward-looking information that involves risks and uncertainties. References to “we,” “us,” “our,” and the “Company,” mean Goldman Sachs BDC, Inc. or Goldman Sachs BDC, Inc. together with its consolidated subsidiaries, as the context may require. The terms “GSAM,” our “Adviser” or our “Investment Adviser” refer to Goldman Sachs Asset Management, L.P., a Delaware limited partnership. The term “Group Inc.” refers to The Goldman Sachs Group, Inc. “GS & Co.” refers to Goldman Sachs & Co. LLC and its predecessors. The term “Goldman Sachs” refers to Group Inc., together with GS & Co., GSAM and its other subsidiaries and affiliates. The discussion and analysis contained in this section refers to our financial condition, results of operations and cash flows. The information contained in this section should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere in this report. Please see “Cautionary Statement Regarding Forward-Looking Statements” for a discussion of the uncertainties, risks and assumptions associated with this discussion and analysis. Our actual results could differ materially from those anticipated by such forward-looking information due to factors discussed under “Cautionary Statement Regarding Forward-Looking Statements” appearing elsewhere in this report.

OVERVIEW

We are a specialty finance company focused on lending to middle-market companies. We are a closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “Investment Company Act”). In addition, we have elected to be treated, and expect to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with our taxable year ended December 31, 2013. From our formation in 2012 through September 30, 2021, we originated more than $5.44 billion in aggregate principal amount of debt and equity investments prior to any subsequent exits and repayments. We seek to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including first lien, unitranche, including last-out portions of such loans, and second lien debt, and unsecured debt, including mezzanine debt, as well as through select equity investments.

“Unitranche” loans are first lien loans that may extend deeper in a company’s capital structure than traditional first lien debt and may provide for a waterfall of cash flow priority between different lenders in the unitranche loan. In a number of instances, we may find another lender to provide the “first-out” portion of such loan and retain the “last-out” portion of such loan, in which case, the “first-out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last-out” portion that we would continue to hold. In exchange for the greater risk of loss, the “last-out” portion generally earns a higher interest rate than the “first-out” portion. We use the term “mezzanine” to refer to debt that ranks senior only to a borrower’s equity securities and ranks junior in right of payment to all of such borrower’s other indebtedness. We may make multiple investments in the same portfolio company.

We invest primarily in U.S. middle-market companies, which we believe are underserved by traditional providers of capital such as banks and the public debt markets. In this report, we generally use the term “middle market companies” to refer to companies with between $5 million and $200 million of annual earnings before interest expense, income tax expense, depreciation and amortization (“EBITDA”) excluding certain one-time, and non-recurring items that are outside the operations of these companies. However, we may from time to time invest in larger or smaller companies. We generate revenues primarily through receipt of interest income from the investments we hold. In addition, we may generate income from various loan origination and other fees, dividends on direct equity investments and capital gains on the sales of investments. Fees received from portfolio companies (directors’ fees, consulting fees, administrative fees, tax advisory fees and other similar compensation) are paid to us, unless, to the extent required by applicable law or exemptive relief therefrom, we only receive our allocable portion of such fees when invested in the same portfolio company as another client account managed by our Investment Adviser (including Goldman Sachs Private Middle Market Credit LLC and Goldman Sachs Private Middle Market Credit II LLC, collectively with other client accounts managed by our Investment Adviser, the “Accounts”). The companies in which we invest use our capital for a variety of purposes, including to support organic growth, fund acquisitions, make capital investments or refinance indebtedness.

Our origination strategy focuses on leading the negotiation and structuring of the loans or securities in which we invest and holding the investments in our portfolio to maturity. In many cases, we are the sole investor in the loan or security in our portfolio. Where there are multiple investors, we generally seek to control or obtain significant influence over the rights of investors in the loan or security. We generally seek to make investments that have maturities between three and ten years and range in size between $10 million and $75 million, although we may make larger or smaller investments on occasion.

For a discussion of the competitive landscape we face, please see “Item 1A. Risk Factors–Competition–We operate in a highly competitive market for investment opportunities” and “Item 1. Business–Competitive Advantages,” in our annual report on Form 10-K for the year ended December 31, 2020.

Table of Contents

Merger with GS MMLC

On October 12, 2020, we completed our merger (the “Merger”) with GS MMLC pursuant to the Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 11, 2020. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of GS MMLC common stock was converted into the right to receive, for each share of GS MMLC common stock, that number of shares of our common stock, par value $0.001 per share (“Common Stock”), with a net asset value (“NAV”) equal to the NAV per share of GS MMLC common stock, in each case calculated as of October 9, 2020. As a result of the Merger, we issued an aggregate of 61,037,311 shares of Common Stock to former GS MMLC stockholders. In connection with the Merger, GSAM reimbursed each of us and GS MMLC, in each case in an amount of $4.00 million, for all fees and expenses incurred and payable by us or GS MMLC, in connection with or related to the Merger (including all documented fees and expenses of counsel, accountants, experts and consultants to us or the special committee of our board of directors (the “Board of Directors”), on the one hand, or GS MMLC or the special committee of its board of directors, on the other hand). For more information, see Note 12 “Merger with GS MMLC” to our consolidated financial statements included in this report.

Impact of COVID-19 Pandemic

During the third quarter of 2021, the spike in infections from the spread of the Delta variant put heightened focus on efforts to increase vaccination rates in order to make further progress against the virus. Although the global recovery continued to progress, the rising number of infections had the effect of tempering the pace of growth. The extent to which the COVID-19 pandemic will continue to affect our business, financial condition, liquidity, our portfolio companies’ results of operations and by extension our operating results are highly uncertain and cannot be predicted. Economies around the world continue to be susceptible to potential adverse developments related to the pandemic, such as additional waves of infection, a worsening of supply chain constraints and an intensification of inflationary pressures.

Our investment portfolio continues to be focused on industries and sectors that are generally expected to be more durable than industries and sectors that are more prone to economic cycles. Given the unprecedented nature of COVID-19 and the difficulty in predicting future government responses and restrictions, the operating environment of our portfolio companies is evolving rapidly. Business disruption experienced by our portfolio companies may reduce, over time, the amount of interest and dividend income that we receive from our investments companies and may require us to contribute additional capital to such portfolio companies. We may need to restructure our investments in some portfolio companies, which could result in reduced interest payments from or permanent impairments of our investments, and could result in the restructuring of certain of our investments from income paying investments into non-income paying equity investments. Any such decrease in our net investment income would increase the percentage of our cash flows dedicated to our debt obligations and distribution payments to our stockholders. As a result, we may be required to reduce the future amount of distributions to our stockholders. The potential exists for the Delta variant or other variants to impede the global economic recovery, and we continue to closely monitor our exposures to industries that would be most negatively impacted by a resurgence in the COVID-19 pandemic.

Goldman Sachs has continued to successfully execute on its Business Continuity Planning (the “BCP”) strategy since initially activating it in the first quarter of 2020 in response to the emergence of the COVID-19 pandemic. Goldman Sachs’ priority has been to safeguard its employees and to ensure continuity of business operations. Goldman Sachs has a central team that continues to manage its COVID-19 response, which is led by its chief administrative officer and chief medical officer. Goldman Sachs remains focused on facilitating the safe return of its employees to their offices, as circumstances permit, and employees in a number of their locations around the world have returned to the office in some capacity, including a majority of employees in the U.S. Given that the situation regarding COVID-19 varies geographically, Goldman Sachs’s approach to transitioning back to the office is tailored to each location, and it evolves as the specific conditions and requirements of each location change. Our systems and infrastructure have continued to support our business operations. We have maintained regular and active communication across senior management, the rest of our private credit group and our Board of Directors. Furthermore, we have ongoing dialogues with our vendors to ensure they continue to meet our criteria for business continuity.

For further information about the risks associated with COVID-19, see “Item 1A. Risk Factors,” in our annual report on Form 10-K for the year ended December 31, 2020.

KEY COMPONENTS OF OPERATIONS

Investments

Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle-market companies, the level of merger and acquisition activity for such companies, the general economic environment, the amount of capital we have available to us and the competitive environment for the type of investments we make.

As a BDC, we may not acquire any assets other than “qualifying assets” specified in the Investment Company Act, unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Pursuant to rules adopted by the Securities and Exchange Commission (the “SEC”), “eligible portfolio companies” include certain companies that do not have any securities listed on a national securities exchange and public companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.

Table of Contents

Revenues

We generate revenues in the form of interest income on debt investments and, to a lesser extent, capital gains and distributions, if any, on equity securities that we may acquire in portfolio companies. Some of our investments may provide for deferred interest payments or payment-in-kind (“PIK”) income. The principal amount of the debt investments and any accrued but unpaid interest generally becomes due at the maturity date.

We generate revenues primarily through receipt of interest income from the investments we hold. In addition, we may generate revenue in the form of commitment, origination, structuring, syndication, exit fees or diligence fees, fees for providing managerial assistance and consulting fees. Portfolio company fees (directors’ fees, consulting fees, administrative fees, tax advisory fees and other similar compensation) will be paid to us, unless, to the extent required by applicable law or exemptive relief, if any, therefrom, we receive our allocable portion of such fees when invested in the same portfolio company as other Accounts, which other Accounts could receive their allocable portion of such fee. We do not expect to receive material fee income as it is not our principal investment strategy. We record contractual prepayment premiums on loans and debt securities as interest income.

Expenses

Our primary operating expenses include the payment of the Management Fee and the Incentive Fee to our Investment Adviser, legal and professional fees, interest and other debt expenses and other operating and overhead related expenses. The Management Fee and Incentive Fee compensate our Investment Adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other expenses of our operations and transactions in accordance with the investment management agreement (the “Investment Management Agreement”) and administration agreement (“Administration Agreement”), including:

•

our operational expenses;

•

fees and expenses, including travel expenses, incurred by our Investment Adviser or payable to third parties related to our investments, including, among others, professional fees (including the fees of consultants and experts) and fees and expenses from evaluating, monitoring, researching and performing due diligence on investments and prospective investments;

•

interest payable on debt, if any, incurred to finance our investments;

•

fees and expenses incurred by us in connection with membership in investment company organizations;

•

brokers’ commissions;

•

the expenses of and fees for registering or qualifying our shares for sale and of maintaining our registration and registering us as a broker or a dealer;

•

fees and expenses associated with calculating our NAV (including expenses of any independent valuation firm);

•

legal, auditing or accounting expenses;

•

taxes or governmental fees;

•

the fees and expenses of our administrator, transfer agent or sub-transfer agent;

•

the cost of preparing stock certificates, including clerical expenses of issue, redemption or repurchase of our shares;

•

the fees and expenses of our directors who are not affiliated with our Investment Adviser;

•

the cost of preparing and distributing reports, proxy statements and notices to our stockholders, the SEC and other regulatory authorities;

•

costs of holding stockholder meetings;

•

listing fees;

•

the fees or disbursements of custodians of our assets, including expenses incurred in the performance of any obligations enumerated by our certificate of incorporation or bylaws insofar as they govern agreements with any such custodian;

•

insurance premiums; and

•

costs incurred in connection with any claim, litigation, arbitration, mediation, government investigation or dispute in connection with our business and the amount of any judgment or settlement paid in connection therewith, or the enforcement of our rights against any person and indemnification or contribution expenses payable by us to any person and other extraordinary expenses not incurred in the ordinary course of our business.

We expect our general and administrative expenses to be relatively stable or decline as a percentage of total assets during periods of asset growth and to increase during periods of asset declines. Costs relating to future offerings of securities would be incremental.

Table of Contents

Leverage

Our senior secured revolving credit agreement (as amended, the “Revolving Credit Facility”) with Truist Bank, as administrative agent, and Bank of America, N.A., as syndication agent, our 4.50% Convertible Notes due 2022 (the “Convertible Notes”), our 3.75% Notes due 2025 (the “2025 Notes”), and our 2.875% Notes due 2026 (the “2026 Notes”) allow us to borrow money and lever our investment portfolio, subject to the limitations of the Investment Company Act, with the objective of increasing our yield. This is known as “leverage” and could increase or decrease returns to our stockholders. The use of leverage involves significant risks. We are permitted to borrow amounts such that our asset coverage ratio, as defined in the Investment Company Act, is at least 150% after such borrowing (if certain requirements are met).

Certain trading practices and investments, such as reverse repurchase agreements, may be considered borrowings or involve leverage and thus may be subject to Investment Company Act restrictions. In accordance with applicable SEC staff guidance and interpretations, when we engage in such transactions, instead of maintaining an asset coverage ratio of at least 150% (if certain requirements are met), we may segregate or earmark liquid assets, or enter into an offsetting position, in an amount at least equal to our exposure, on a mark-to-market basis, to such transactions (as calculated pursuant to requirements of the SEC). Short-term credits necessary for the settlement of securities transactions and arrangements with respect to securities lending will not be considered borrowings for these purposes. Practices and investments that may involve leverage but are not considered borrowings are not subject to the Investment Company Act’s asset coverage requirement, and we will not otherwise segregate or earmark liquid assets or enter into offsetting positions for such transactions. The amount of leverage that we employ will depend on our Investment Adviser’s and our Board of Directors’ assessment of market conditions and other factors at the time of any proposed borrowing.

PORTFOLIO AND INVESTMENT ACTIVITY

Our portfolio (excluding investments in money market funds, if any) consisted of the following:

	As of
	September 30, 2021				December 31, 2020
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
	(in millions)				(in millions)
First Lien/Senior Secured Debt	$	2,596.09	$	2,622.90	$	2,489.28	$	2,526.97
First Lien/Last-Out Unitranche		157.33		162.18		138.96		143.23
Second Lien/Senior Secured Debt		281.06		274.34		458.92		457.73
Unsecured Debt		2.49		1.81		1.05		0.33
Preferred Stock		16.75		20.17		19.87		48.08
Common Stock		68.84		30.64		73.74		65.40
Warrants		0.76		0.08		0.76		1.03
Total Investments	$	3,123.32	$	3,112.12	$	3,182.58	$	3,242.77

The weighted average yield by asset type of our total portfolio (excluding investments in money market funds, if any), at amortized cost and fair value, was as follows:

	As of
	September 30, 2021						December 31, 2020
	Amortized Cost			Fair Value			Amortized Cost			Fair Value
Weighted Average Yield⁽¹⁾
First Lien/Senior Secured Debt⁽²⁾		8.3	%		8.3	%		8.3	%		8.6	%
First Lien/Last-Out Unitranche^{(2) (3)}		9.3			9.0			9.3			9.4
Second Lien/Senior Secured Debt⁽²⁾		10.0			10.2			10.4			10.7
Unsecured Debt⁽²⁾		8.1			11.2			0.0			0.0
Preferred Stock⁽⁴⁾		—			—			—			—
Common Stock⁽⁴⁾		—			—			—			—
Warrants⁽⁴⁾		—			—			—			—
Total Portfolio		8.3	%		8.4	%		8.4	%		8.6	%

⁽¹⁾	The weighted average yield at amortized cost of our portfolio excludes the purchase discount and amortization related to the Merger and does not represent the total return to our stockholders.

⁽²⁾

Computed based on (a) the annual actual interest rate or yield earned plus amortization of fees and discounts on the performing debt and other income producing investments as of the reporting date, divided by (b) the total investments (including investments on non-accrual and non-income producing investments) at amortized cost or fair value. This calculation excludes exit fees that are receivable upon repayment of certain loan investments.

⁽³⁾	The calculation includes incremental yield earned on the “last-out” portion of the unitranche loan investments.

⁽⁴⁾	Computed based on (a) the stated coupon rate, if any, for each income-producing investment, divided by (b) the total investments (including investments on non-accrual and non-income producing investments) at amortized cost or fair value.

As of September 30, 2021, the total portfolio weighted average yield measured at amortized cost and fair value was 8.3% and 8.4%, as compared to 8.4% and 8.6%, as of December 31, 2020. Within Unsecured Debt, the increase in weighted average yield at amortized cost and fair value was primarily driven by the exchange of our First Lien/Senior Secured Debt investment in ATX Networks Corp. for First Lien/Senior Secured Debt, Unsecured Debt and Common Stock.

Table of Contents

The following table presents certain selected information regarding our investment portfolio (excluding investments in money market funds, if any)

		As of
		September 30, 2021			December 31, 2020
Number of portfolio companies			111				123
Percentage of performing debt bearing a floating rate⁽¹⁾			99.3	%			99.1	%
Percentage of performing debt bearing a fixed rate⁽¹⁾⁽²⁾			0.7	%			0.9	%
Weighted average yield on debt and income producing investments, at amortized cost⁽³⁾			8.6	%			8.7	%
Weighted average yield on debt and income producing investments, at fair value⁽³⁾			8.5	%			8.9	%
Weighted average leverage (net debt/EBITDA)⁽⁴⁾		6.0x				6.0x
Weighted average interest coverage⁽⁴⁾		2.5x				2.6x
Median EBITDA⁽⁴⁾	$	39.28 million			$	34.20 million

⁽¹⁾	Measured on a fair value basis. Excludes investments, if any, placed on non-accrual.

⁽²⁾	Includes income producing preferred stock investments.

⁽³⁾

Computed based on (a) the annual actual interest rate or yield earned plus amortization of fees and discounts on the performing debt and other income producing investments as of the reporting date, divided by (b) the total performing debt and other income producing investments (excluding investments on non-accrual). Excludes the purchase discount and amortization related to the Merger.

⁽⁴⁾

For a particular portfolio company, we calculate the level of contractual indebtedness net of cash (“net debt”) owed by the portfolio company and compare that amount to measures of cash flow available to service the net debt. To calculate net debt, we include debt that is both senior and pari passu to the tranche of debt owned by us but exclude debt that is legally and contractually subordinated in ranking to the debt owned by us. We believe this calculation method assists in describing the risk of our portfolio investments, as it takes into consideration contractual rights of repayment of the tranche of debt owned by us relative to other senior and junior creditors of a portfolio company. We typically calculate cash flow available for debt service at a portfolio company by taking EBITDA for the trailing twelve-month period. Weighted average net debt to EBITDA is weighted based on the fair value of our debt investments and excluding investments where net debt to EBITDA may not be the appropriate measure of credit risk, such as cash collateralized loans and investments that are underwritten and covenanted based on recurring revenue.

For a particular portfolio company, we also calculate the level of contractual interest expense owed by the portfolio company, and compare that amount to EBITDA (“interest coverage ratio”). We believe this calculation method assists in describing the risk of our portfolio investments, as it takes into consideration contractual interest obligations of the portfolio company. Weighted average interest coverage is weighted based on the fair value of our performing debt investments, excluding investments where interest coverage may not be the appropriate measure of credit risk, such as cash collateralized loans and investments that are underwritten and covenanted based on recurring revenue.

Median EBITDA is based on our debt investments, excluding investments where net debt to EBITDA may not be the appropriate measure of credit risk, such as cash collateralized loans and investments that are underwritten and covenanted based on recurring revenue.

Portfolio company statistics are derived from the most recently available financial statements of each portfolio company as of the reported end date. Statistics of the portfolio companies have not been independently verified by us and may reflect a normalized or adjusted amount. As of September 30, 2021 and December 31, 2020, investments where net debt to EBITDA may not be the appropriate measure of credit risk represented 37.4% and 33.1%, of total debt investments.

Our Investment Adviser monitors the financial trends of each portfolio company on an ongoing basis to determine if it is meeting its respective business plan and to assess the appropriate course of action for each company. Our Investment Adviser has several methods of evaluating and monitoring the performance and fair value of our investments, which may include (i) assessment of success in adhering to the portfolio company’s business plan and compliance with covenants; (ii) periodic or regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor to discuss financial position, requirements and accomplishments; (iii) comparisons to our other portfolio companies in the industry, if any; (iv) attendance at and participation in board meetings or presentations by portfolio companies; and (v) review of monthly and quarterly financial statements and financial projections of portfolio companies.

As part of the monitoring process, our Investment Adviser also employs an investment rating system to categorize our investments. In addition to various risk management and monitoring tools, our Investment Adviser grades the credit risk of all investments on a scale of 1 to 4 no less frequently than quarterly. This system is intended primarily to reflect the underlying risk of a portfolio investment relative to our initial cost basis in respect of such portfolio investment (e.g., at the time of origination or acquisition), although it may also take into account under certain circumstances the performance of the portfolio company’s business, the collateral coverage of the investment and other relevant factors. The grading system for our investments is as follows:

•

Grade 1 investments involve the least amount of risk to our initial cost basis. The trends and risk factors for this investment since origination or acquisition are generally favorable, which may include the performance of the portfolio company or a potential exit;

•

Grade 2 investments involve a level of risk to our initial cost basis that is similar to the risk to our initial cost basis at the time of origination or acquisition. This portfolio company is generally performing as expected and the risk factors to our ability to ultimately recoup the cost of our investment are neutral to favorable. All investments or acquired investments in new portfolio companies are initially assessed a grade of 2;

•

Grade 3 investments indicate that the risk to our ability to recoup the initial cost basis of such investment has increased materially since origination or acquisition, including as a result of factors such as declining performance and non-compliance with debt covenants; however, payments are generally not more than 120 days past due; and

Table of Contents

•

Grade 4 investments indicate that the risk to our ability to recoup the initial cost basis of such investment has substantially increased since origination or acquisition, and the portfolio company likely has materially declining performance. For debt investments with an investment grade of 4, in most cases, most or all of the debt covenants are out of compliance and payments are substantially delinquent. For investments graded 4, it is anticipated that we will not recoup our initial cost basis and may realize a substantial loss of our initial cost basis upon exit.

Our Investment Adviser grades the investments in our portfolio at least quarterly and it is possible that the grade of a portfolio investment may be reduced or increased over time. For investments graded 3 or 4, our Investment Adviser enhances its level of scrutiny over the monitoring of such portfolio company. The following table shows the composition of our portfolio on the 1 to 4 grading scale:

	As of
	September 30, 2021					December 31, 2020
Investment Performance Rating	Fair Value		Percentage of Total			Fair Value		Percentage of Total
	(in millions)					(in millions)
Grade 1	$	72.21		2.3	%	$	64.15		2.0	%
Grade 2		2,869.42		92.2			2,822.45		87.0
Grade 3		165.58		5.3			353.16		10.9
Grade 4		4.91		0.2			3.01		0.1
Total Investments	$	3,112.12		100.0	%	$	3,242.77		100.0	%

The decrease in investments with a grade 3 investment performance rating was primarily driven by investments with an aggregate fair value of $115.01 million being upgraded to a grade 2 investment performance rating due to financial improvement and an investment with an aggregate fair value of $30.80 million being upgraded to a grade 1 investment performance rating due to a potential exit.

The following table shows the amortized cost of our performing and non-accrual investments:

	As of
	September 30, 2021					December 31, 2020
	Amortized Cost		Percentage of Total			Amortized Cost		Percentage of Total
	(in millions)					(in millions)
Performing	$	3,102.93		99.3	%	$	3,160.47		99.3	%
Non-accrual		20.39		0.7			22.11		0.7
Total Investments	$	3,123.32		100.0	%	$	3,182.58		100.0	%

Table of Contents

The following table shows our investment activity by investment type⁽¹⁾:

	For the Three Months Ended
	September 30, 2021			September 30, 2020
	($ in millions)
Amount of investments committed at cost:
First Lien/Senior Secured Debt	$	633.36		$	11.56
First Lien/Last-Out Unitranche		24.50			—
Second Lien/Senior Secured Debt		8.25			—
Preferred Stock		—			0.02
Common Stock		4.57			—
Total	$	670.68		$	11.58
Proceeds from investments sold or repaid:
First Lien/Senior Secured Debt	$	502.94		$	24.53
First Lien/Last-Out Unitranche		0.04			0.12
Second Lien/Senior Secured Debt		120.15			—
Preferred Stock		34.44			—
Common Stock		14.08			—
Total	$	671.65		$	24.65
Net increase (decrease) in portfolio	$	(0.97	)	$	(13.07	)
Number of new portfolio companies with new investment commitments		10			4
Total new investment commitment amount in new portfolio companies	$	312.21		$	1.93
Average new investment commitment amount in new portfolio companies	$	31.22		$	0.48
Number of existing portfolio companies with new investment commitments		17			1
Total new investment commitment amount in existing portfolio companies	$	358.47		$	9.65
Weighted average remaining term for new investment commitments (in years)⁽²⁾		5.5			5.9
Percentage of new debt investment commitments at cost for floating interest rates		100.0	%		100.0	%
Percentage of new debt investment commitments at cost for fixed interest rates⁽³⁾		0.0	%		0.0	%
Weighted average yield on new debt and income producing investment commitments⁽⁴⁾		7.7	%		8.6	%
Weighted average yield on new investment commitments⁽⁵⁾		7.6	%		8.6	%
Weighted average yield on debt and income producing investments sold or repaid⁽⁶⁾		7.6	%		7.0	%
Weighted average yield on investments sold or repaid⁽⁷⁾		7.0	%		7.0	%

⁽¹⁾

Figures for new investment commitments are shown net of capitalized fees, expenses and original issue discount (“OID”) that occurred at the initial close. Figures for new investment commitments may also include positions originated during the period but not held at the reporting date. Figures for investments sold or repaid, excludes unfunded commitments that may have expired or otherwise been terminated without receipt of cash proceeds or other consideration.

⁽²⁾	Calculated as of the end of the relevant period and the maturity date of the individual investments.

⁽³⁾	May include preferred stock investments.

⁽⁴⁾

Computed based on (a) the annual actual interest rate on new debt and income producing investment commitments divided by (b) the total new debt and income producing investment commitments. The calculation includes incremental yield earned on the “last-out” portion of the unitranche loan investments and excludes investments that are non-accrual. The annual actual interest rate used is as of the respective quarter end date when the investment activity occurred.

⁽⁵⁾

Computed based on (a) the annual actual interest rate on new investment commitments divided by (b) the total new investment commitments (including investments on non-accrual and non-income producing investments). The calculation includes incremental yield earned on the “last-out” portion of the unitranche loan investments. The annual actual interest rate used is as of the respective quarter end date when the investment activity occurred.

⁽⁶⁾

Computed based on (a) the annual actual interest rate on debt and income producing investments sold or paid down, divided by (b) the total debt and income producing investments sold or paid down. The calculation includes incremental yield earned on the “last-out” portion of the unitranche loan investments and excludes prepayment premiums earned on exited investments and investments that are on non-accrual.

⁽⁷⁾

Computed based on (a) the annual actual interest rate on investments sold or paid down, divided by (b) the total investments sold or paid down (including investments on non-accrual and non-income producing investments). The calculation includes incremental yield earned on the “last-out” portion of the unitranche loan investments and excludes prepayment premiums earned on exited investments.

Table of Contents

RESULTS OF OPERATIONS

Our operating results were as follows:

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
	(in millions)
Total investment income	$	96.68		$	31.45		$	263.22		$	94.03
Net expenses		32.05			12.88			82.20			38.28
Net investment income before taxes		64.63			18.57			181.02			55.75
Income tax expense, including excise tax		0.30			0.37			0.93			1.19
Net investment income after taxes		64.33			18.20			180.09			54.56
Net realized gain (loss) on investments		34.31			(35.98	)		40.54			(47.51	)
Net unrealized appreciation (depreciation) on investments		(62.06	)		51.94			(71.38	)		(1.96	)
Net realized and unrealized gain (losses) on forward contracts, translations and transactions		1.53			(1.71	)		4.52			(1.70	)
Net realized and unrealized gains (losses)		(26.22	)		14.25			(26.32	)		(51.17	)
Income tax (provision) benefit for realized and unrealized gains		(0.08	)		(0.01	)		(0.30	)		0.09
Net increase in net assets from operations	$	38.03		$	32.44		$	153.47		$	3.48

Net increase in net assets from operations can vary from period to period as a result of various factors, including acquisitions, the level of new investment commitments, the recognition of realized gains and losses and changes in unrealized appreciation and depreciation on the investment portfolio.

On October 12, 2020, we completed our Merger with GS MMLC. The Merger was accounted for as an asset acquisition in accordance with ASC 805-50, Business Combinations — Related Issues. The consideration paid to GS MMLC’s stockholders was less than the aggregate fair values of the assets acquired and liabilities assumed, which resulted in a purchase discount (the “purchase discount”). The purchase discount was allocated to the cost of GS MMLC investments acquired by us on a pro-rata basis based on their relative fair values as of the closing date. Immediately following the Merger with GS MMLC, we marked the investments to their respective fair values and, as a result, the purchase discount allocated to the cost basis of the investments acquired was immediately recognized as unrealized appreciation on our Consolidated Statement of Operations. The purchase discount allocated to the loan investments acquired will amortize over the life of each respective loan through interest income with a corresponding adjustment recorded as unrealized depreciation on such loans acquired through their ultimate disposition. The purchase discount allocated to equity investments acquired will not amortize over the life of such investments through interest income and, assuming no subsequent change to the fair value of the equity investments acquired and disposition of such equity investments at fair value, we will recognize a realized gain with a corresponding reversal of the unrealized appreciation on disposition of such equity investments acquired.

As a supplement to our financial results reported in accordance with GAAP, we have provided, as detailed below, certain non-GAAP financial measures to our operating results that exclude the aforementioned purchase discount and the ongoing amortization thereof, as determined in accordance with GAAP. The non-GAAP financial measures include (i) Adjusted net investment income after taxes; and (ii) Adjusted net realized and unrealized gains (losses). We believe that the adjustment to exclude the full effect of the purchase discount is meaningful because it is a measure that we and investors use to assess our financial condition and results of operations. Although these non-GAAP financial measures are intended to enhance investors’ understanding of our business and performance, these non-GAAP financial measures should not be considered an alternative to GAAP. The aforementioned non-GAAP financial measures may not be comparable to similar non-GAAP financial measures used by other companies.

	For the Three Months Ended					For the Nine Months Ended
	September 30, 2021			September 30, 2020		September 30, 2021			September 30, 2020
	(in millions)
Net investment income after taxes	$	64.33		$	18.20	$	180.09		$	54.56
Less: Purchase discount amortization		15.49			—		34.02			—
Adjusted net investment income after taxes	$	48.84		$	18.20	$	146.07		$	54.56

Net realized and unrealized gains (losses)	$	(26.22	)	$	14.25	$	(26.32	)	$	(51.17	)
Add: Net change in unrealized appreciation due to the purchase discount		15.49			—		34.42			—
Add: Realized gain due to the purchase discount		—			—		(0.40	)		—
Adjusted net realized and unrealized gains (losses)	$	(10.73	)	$	14.25	$	7.70		$	(51.17	)

Table of Contents

Investment Income

	For the Three Months Ended				For the Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
	(in millions)
Interest	$	90.18	$	28.61	$	246.92	$	87.48
Dividend income		0.09		0.03		0.92		0.08
Payment-in-kind		5.31		1.65		12.66		4.78
Other income		1.10		1.16		2.72		1.69
Total Investment Income	$	96.68	$	31.45	$	263.22	$	94.03

In the table above:

•

Interest income from investments increased from $28.61 million for the three months ended September 30, 2020 to $90.18 million for the three months ended September 30, 2021. The increase is primarily driven from the interest-bearing investments acquired from the Merger and the amortization of the purchase discount from the Merger. Included in interest income for the three months ended September 30, 2021 and 2020 is $0.84 million and $0.46 million in prepayment premiums and $25.33 million and $0.17 million in accelerated accretion of upfront loan origination fees and unamortized discounts.

•

Interest income from investments increased from $87.48 million for the nine months ended September 30, 2020 to $246.92 million for the nine months ended September 30, 2021. The increase is primarily driven from the interest-bearing investments acquired from the Merger and the amortization of the purchase discount from the Merger. Included in interest income for the nine months ended September 30, 2021 and 2020 is $1.51 million and $0.56 million in prepayment premiums and 43.54 million and $0.78 million in accelerated accretion of upfront loan origination fees and unamortized discounts.

•

PIK income from investments increased from $1.65 million and $4.78 million for the three and nine months ended September 30, 2020 to $5.31 million and $12.66 million for the three and nine months ended September 30, 2021. The increase was due to the increase in the number of investments earning PIK income.

Expenses

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
	(in millions)
Interest and other debt expenses	$	14.45		$	8.89		$	43.95		$	26.90
Incentive fees		9.33			0.73			32.55			0.73
Management fees		7.96			3.62			24.24			10.90
Professional fees		0.73			0.55			2.26			1.89
Directors’ fees		0.23			0.14			0.70			0.42
Other general and administrative expenses		0.79			0.68			2.69			1.98
Total Expenses	$	33.49		$	14.61		$	106.39		$	42.82
Fee waivers		(1.44	)		(1.73	)		(24.19	)		(4.54	)
Net Expenses	$	32.05		$	12.88		$	82.20		$	38.28

In the table above:

•

Interest and other debt expenses increased from $8.89 million and $26.90 million for the three and nine months ended September 30, 2020 to $14.45 million and $43.95 million for the three and nine months ended September 30, 2021. The increase is primarily driven by the issuance of the 2026 Notes.

•

Net Management fees increased from $2.62 million and $7.09 million for the three and nine months ended September 30, 2020 to $7.96 million and $23.74 million for the three and nine months ended September 30, 2021. The increase was primarily as a result of an increase in our gross assets from the Merger.

•

Our Investment Adviser contractually waived Incentive fees by $4.54 million for the nine months ended September 30, 2021 and voluntarily waived Incentive fees by $1.44 million and $19.15 million for the three and nine months ended September 30, 2021 in connection with the Merger. For additional information see Note 3 “Significant Agreements and Related Party Transactions” in our consolidated financial statements included in this report. Incentive fees for the three and nine months ended September 30, 2020 were impacted by our Investment Adviser waiving Incentive fees permanently in connection with the Merger and net realized losses on certain portfolio companies.

Table of Contents

Net Realized Gains (Losses) and Net Change in Unrealized Appreciation (Depreciation) on Investments

The realized gains and losses on fully exited and partially exited portfolio companies consisted of the following:

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
	(in millions)
Animal Supply Holdings, LLC	$	—		$	(35.98	)	$	—		$	(35.98	)
MPI Products LLC		—			—			—			(5.58	)
Bolttech Mannings, Inc.		—			—			—			(4.70	)
SMS Systems Maintenance Services, Inc.		—			—			—			(0.90	)
MPI Engineered Technologies, LLC		—			—			(0.01	)		(0.28	)
Conergy Asia & ME Pte. LTD.		—			—			—			(0.21	)
Wrike, Inc.		—			—			7.54			—
CB-HDT Holdings, Inc. (dba Hunter Defense Technologies)		35.92			—			35.92			—
Other, net		(1.61	)		—			(2.91	)		0.14
Net realized gain (loss)	$	34.31		$	(35.98	)	$	40.54		$	(47.51	)

For the nine months ended September 30, 2021, net realized gains were primarily driven by our investments in two portfolio companies. In August 2021, we fully exited our preferred and common stock investments in CB-HDT Holdings, Inc. (dba Hunter Defense Technologies), which resulted in a realized gain of $35.92 million. In February 2021, we fully exited our common stock investment in Wrike, Inc., which resulted in a realized gain of $7.54 million.

For the nine months ended September 30, 2020, net realized losses were primarily driven by our investments in three portfolio companies. In August 2020, our first lien debt investment, preferred and common equity in Animal Supply Holdings, LLC was exchanged for second lien debt, common equity and a right to purchase additional first lien debt, second lien debt and common equity, which resulted in a realized loss of $35.98 million. In March 2020, there was a restructure of our second lien debt investment in MPI Products LLC (“MPI”), which resulted in a realized loss of $5.58 million. The private equity sponsor that purchased MPI provided it with new capital and we received newly issued second lien debt and non-interest bearing second lien debt. Also in March 2020, our second lien debt investment in Bolttech Mannings, Inc. was exchanged for common equity, which resulted in a realized loss of $4.70 million.

Any changes in fair value are recorded as a change in unrealized appreciation (depreciation) on investments. For further details on the valuation process, refer to Note 2 “Significant Accounting Policies—Investments” in our consolidated financial statements. Net change in unrealized appreciation (depreciation) on investments were as follows:

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
	($ in millions)
Unrealized appreciation	$	12.85		$	60.50		$	32.08		$	49.70
Unrealized depreciation		(74.91	)		(8.56	)		(103.46	)		(51.66	)
Net Change in Unrealized Appreciation (Depreciation) on Investments	$	(62.06	)	$	51.94		$	(71.38	)	$	(1.96	)

Table of Contents

The change in unrealized appreciation (depreciation) on investments consisted of the following:

	For the Three Months Ended September 30, 2021			For the Nine Months Ended September 30, 2021
Portfolio Company:	($ in millions)
Convene 237 Park Avenue, LLC (dba Convene)	$	2.31		$	(3.98	)
Picture Head Midco LLC		0.94			1.00
iCIMS, Inc.		0.90			0.69
ATX Networks Corp.		0.89			0.89
Chronicle Bidco Inc. (dba Lexitas)		0.66			0.98
Odyssey Logistics & Technology Corporation		0.58			3.50
PT Intermediate Holdings III, LLC (dba Parts Town)		0.39			1.67
Jill Acquisition LLC (dba J. Jill)		0.29			1.51
HS4 AcquisitionCo, Inc. (dba HotSchedules & Fourth)		0.10			1.25
GK Holdings, Inc. (dba Global Knowledge)		—			1.58
Wrike, Inc.		—			(8.91	)
Animal Supply Holdings, LLC		(2.12	)		(9.41	)
Gastro Health Holdco, LLC		(2.53	)		(1.60	)
SMB Shipping Logistics, LLC (dba Worldwide Express)		(2.78	)		0.25
Integral Ad Science, Inc.		(3.00	)		(2.09	)
Chase Industries, Inc. (dba Senneca Holdings)		(5.65	)		(5.84	)
Other, net⁽¹⁾		(17.88	)		(16.71	)
CB-HDT Holdings, Inc. (dba Hunter Defense Technologies)		(35.16	)		(36.16	)
Total	$	(62.06	)	$	(71.38	)

⁽¹⁾	For the three and nine months ended September 30, 2021, other, net includes gross unrealized appreciation of $5.79 million and $18.76 million, respectively, and gross unrealized depreciation of $(23.67) million and $(35.47) million, respectively.

Net change in unrealized appreciation (depreciation) in our investments for the three months ended September 30, 2021 was driven by the reversal of unrealized appreciation in connection with the aforementioned sale of CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) and the financial underperformance of Chase Industries, Inc. (dba Senneca Holdings).

Net change in unrealized appreciation (depreciation) in our investments for the nine months ended September 30, 2021 was primarily driven by the reversal of unrealized appreciation in connection with the aforementioned sales of CB-HDT Holdings, Inc. (dba Hunter Defense Technologies) and Wrike, Inc., and the financial underperformance of Chase Industries, Inc. (dba Senneca Holdings) and Animal Supply Holdings, LLC.

	For the Three Months Ended September 30, 2020			For the Nine Months Ended September 30, 2020
Portfolio Company:	($ in millions)
Animal Supply Holdings, LLC	$	31.72		$	7.39
Other, net⁽¹⁾		16.34			(21.98	)
CB-HDT Holdings, Inc. (dba Hunter Defense Technologies)		4.47			16.54
Zep Inc.		3.11			6.65
CST Buyer Company (dba Intoxalock)		1.56			(0.03	)
Badger Sportswear, Inc.		1.07			(1.44	)
Wrike, Inc.		0.75			3.07
Odyssey Logistics & Technology Corporation		0.55			(2.56	)
Convene 237 Park Avenue, LLC (dba Convene)		0.01			(3.57	)
MPI Products LLC		—			6.39
IHS Intermediate Inc. (dba Interactive Health Solutions)		—			(2.50	)
CorePower Yoga LLC		(0.48	)		(1.41	)
Ansira Partners, Inc.		(0.60	)		(0.70	)
Bolttech Mannings, Inc.		(0.81	)		(1.10	)
GK Holdings, Inc. (dba Global Knowledge)		(2.23	)		(3.19	)
ASC Acquisition Holdings, LLC		(3.52	)		(3.52	)
Total	$	51.94		$	(1.96	)

⁽¹⁾	For the three and nine months ended September 30, 2020, other, net includes gross unrealized appreciation of $17.26 million and $9.66 million, respectively, and gross unrealized depreciation of $(0.92) million and $(31.64) million, respectively.

Net change in unrealized appreciation (depreciation) in our investments for the three and nine months ended September 30, 2020 was impacted by the COVID-19 pandemic. In addition, the net change in unrealized appreciation (depreciation) was driven by the reversal of unrealized depreciation in connection with the aforementioned exchange with Animal Supply Holdings, LLC, the financial improvement of CB-HDT Holdings, Inc. and Zep Inc, and the reversal of unrealized depreciation in connection with the aforementioned sale of MPI.

Table of Contents

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

The primary use of existing funds and any funds raised in the future is expected to be for our investments in portfolio companies, cash distributions to our stockholders or for other general corporate purposes, including paying for operating expenses or debt service to the extent we borrow or issue senior securities.

We expect to generate cash primarily from the net proceeds of any future offerings of securities, future borrowings and cash flows from operations. To the extent we determine that additional capital would allow us to take advantage of additional investment opportunities, if the market for debt financing presents attractively priced debt financing opportunities, or if our Board of Directors otherwise determines that leveraging our portfolio would be in our best interest and the best interests of our stockholders, we may enter into credit facilities in addition to our existing credit facilities as discussed below, or issue other senior securities. We would expect any such credit facilities may be secured by certain of our assets and may contain advance rates based upon pledged collateral. The pricing and other terms of any such facilities would depend upon market conditions when we enter into any such facilities as well as the performance of our business, among other factors. As a BDC, with certain limited exceptions, we are only permitted to borrow amounts such that our asset coverage ratio, as defined in the Investment Company Act, is at least 150% after such borrowing (if certain requirements are met). See “—Key Components of Operations—Leverage.” As of September 30, 2021 and December 31, 2020, our asset coverage ratio based on the aggregate amount outstanding of our senior securities was 199% and 198%. We may also refinance or repay any of our indebtedness at any time based on our financial condition and market conditions.

We may enter into investment commitments through signed commitment letters which may ultimately become investment transactions in the future. We regularly evaluate and carefully consider our unfunded commitments using GSAM’s proprietary risk management framework for the purpose of planning our capital resources and ongoing liquidity, including our financial leverage.

Equity Issuances

There were no sales of our common stock during the three and nine months ended September 30, 2021 and 2020.

Common Stock Repurchase Plans

In February 2019, our Board of Directors approved a 10b5-1 plan (the “former 10b5-1 plan”), which provided for us to repurchase of up to $25.00 million of shares of our common stock if the stock traded below the most recently announced NAV per share, subject to limitations. The former 10b5-1 plan took effect on March 18, 2019, was temporarily suspended on December 9, 2019 and expired on March 18, 2020. We did not repurchase any of our common stock pursuant to the former 10b5-1 plan or otherwise.

In November 2020, our Board of Directors authorized the adoption of a new common stock repurchase plan (the “10b5-1 Plan”), which provides for us to repurchase up to $75.00 million of shares of our common stock if the stock trades below the most recently announced quarter-end NAV per share, subject to limitations. The 10b5-1 Plan was adopted and took effect on November 9, 2020. The 10b5-1 Plan will expire on November 9, 2021. We did not repurchase any of our common stock pursuant to the plan or otherwise.

For further details, see Note 3 “Significant Agreements and Related Party Transactions” to our consolidated financial statements included in this report.

Dividend Reinvestment Plan

We have a dividend reinvestment plan that provides for reinvestment of all cash distributions declared by our Board of Directors unless a stockholder elects to “opt out” of the plan. As a result, if our Board of Directors declares a cash distribution, then the stockholders who have not “opted out” of the dividend reinvestment plan will have their cash distributions automatically reinvested in additional shares of common stock, rather than receiving the cash distribution. Due to regulatory considerations, Group Inc. has opted out of the dividend reinvestment plan, and GS & Co. has opted out of the dividend reinvestment plan in respect of any shares of our common stock acquired through the GS 10b5-1 Plan. For further details, see Note 9 “Net Assets” to our consolidated financial statements included in this report.

Contractual Obligations

We have entered into certain contracts under which we have future commitments. Payments under the Investment Management Agreement, pursuant to which GSAM has agreed to serve as our Investment Adviser, are equal to (1) a percentage of value of our average gross assets and (2) a two-part Incentive Fee. Under the Administration Agreement, pursuant to which State Street Bank and Trust Company has agreed to furnish us with the administrative services necessary to conduct our day-to-day operations, we pay our administrator such fees as may be agreed between us and our administrator that we determine are commercially reasonable in our sole discretion. Either party or the stockholders, by a vote of a majority of our outstanding voting securities, may terminate the Investment Management Agreement without penalty on at least 60 days’ written notice to the other party. Either party may terminate the Administration Agreement without penalty upon at least 30 days’ written notice to the other party. The following table shows our contractual obligations as of September 30, 2021:

Table of Contents

	Payments Due by Period (in millions)
	Total		Less Than 1 Year		1 – 3 Years		3 – 5 Years		More Than 5 Years
Convertible Notes	$	155.00	$	155.00	$	—	$	—	$	—
2025 Notes	$	360.00	$	—	$	—	$	360.00	$	—
2026 Notes	$	500.00	$	—	$	—	$	500.00	$	—
Revolving Credit Facility⁽¹⁾	$	624.86	$	—	$	—	$	624.86	$	—

⁽¹⁾

We may borrow amounts in USD or certain other permitted currencies. Debt outstanding denominated in currencies other than USD has been converted to USD using the applicable foreign currency exchange rate as of the applicable reporting date. As of September 30, 2021, we had outstanding borrowings denominated in USD of $581.07 million, in Euros (EUR) of 37.70 million, and Canadian Dollar (CAD) of 0.15 million.

Revolving Credit Facility

On September 19, 2013, we entered into a Revolving Credit Facility with various lenders. Truist Bank serves as administrative agent and Bank of America N.A. serves as syndication agent under the Revolving Credit Facility. We amended and restated the Revolving Credit Facility on October 3, 2014, November 3, 2015, December 16, 2016, February 21, 2018, September 17, 2018, February 25, 2020, November 20, 2020 and August 13, 2021.

The aggregate committed borrowing amount under the Revolving Credit Facility is $1,695.00 million. The Revolving Credit Facility includes an uncommitted accordion feature that allows us, under certain circumstances, to increase the borrowing capacity of the Revolving Credit Facility to up to $2,250.00 million.

Borrowings denominated in USD, including amounts drawn in respect of letters of credit, bear interest (at our election) of either (i) LIBOR plus a margin of either (x) 2.00%, (y) 1.875% (subject to maintenance of certain long-term corporate debt ratings) or (z) 1.75% (subject to certain borrowing base conditions) or (ii) an alternative base rate, which is the highest of 0%, the Prime Rate, the Federal Funds Effective Rate plus 0.50% and overnight LIBOR plus 1.00%, plus a margin of either (x) 1.00%, (y) 0.875% (subject to maintenance of certain long-term corporate debt ratings) or (z) 0.75% (subject to certain borrowing base conditions). Borrowings denominated in non-USD bear interest of LIBOR plus a margin of either 2.00%, 1.875% or 1.75% (subject to the conditions applicable to borrowings denominated in USD that bear interest based on LIBOR) plus, in the case of borrowings denominated in GBP only, an additional 0.1193% credit adjustment spread. With respect to borrowings denominated in USD, we may elect either LIBOR, or an alternative base rate at the time of borrowing, and such borrowings may be converted from one benchmark to another at any time, subject to certain conditions. Interest is payable quarterly in arrears. We pay a fee of 0.375% per annum on committed but undrawn amounts under the Revolving Credit Facility, payable quarterly in arrears. Any amounts borrowed under the Revolving Credit Facility will mature, and all accrued and unpaid interest will be due and payable, on August 13, 2026.

For further details, see Note 6 “Debt – Revolving Credit Facility” to our consolidated financial statements included in this report.

Convertible Notes

On October 3, 2016, we closed an offering of $115.00 million aggregate principal amount of unsecured Convertible Notes, which included $15.00 million aggregate principal amount issued pursuant to the initial purchasers’ exercise in full of an over-allotment option (the “Initial Convertible Notes”). On July 2, 2018, we closed an offering of $40.00 million aggregate additional principal amount (the “Additional Convertible Notes” and, together with the Initial Convertible Notes, the “Convertible Notes”). The Additional Convertible Notes have identical terms, are fungible and are part of the Initial Convertible Notes.

The Convertible Notes bear interest at a rate of 4.50% per year, payable semi-annually in arrears on April 1 and October 1 of each year, commencing on April 1, 2017. The Convertible Notes will mature on April 1, 2022, unless repurchased or converted in accordance with their terms prior to such date. We will not have the right to redeem the Convertible Notes prior to maturity.

For further details, see Note 6 “Debt – Convertible Notes” to our consolidated financial statements included in this report.

2025 Notes

On February 10, 2020, we closed an offering of $360.00 million aggregate principal amount of unsecured notes. The 2025 Notes were issued pursuant to an indenture between us and Wells Fargo Bank, as Trustee. Wells Fargo Bank and/or its affiliates provide bank lending and distribution services to certain Goldman Sachs funds. The 2025 Notes bear interest at a rate of 3.75% per year, payable semi-annually in arrears on February 10 and August 10 of each year, commencing on August 10, 2020. The 2025 Notes will mature on February 10, 2025 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the indenture. For further details, see Note 6 “Debt – 2025 Notes” to our consolidated financial statements included in this report.

2026 Notes

On November 24, 2020, we closed an offering of $500.00 million aggregate principal amount of unsecured notes. The 2026 Notes were issued pursuant to an indenture between us and Wells Fargo Bank, as Trustee. Wells Fargo Bank and/or its affiliates provide bank lending

Table of Contents

and distribution services to certain Goldman Sachs funds. The 2026 Notes bear interest at a rate of 2.875% per year, payable semi-annually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2026 Notes will mature on January 15, 2026 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the indenture. For further details, see Note 6 “Debt – 2026 Notes” to our consolidated financial statements included in this report.

Off-Balance Sheet Arrangements

We may become a party to investment commitments and to financial instruments with off-balance sheet risk in the normal course of our business to fund investments and to meet the financial needs of our portfolio companies. These instruments may include commitments to extend credit and involve, to varying degrees, elements of liquidity and credit risk in excess of the amount recognized in the balance sheet. As of September 30, 2021, we believed that we had adequate financial resources to satisfy our unfunded commitments. Our unfunded commitments to provide funds to portfolio companies were as follows:

	As of
	September 30, 2021		December 31, 2020
	(in millions)
Unfunded Commitments
First Lien/Senior Secured Debt	$	401.78	$	242.91
Total	$	401.78	$	242.91

HEDGING

Subject to applicable provisions of the Investment Company Act and applicable Commodity Futures Trading Commission (“CFTC”) regulations, we may enter into hedging transactions in a manner consistent with SEC guidance. To the extent that any of our loans are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of futures, options, swaps and forward contracts. Costs incurred in entering into such contracts or in settling them, if any, will be borne by us. Our Investment Adviser has claimed no-action relief from CFTC registration and regulation as a commodity pool operator pursuant to a CFTC Rule 4.5 with respect to our operations, with the result that we will be limited in our ability to use futures contracts or options on futures contracts or engage in swap transactions. Specifically, CFTC Rule 4.5 imposes strict limitations on using such derivatives other than for hedging purposes, whereby the use of derivatives not used solely for hedging purposes is generally limited to situations where (i) the aggregate initial margin and premiums required to establish such positions does not exceed five percent of the liquidation value of our portfolio, after taking into account unrealized profits and unrealized losses on any such contracts it has entered into; or (ii) the aggregate net notional value of such derivatives does not exceed 100% of the liquidation value of our portfolio. Moreover, we anticipate entering into transactions involving such derivatives to a very limited extent solely for hedging purposes or otherwise within the limitations of CFTC Rule 4.5.

RECENT DEVELOPMENTS

On October 22, 2021, our Board of Directors approved Carmine Rossetti as our Chief Financial Officer, Treasurer and principal financial officer effective November 8, 2021. Joseph DiMaria has served as our Interim Chief Financial Officer and Interim Treasurer while we were seeking a permanent replacement, and Mr. DiMaria will resign from those roles on the effective date of Mr. Rossetti’s appointment. Mr. DiMaria’s expected resignation is not the result of any disagreement with us.

On November 4, 2021, our Board of Directors declared a quarterly distribution of $0.45 per share payable on January 27, 2022 to holders of record as of December 31, 2021.

CRITICAL ACCOUNTING POLICIES

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially.

For a description of our critical accounting policies, see Note 2 “Significant Accounting Policies” to our consolidated financial statements included in this report. We consider the most significant accounting policies to be those related to our Valuation of Portfolio Investments, Revenue Recognition, Non-Accrual Investments, Distribution Policy, and Income Taxes.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are subject to financial market risks, most significantly changes in interest rates. Interest rate sensitivity refers to the change in our earnings that may result from changes in the level of interest rates. Because we expect to fund a portion of our investments with borrowings, our net investment income is expected to be affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

As of September 30, 2021 and December 31, 2020, on a fair value basis, approximately 0.7% and 0.9% of our performing debt investments bore interest at a fixed rate (including income producing preferred stock investments), and approximately 99.3% and 99.1% of our performing debt investments bore interest at a floating rate. Our borrowings under our Revolving Credit Facility bear interest at a floating rate and our Convertible Notes, 2025 Notes and 2026 Notes bear interest at a fixed rate.

We regularly measure our exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate sensitive assets to our interest rate sensitive liabilities.

Based on our September 30, 2021 balance sheet, the following table shows the annual impact on net income of base rate changes in interest rates (considering interest rate floors for variable rate instruments) assuming no changes in our investment and borrowing structure:

As of September 30, 2021 Basis Point Change	Interest Income			Interest Expense			Net Income
(in millions)
Up 300 basis points	$	54.56		$	(17.39	)	$	37.17
Up 200 basis points		28.94			(11.59	)		17.35
Up 100 basis points		3.74			(5.80	)		(2.06	)
Up 75 basis points		0.59			(4.35	)		(3.76	)
Up 50 basis points		0.30			(2.90	)		(2.60	)
Up 25 basis points		0.15			(1.45	)		(1.30	)
Down 25 basis points		(0.06	)		0.47			0.41
Down 50 basis points		(0.06	)		0.47			0.41
Down 75 basis points		(0.06	)		0.47			0.41
Down 100 basis points		(0.06	)		0.47			0.41
Down 200 basis points		(0.06	)		0.47			0.41
Down 300 basis points		(0.06	)		0.47			0.41

We may, in the future, hedge against interest rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the Investment Company Act, applicable CFTC regulations and in a manner consistent with SEC guidance. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates with respect to our portfolio of investments with fixed interest rates.

Table of Contents

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures. As of the end of the period covered by this report, our management carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Interim Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our Chief Executive Officer and Interim Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2021. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter ended September 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under loans to or other contracts with our portfolio companies. We are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us.

Item 1A. Risk Factors.

An investment in our securities involves a high degree of risk. Except as set forth below, there have been no material changes to the risk factors previously reported under Item 1A. “Risk Factors” of our annual report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on February 25, 2021. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially affect our business, financial condition and/or operating results.

Market Developments and General Business Environment

Political, social and economic uncertainty, including uncertainty related to the COVID-19 pandemic, creates and exacerbates risks.

Social, political, economic and other conditions and events will occur that create uncertainty and have significant impacts on issuers, industries, governments and other systems, including the financial markets, to which the Company and its investments are exposed. In addition, global economies and financial markets are increasingly interconnected, and political, economic and other conditions and events in one country, region, or financial market may adversely impact issuers in a different country, region or financial market. Furthermore, the occurrence of, among other events, natural or man-made disasters, severe weather or geological events, fires, floods, earthquakes, outbreaks of disease (such as COVID-19, avian influenza or H1N1/09), epidemics, pandemics, malicious acts, cyber-attacks, terrorist acts or the occurrence of climate change, also adversely impact our performance from time to time. Such events may result in, and have resulted in, closing borders, securities exchange closures, health screenings, healthcare service delays, quarantines, cancellations, supply chain disruptions, lower consumer demand, market volatility and general uncertainty. Such events have adversely impacted, and may continue to adversely impact our portfolio companies and markets and economies over the short- and long-term, including in ways that cannot necessarily be foreseen. We have been, and may continue to be negatively impacted if the value of our portfolio company holdings were harmed by such political or economic conditions or events. Moreover, such negative political and economic conditions and events have disrupted, and could continue to disrupt the processes necessary for our operations. This has created, and may continue to create widespread business continuity issues for us and our portfolio companies and heightened cybersecurity, information security and operational risks as a result of, among other things, remote work arrangements.

For example, in December 2019, COVID-19 emerged in China and has since spread rapidly to other countries, including the United States. This outbreak has led, and for an unknown period of time will continue to lead, to disruptions in local, regional, national and global markets and economies affected thereby. The global impact of the outbreak is rapidly evolving, and many countries have reacted by instituting quarantines, prohibitions on travel and the closure of offices, businesses, schools, retail stores and other public venues. While several countries, as well as certain states in the United States, have liberalized public health restrictions as to further reopen their economies, recurring COVID-19 outbreaks have led to the re-introduction of such restrictions in certain states in the United States and globally and could continue to lead to the re-introduction of such restrictions elsewhere. Comprehensive vaccination programs have led to the lifting of health and safety restrictions in some countries, such as the U.S. and China. However, other countries have encountered more challenging circumstances as a result of slower distribution of vaccines and the spread of new variants, most notably the Delta variant. Even after the COVID-19 pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and we anticipate our business and operations could be materially adversely affected by a prolonged recession in the U.S. and other major markets. The potential exists for the Delta variant or other variants of COVID-19 to impede the global economic recovery and may exacerbate geographic differences in the spread of, and response to, COVID-19. With respect to the U.S. credit markets (in particular for middle market

Table of Contents

loans), this outbreak has resulted in, and until fully resolved is likely to continue to result in, the following, among other things: (i) government imposition and/or re-imposition of various forms of shelter-in-place orders and the closing of "non-essential" businesses, resulting in significant disruption to the businesses of many middle-market loan borrowers including supply chains, demand and practical aspects of their operations, as well as furloughs or lay-offs of employees (while such measures are hoped to be temporary, their impact may persist or become permanent); (ii) increased draws by borrowers on revolving lines of credit; (iii) increased requests by borrowers for amendments, forbearance agreements and waivers of provisions of their credit agreements in order to avoid default, increased defaults by such borrowers and/or increased difficulty in obtaining refinancing at the maturity dates of their loans; (iv) volatility and disruption of these markets including greater volatility in pricing and spreads and difficulty in valuing loans during periods of increased volatility, and liquidity issues; and (v) rapidly evolving proposals and/or actions by state and federal governments to address problems in functioning of the markets and by businesses and the economy in general which will not necessarily adequately address the problems facing the loan market and middle market businesses. The COVID-19 outbreak is having, and any future outbreaks could have, an adverse impact on the markets and the economy in general, which could have a material adverse impact on, among other things, the ability of lenders to originate loans, the volume and type of loans originated, and the volume and type of amendments and waivers granted to borrowers and remedial actions taken in the event of a borrower default, each of which could negatively impact the amount and quality of loans available for investment by us and returns to us, among other things. As of the date of this quarterly report on Form 10-Q, it is impossible to determine the scope of this outbreak, or any future outbreaks, how long any such outbreak, market disruption or uncertainties may last, the effect any governmental actions will have or the full potential impact on us and our portfolio companies. Further, even after the pandemic subsides, the U.S. economy, as well as most other major global economies may continue to experience a recession, and we anticipate our business could be materially and adversely affected by a prolonged recession in the U.S. and other major markets.

Although it is impossible to predict the precise nature and consequences of these events, or of any political or policy decisions and regulatory changes occasioned by emerging events or uncertainty on applicable laws or regulations that impact us, our portfolio companies and our investments, it is clear that these types of events are impacting and will, for at least some time, continue to impact us and our portfolio companies. In many instances, the impact will be adverse and profound. For example, middle market companies in which we may invest are being significantly impacted by these emerging events and the uncertainty caused by these events. The effects of a public health emergency may materially and adversely impact (i) the value and performance of us and our portfolio companies, (ii) the ability of our borrowers to continue to meet loan covenants or repay loans provided by us on a timely basis or at all, which may require us to restructure our investments or write down the value of our investments, (iii) our ability to comply with the covenants and other terms of our debt obligations and to repay such obligations, on a timely basis or at all, (iv) our ability to comply with certain regulatory requirements, such as asset coverage requirements under the Investment Company Act, (v) our ability to maintain our distributions at their current level or to pay them at all or (vi) our ability to source, manage and divest investments and achieve our investment objectives, all of which could result in significant losses to us. We will also be negatively affected if the operations and effectiveness of any of our portfolio companies (or any of the key personnel or service providers of the foregoing) is compromised or if necessary or beneficial systems and processes are disrupted.

Disruptions in the capital markets caused by the COVID-19 pandemic have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets. These and future market disruptions and/or illiquidity can be expected to have an adverse effect on our business, financial condition, results of operations and cash flows. Unfavorable economic conditions also would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events have limited and could continue to limit our investment originations, limit our ability to grow and have a material negative impact on our and our portfolio companies’ operating results and the fair values of our debt and equity investments.

Risks Relating to Our Business and Structure

We are exposed to risks associated with changes in interest rates.

Our debt investments may be based on floating rates, such as LIBOR, the Euro Interbank Offered Rate, the Federal Funds Rate or the Prime Rate. General interest rate fluctuations may have a substantial negative impact on our investments, the value of our securities and our rate of return on invested capital. Currently, most of our floating rate investments are linked to LIBOR and it is unclear how increased regulatory oversight and the future of LIBOR may affect market liquidity and the value of the financial obligations to be held by or issued to us that are linked to LIBOR, or how such changes could affect our investments and transactions and financial condition or results of operations. Central banks and regulators in a number of major jurisdictions (for example, the United States, United Kingdom, European Union, Switzerland and Japan) have convened working groups to find, and implement the transition to suitable replacements for interbank offered rates (“IBORs”). On March 5 2021, the Financial Conduct Authority (“FCA”) and ICE Benchmark Authority formally announced the dates after which the LIBORs will no longer be representative and subsequently cease publication. The Alternative Reference Rates Committee confirmed that this announcement constitutes a “Benchmark Transition Event”. The publication of all EUR and CHF LIBOR settings, the Spot Next/Overnight, 1 week, 2 month and 12 month JPY and GBP LIBOR settings, and the 1 week and 2 months US dollar LIBOR settings will cease after December 31, 2021. The publication of the overnight, 1 month, 3 month, 6 month, and 12 months USD LIBOR settings will cease after June 30, 2023. The FCA plans to consult the market on creating “synthetic” 1 month, 3 month and 6 month rates for GBP and JPY LIBOR, to be published for a limited time. New York State legislation was signed into law to aid “tough legacy” LIBOR contracts. Other legislative solutions are being pursued at the Federal level, in the U.K., and in Europe. The U.S. federal banking agencies have also issued guidance encouraging banking and global organizations to cease reference to USD LIBOR as soon as practicable and in any event by December 31, 2021. The E.U. Benchmarks Regulation imposed conditions under which only compliant benchmarks may be used in new contracts after

Table of Contents

2021. To identify a successor rate for U.S. dollar LIBOR, the Alternative Reference Rates Committee (“ARRC”), a U.S.-based group convened by the Federal Reserve Board and the Federal Reserve Bank of New York, was formed. The ARRC has identified the Secured Overnight Financing Rate (“SOFR”) as its preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by the U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. However, the outbreak of COVID-19 may adversely impact the timing of many firms’ transition planning, and we continue to assess the potential impact of the COVID-19 outbreak on our transition plans. Although SOFR appears to be the preferred replacement rate for U.S. dollar LIBOR, at this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates, whether the COVID-19 outbreak will have further effect on LIBOR transition timelines or plans, or other reforms to LIBOR that may be enacted in the United States, United Kingdom or elsewhere. The elimination of LIBOR or any other changes or reforms to the determination or supervision of LIBOR or alternative reference rates could have an adverse impact on the market for or value of any LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by or due to us. In addition, if LIBOR ceases to exist, we may need to renegotiate the credit agreements extending beyond 2021 with our portfolio companies that utilize one-week and two-month USD LIBOR terms or sterling, euro, Swiss franc and Japanese yen settings as a factor in determining the interest rate, in order to replace LIBOR with the new standard that is established, which may have an adverse effect on our overall financial condition or results of operations. As such, some or all of these credit agreements may bear a lower interest rate, which would adversely impact our financial condition or results of operations. Moreover, if LIBOR ceases to exist, we may need to renegotiate certain terms of our Revolving Credit Facility. If we are unable to do so, amounts drawn under the Revolving Credit Facility may bear interest at a higher rate, which would increase the cost of our borrowings and, in turn, affect our results of operations.

Because we have borrowed money, and may issue preferred stock to finance investments, our net investment income depends, in part, upon the difference between the rate at which we borrow funds or pay distributions on preferred stock and the rate that our investments yield. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

A reduction in the interest rates on new investments relative to interest rates on current investments could also have an adverse impact on our net interest income. However, an increase in interest rates could decrease the value of any investments we hold which earn fixed interest rates, including subordinated loans, senior and junior secured and unsecured debt securities and loans and high yield bonds, and also could increase our interest expense, thereby decreasing our net income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our dividend rate, which could reduce the value of our common stock.

In periods of rising interest rates, to the extent we borrow money subject to a floating interest rate, our cost of funds would increase, which could reduce our net investment income. Further, rising interest rates could also adversely affect our performance if such increases cause our borrowing costs to rise at a rate in excess of the rate that our investments yield. Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum interest rates (such as a LIBOR floor), while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may increase our interest expense, even though our interest income from investments is not increasing in a corresponding manner as a result of such minimum interest rates.

If general interest rates rise, there is a risk that the portfolio companies in which we hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with us. Rising interest rates could also cause portfolio companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on us to provide fixed rate loans to our portfolio companies, which could adversely affect our net investment income, as increases in our cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments.

A change in the general level of interest rates can be expected to lead to a change in the interest rate we receive on many of our debt investments. Accordingly, a change in the interest rate could make it easier for us to meet or exceed the performance threshold in the Investment Management Agreement and may result in a substantial increase in the amount of incentive fees payable to our Investment Adviser with respect to the portion of the Incentive Fee based on income.

Interest rates in the United States are currently at historically low levels. Certain countries have experienced negative interest rates on certain fixed-income instruments. Very low or negative interest rates may magnify interest rate risk. Changing interest rates, including rates that fall below zero, may have unpredictable effects on markets, may result in heightened market volatility and may detract from our performance to the extent we are exposed to such interest rates and/or volatility.

Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

Not applicable.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

The exhibits filed as part of this quarterly report on Form 10-Q are set forth on the Index to Exhibits, which is incorporated herein by reference.

Exhibit No		Description of Exhibits

3.1	Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (file no. 814-00998), filed on October 13, 2020).

3.2	Bylaws (incorporated by reference to Exhibit (b) to pre-effective Amendment No. 7 to the Company’s Registration Statement on Form N-2 (file no. 333-187642), filed on March 3, 2015).

10.1	Eighth Amendment to Senior Secured Revolving Credit Agreement, dated as of August 13, 2021, among the Company, as Borrower, the lenders party thereto, Truist Bank, as Administrative Agent and as Collateral Agent and other parties party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (file no.814-00998), filed on August 19, 2021).

31.1*	Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*	Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

*Filed herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


			GOLDMAN SACHS BDC, INC.

Date: November 4, 2021			/s/ Brendan McGovern
			Brendan McGovern Chief Executive Officer and President (Principal Executive Officer)

Date: November 4, 2021			/s/ Joseph DiMaria
			Joseph DiMaria Interim Chief Financial Officer and Interim Treasurer (Principal Financial Officer)